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 One of the most troubling aspects of addiction is the chronic and cyclical nature 
of this disorder. In particular, the desire to use drugs and subsequent relapse can occur 
after months or even years of absence. Amongst human drug abusers, exposure to 
stressful life events and style of stress-coping have been shown to predict relapse. 
Similarly, in rodents stress can induce the reinstatement of drug seeking, a model of 
stress-induced relapse. In the following series of experiments the neuronal mechanisms 
mediating acute 21-48h food deprivation (FD)-induced reinstatement of heroin seeking 
are investigated. Previously, our laboratory has demonstrated that this form of 
reinstatement can be attenuated by systemic injection of the dopamine (DA) D1 receptor 
antagonist SCH 23390. Thus, in chapter 1, the neuronal circuitry mediating the role of 
DA, acting at the D1 receptor, in acute FD-induced reinstatement was examined. The five 
experiments described in the chapter reveal a significant attenuation of heroin seeking in 
rats infused with SCH 23390 into the nucleus accumbens (NAc) shell, dorsal medial 
prefrontal cortex (dmPFC) or basolateral amygdala (BLA). However, acute FD-induced 
reinstatement was not affected by infusions of SCH 23390 into the NAc core, or ventral 
medial prefrontal cortex (vmPFC).  
 Compulsive drug seeking and the propensity to relapse have been attributed to 
pathological synaptic plasticity, resulting from drug-induced changes in glutamate 
synapses. Thus, in chapters 2 and 3 the role of glutamate in acute FD-induced 
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reinstatement was inspected. In chapter 2, neuroadaptations in the glutamatergic 
projection from the ventral subiculum (vSub) of the hippocampus to the NAc shell were 
investigated. The vSub to NAc shell pathway is an important excitatory input, providing 
spatial and affective information that is modulated by DA release within the NAc. Here, 
acute 48h FD was shown to block the induction of long-term potentiation (LTP) in both 
heroin-trained and heroin-naïve rats. In chapter 3, changes in the expression of α-amino-
3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and N-methyl-D-aspartate 
(NMDA) glutamate receptor subunits were investigated in rats trained to self-administer 
heroin and subsequently tested for acute FD-induced reinstatement of drug seeking. The 
results of this study revealed a tendency toward a reduction in GluA2 and NR1 
expression in the dmPFC and NAc, respectively, of heroin-trained food deprived rats, 
compared to heroin-trained sated rats, as well as a significant increase in GluA2 
expression in the VTA of heroin-trained-sated rats compared to drug-naïve sated rats. 
Finally, FD increased GluA2 expression, in the BLA, in drug-naïve but not heroin-trained 
rats. Together, these findings demonstrate an important role for both DA and glutamate in 
acute FD-induced reinstatement. The current results support existing models that suggest 
a critical role for DA and glutamate transmission, and the interaction between the two 
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Figure 1.                      45 
Anatomical position of microinjector tips targeting the NAc.  Top: closed circles indicate 
NAc shell placements (n = 30) and open squares indicate the NAc core (n = 30) 
placements. Images correspond to Figures 12-21 (2.76-1.44 mm from bregma) from the 
atlas of Paxinos & Watson (2005).  Figures are arranged from top to bottom with Figure 
12 being the bottom left and Figure 21 being the top right. Bottom: sample 
photomicrographs from the NAc shell (left) and core (right) placement. 
Figure 2.                   47 
Heroin self-administration for rats with guide cannulae located in the NAc. Data shown 
are the mean (+/- SEM) numbers of active lever presses, inactive lever presses and heroin 
infusions (0.1 mg/kg/infusion) for the 60 rats with confirmed placement in the NAc for 
the ten training days (T1-10; days 1-5: three 3h sessions, FR-1; days 6-10: one 3h 
session, FR-1) and the first extinction day (Ext 1). A significant difference existed 
between active and inactive lever responding on all training days and during extinction (p 
< .05).   
Figure 3.                   50 
The effect of intra-NAc SCH 23390 infusion on acute FD-induced reinstatement of 
heroin seeking. Data are mean (+SEM) number of active (left) and inactive (right) lever 
responses made during baseline (BL), following 48h unlimited access to food (Sated) and 
following 48h FD for rats with placements into the NAc shell (A) or NAc core (B). 
Different groups of rats were used for each dose of SCH 23390 (Shell: Veh (0.0 µg), n = 
 x 
7; Low (0.3 µg), n = 14; High (0.6 µg), n = 9; Core: Veh, n = 9; Low, n = 8; High, n = 
13). * p < .01 when compared to BL and sated conditions, @ p < .05 when compared to 
the vehicle group, under FD, + p < .05 when compared to the sated condition. 
Figure 4.                52 
Number of photocell breaks for rats with confirmed placements in the NAc shell during 
reinstatement. Data shown are mean (+SEM) number of photocell breaks on baseline 
(BL), sated and food deprived (FD) days for rats in the vehicle (n = 5), low (n = 10) and 
high (n = 5) SCH 23390 dose groups. * Indicates a significant difference relative to low 
antagonist dose (p < .05). 
Figure 5.                54 
Anatomical position of microinjector tips for rats with guide cannulae targeting the BLA. 
Top: confirmed BLA placements (n = 24) are indicated by closed circles; anatomical 
control placements (n = 8) are indicated by squares. Images correspond to Figures 52-56  
(-2.28 to -2.76 mm from bregma) from the atlas of Paxinos & Watson (2005).  Figures 
are arranged from top to bottom with Figure 52 being the bottom left and Figure 56 being 
the top right. Bottom: photomicrographs for the BLA (left) and control rats (right).  
Figure 6.                55 
Heroin self-administration for rats with guide cannulae located in the BLA. Data shown 
are the mean (+/- SEM) numbers of active lever presses, inactive lever presses and heroin 
infusions (0.1 mg/kg/infusion) for the 24 rats with confirmed placement in the BLA for 
the ten training days (T1-10; days 1-5: three 3h sessions, FR-1; days 6-10: three 3h 
sessions, FR-3) and the first extinction day (Ext 1). A significant difference existed 
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between active and inactive lever responding on all training days and during extinction (p 
< .05).  
Figure 7.                   57 
The effect of intra- BLA SCH 23390 infusion on acute FD-induced reinstatement of 
heroin seeking. Data are mean (+SEM) number of active (left) and inactive (right) lever 
responses made during baseline (BL), following 21h FD or sated condition for rats with 
confirmed placements in the BLA (A) and anatomical control rats (B). Different groups 
of rats were used for each dose of SCH 23390 (BLA: Veh (0.0 µg), n = 10; Low (1.0 µg), 
n = 7; High (2.0 µg), n = 7; Control: Veh, n = 1; Low µg, n = 2; High, n = 6). * p < .05 
compared to BL and sated conditions, @ p < .05 compared to Veh group under FD 
conditions, + p < .05 relative to the BL and FD conditions. 
Figure 8.                 59 
Number of photocell breaks for rats with confirmed placements in the BLA during the 
reinstatement test. Data shown are the mean (+ SEM) number of photocell breaks on 
baseline (BL), sated and food deprived (FD) days for rats in the vehicle (n = 6), low (n = 
6) and high (n = 5) SCH 23390 dose groups.  
Figure 9.                 61 
Anatomical position of microinjector tips targeting the mPFC. Top: approximate 
anatomical position of microinjector tips for rats with guide cannulae targeting the 
dmPFC (n = 31; closed circles) and the vmPFC (n = 14; open squares). Images 
correspond to Figures 9-13 (3.72 -2.52 mm from bregma) from the atlas of Paxinos & 
Watson (2005).  Figures are arranged from lowest to highest from top left to bottom right. 
Bottom: sample photomicrographs of a dmPFC (right) and vmPFC (left) placements. 
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Figure 10.                  63 
Heroin self-administration for rats with guide cannulae located in the mPFC. Data shown 
are the mean (+/- SEM) numbers of active lever presses, inactive lever presses and heroin 
infusions (0.1 mg/kg/infusion) for the 45 rats with confirmed placement in the mPFC for 
the ten training days (T1-10; days 1-5: three 3h sessions, FR-1; days 6-10: three 3h 
sessions, FR-3) and the first extinction day (Ext 1). A significant difference existed 
between active and inactive lever responding on all training days and during extinction (p 
< .05).   
Figure 11.                   65 
The effect of intra-PFC SCH 23390 infusion on acute FD-induced reinstatement of heroin 
seeking. Data are mean (+SEM) number of active (left) and inactive (right) lever 
responses made during baseline (BL), following a 21h sated period, and following 21h of 
FD for rats with placements in the dmPFC (A) or vmPFC (B). Different groups of rats 
were used for each dose of SCH 23390 (dmPFC: Veh (0.0 µg), n = 11; Low (0.2 µg), n = 
9; High (2.0 µg), n = 11; vmPFC: Veh (0.0 µg), n = 8; High (2.0 µg), n = 6). * p < .05 
when compared to BL and sated conditions, @ p < .01 compared to the Veh and Low 
antagonist groups on the FD test day, + p < .05 relative to responding in the vehicle group 
under sated and FD conditions.  
Figure 12.                 67 
Number of photocell breaks for rats with confirmed placements in the dmPFC during 
reinstatement tests. Data shown are the mean (+ SEM) number of photocell breaks on 
baseline (BL), sated and food deprived (FD) days for rats in the vehicle (n = 5), low (n = 
10) and high (n = 5) SCH 23390 dose groups.  
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Chapter 2 
Figure 1.                  98 
Mean (+/- SEM), number of active lever presses, inactive lever presses and infusions (0.1 
mg/kg/infusion) for the 11 rats trained to self-administer heroin. Rats were trained to self-
administer heroin over a minimum of 10 training days (T1-10; three-3h session per day) 
and the first extinction day (Ext 1). A significant difference existed between active and 
inactive lever responding on all training days and during the first day of extinction (p < 
.05).  
Figure 2.                100 
The effect of an acute 48h FD on heroin seeking in abstinent animals. Data are mean (+/-
SEM) number of active (A) and inactive lever (B) responses made during the baseline 
(BL) extinction session and following 48h unlimited access to food (Sated, n = 5) or food 
deprived (FD, n = 6). * p < .05 relative to the baseline condition. @ p < .05 compared to 
the BL and compared to sated rats on the test day. 
Figure 3.                103 
Input/Output tests recording across experimental days for heroin-trained (A) and drug-
naïve rats (B) animals, that were tested under sated or food deprived (FD) conditions. All 
data points are standardized to the 1000 uA response on the second day of baseline 
recording.  
Figure 4.               104 
% fEPSP amplitude relative to baseline. Data are mean (+SEM) % fEPSP amplitude 
standardized to the mean of the baseline period. Data are shown in 2.5 min segments 
consisting of the average of 5 recording points over the course of a 10 min baseline and 
 xiv 
48 min of recording after the stimulus train delivery. BL1-4 correspond to the 4 baseline 
records and P1-19 correspond to the 19 recording periods following delivery of the 
tetanic train. 
Figure 5.              105 
Mean (+SEM) % fEPSP amplitude expressed as the percent change from baseline for the 
average of the last 10 min of recording. Bars correspond to the mean (+SEM) for sated 
rats (heroin-trained and naïve sated; white) and food deprived (heroin-trained and naïve 
food deprived, FD; black) rats. * significantly greater than baseline, p < .05. Additionally, 
a sample traces from the baseline (left trace) and final 10 min of recording (right trace) 
are shown for a sample FD rat (dashed line) and a sample sated (solid line) rat. Traces 
were created using a mean of 5 traces from each time period. Calibration: Vertical scale 
bar = 0.2 mV, horizontal scale bar = 10 ms. 
Figure 6.               106 
Scatterplot and trend line demonstrating the relationship between LTP magnitude (the 
average of the last 10 min of recording during the LTP test) and drug seeking behavior 
(Active lever responding on the test day – Active lever responding on the baseline day 
prior to the food deprivation or sated test). Rats that were food deprived on the test day 
are indicated by diamonds, and sated rats are indicated by circles. A significant 
correlation is present, r (9) = -.72, p = .01.  
Chapter 3 
Figure 1.               135 
Western Immunoblot Punches. Displayed above are the starting point and location of the 
dmPFC (top left), NAc (top left), BLA (top right) and VTA (bottom center) punches. For 
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each region, with the exception of the dmPFC, two 500 µm thick, 0.83 mm in 
circumference bilateral punches were taken. For the dmPFC an additional set of punches 
were taken. Circles correspond to the appropriate region and size of the punch.  
Figure 2.              140 
Mean (+/- SEM), number of active lever presses, inactive lever presses, and heroin 
infusions. Rats were trained to self-administer heroin (0.1 mg/kg/infusion) over a 10-day 
training period (days 1-5: three 3h sessions, FR-1; days 6-10: three 3h sessions, FR-3). 
Also shown is the number of active and inactive lever responses for the first day of 
extinction. A significant difference existed between active and inactive lever responding 
on all training days and during extinction (p < .05).   
Figure 3.               141 
The effect of acute food deprivation (FD) on the reinstatement of heroin seeking 
behavior. Data are mean (+SEM) number of active (left) and inactive (right) lever 
responses made during baseline (BL) and following 21h FD or unlimited access to food 
(Sated) for rats trained to self-administer heroin for 10 days and subsequently given 
extinction training. * p < .05 when compared to baseline; @ p < .05 when compared to 
FD condition. 
Figure 4.              143 
Mean (+SEM) GluA1 (A), GluA2 (B), and NR1 (C) GluR subunit expression in the 
dmPFC for rats trained to self-administer heroin (0.1 mg/kg for a minimum of 10 days; 3-
3h sessions per day) or drug naïve rats. Heroin-trained rats received extinction training 
and were tested for a reinstatement of drug seeking (2h test) under sated or 21h food 
deprivation (FD) conditions. Drug-naïve rats were sated or food deprived for 23h before 
 xvi 
their brains were collected. GluR subunit expression is presented as percent change from 
the drug-naïve-sated group.  + p = .08 relative to heroin-trained sated rats. Blots to the 
right show a sample band for Naïve-Sated, Naïve-FD, Heroin-Sated and Heroin-FD, in 
that order. 
Figure 5.                146 
Mean (+SEM) GluA1 (A), GluA2 (B), and NR1 (C) GluR subunit expression in the NAc 
for rats trained to self-administer heroin (0.1 mg/kg for 10 days) or drug naïve colony 
rats. Heroin-trained rats received extinction training and were tested for a reinstatement 
of drug seeking under sated or 21h food deprivation (FD) conditions. Drug-naïve rats 
were sated or food deprived for 23h before their brains were collected. GluR subunit 
expression is presented as percent change from the drug-naïve-sated group.  + p = .08 
relative to heroin-trained sated rats. Blots to the right show a sample band for Naïve-
Sated, Naïve-FD, Heroin-Sated and Heroin-FD, in that order. 
Figure 6.                150 
Mean (+SEM) GluA1 (A), GluA2 (B), and NR1 (C) GluR subunit expression in the VTA 
for rats trained to self-administer heroin (0.1 mg/kg for 10 days) or drug naïve colony 
rats. Heroin-trained rats received extinction training and were tested for a reinstatement 
of drug seeking under sated or 21h food deprivation (FD) conditions. Drug-naïve rats 
were sated or food deprived for 23h before their brains were collected. GluR subunit 
expression is presented as percent change from the drug-naïve-sated group.  * p < .05 
relative to drug-naïve sated rats. Blots to the right show a sample band for Naïve-Sated, 
Naïve-FD, Heroin-Sated and Heroin-FD, in that order. 
 xvii 
Figure 7.               153 
Mean (+SEM) GluA2 (A) and NR1 (B) GluR subunit expression in the VTA for rats 
trained to self-administer heroin (0.1 mg/kg for 10 days) or drug naïve colony rats. 
Heroin-trained rats received extinction training and were tested for a reinstatement of 
drug seeking under sated or 21h food deprivation (FD) conditions. Drug-naïve rats were 
sated or food deprived for 23h before their brains were collected. GluR subunit 
expression is presented as percent change from the drug-naïve-sated group.  * p < .05 
relative to drug-naïve sated rats. Blots to the right show a sample band for Naïve-Sated, 
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One out of every 6 Canadians reports having used an illicit drug other than 
Cannabis at some point in life (Health Canada, 2005). However, the vast majority of 
these individuals do not develop drug dependency. It is currently estimated that 200,000 
Canadians (roughly 0.08% of the population) are addicted to an illicit drug, or drugs 
(Ronald, Connoly, & Bédard, 2004). Drug addiction or substance dependence disorder, as 
it is referred to clinically, is defined as a cluster of symptoms including a preoccupation 
with the abused drug, tolerance to the effects of the drug, persistent failed efforts to 
control drug use, withdrawal symptoms during periods of drug abstinence, unintentional 
drug overuse and continued drug use despite major drug related problems (Diagnostic 
Statistical Manual (DSM)-IV-TR; American Psychiatric Association, 2000). Implied in 
this definition is a difficulty in ceasing drug use and a high likelihood of relapse during 
periods of drug abstinence. Sadly, even in long-time abstinent addicts there is a high 
probability of relapse. Relapse to drug use can come months or even years after drug use 
has ceased, at a time when the individual is no longer suffering from physical symptoms 
associated with drug withdrawal (Jaffe, 1990; O'Brien, & McLellan, 1996). 
 Understanding the compulsion to seek drugs during periods of abstinence is of the 
utmost importance in treating addiction and curtailing the negative consequences of this 
disorder to society and the individual. Within Canada illicit drug use results in 
approximately 1,695 deaths per year. Moreover, illness associated with illicit drug use is 
associated with 352,121 days of hospitalization, per year, as well as $1,134.6 million in 
health care costs. Illicit drug use is also associated with $2,335.5 million in law 
enforcement costs, and $4,678.6 million in costs associated with lost productivity due to 
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illness and premature death (Rehm et al., 2006). As mentioned above, a hallmark of 
addiction is persistent drug use despite negative consequences. Thus, for addicted 
individuals the personal costs of drug use can be immense. In addition to health risks, 
potential incarceration, and loss of employment many addicts also lose significant 
relationships with family and friends and migrate to the periphery of society  (Parliament 
of Canada, 2001).  
Amongst human drug abusers stress appears to be a central factor in the initiation, 
maintenance and relapse to drug seeking during periods of abstinence. Individuals 
exposed to high levels of stress such as those having experienced sexual and physical 
abuse begin illicit drug and alcohol use at an earlier age and have an increased risk for 
dependency (Dembo, Dertke, Borders, Washburn, & Schmeidler, 1988; Widom, Weiler, 
& Cottler, 1999). Moreover, maladaptive stress coping is predictive of an escalation of 
drug use, in current drug users, and stress-induced craving in abstinent users (Grüsser, 
Mörsen, Wölfling, & Flor, 2007; Hser, 2007; Wills, McNamara, Vaccaro, & Hirky, 
1996). Since it is highly unlikely that recovering addicts will be able to avoid exposure to 
stressful live events, elucidating the brain mechanisms that underlie stress-induced 
relapse is essential for the development of effective treatments for addiction.  
Numerous experimental methodologies have been designed to study relapse in 
human drug abusers. These studies have contributed greatly to our knowledge of 
addiction; however, studies of this nature can also be limited by ethical and 
methodological constraints surrounding the study of human drug users. These constraints, 
as well as ease of pharmacological manipulation, have lead to the popularization of 
animal models of relapse, most notably the reinstatement procedure (de Wit & Stewart, 
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1981; Epstein, Preston, Stewart, & Shaham, 2006; Shaham, Shalev, Lu, de Wit, & 
Stewart, 2003). Using this procedure in rodents, various stressors, including acute 21-48h 
food deprivation (FD) (Shalev, Highfield, Yap, & Shaham, 2000; Tobin, Newman, 
Quinn, & Shalev, 2009), have been shown to reinstate extinguished drug-seeking 
behavior. In this thesis, the mechanisms underlying acute FD-induced reinstatement are 
investigated in rats with a history of heroin self-administration. The experiments 
described below were designed to address some of the existing knowledge gaps regarding 
the mechanisms involved in stress-induced reinstatement. 
Studying Relapse in Humans  
Estimates of drug relapse vary greatly depending upon the definition of relapse, 
the time elapsed since treatment or detoxification, and the drug of abuse. For heroin 
abusers, relapse rates tend to be high. In one study of 242 clients seeking treatment for 
heroin abuse in one of 23 residential treatment programs, it was found that 60% (145 
people) of the sample relapsed before a follow-up interview conducted 94 days (SD = 
107) after leaving treatment. Of those relapsing, defined as using the drug at least once, 
34% of the original 242 relapsed within 3 days and 50% relapsed within 14 days of the 
cessation of treatment (Gossop, Stewart, Browne, & Marsden, 2002). Further research 
has suggested that approximately 25% of heroin users remain abstinent 5 years after 
treatment (Hunt & Bespalec, 1974). 
Given the high likelihood of relapse, the empirical study of this phenomenon is of 
the utmost importance. Conventional studies of relapse have involved interviewing 
recovering addicts after lapses. Studies of this type are limited in that they are 
retrospective; thus, individuals may not remember or be aware of the cause of their lapse 
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at the time of the interview (McKay, Franklin, Patapis, & Lynch, 2006). Despite these 
limitations, it has been revealed that drug lapses are often preceded by re-exposure to the 
previously abused or similar drugs, exposure to cues associated with drug use such as 
drug associated peers, places and paraphernalia, and stressful life events capable of 
producing a negative mood (Childress et al., 1994; Sinha, 2001). For example, alcohol 
and illicit drug abusers often cite negative affect and stress as reasons for relapse 
(Bradley, Phillips, Green, & Gossop, 1989; Litman, Eiser, Rawson, & Oppenheim, 1977; 
McKay, Rutherford, Alterman, & Cacciola, 1996; Wallace, 1989). 
In order to avoid the confounds associated with retrospective self-report, Epstein 
and colleagues (2009) provided cocaine- and heroin-abusing outpatients with personal 
digital assistants to gain ecological momentary assessment data. The results of this study 
showed that cocaine craving was associated with exposure to drug cues and good mood; 
whereas, heroin craving was associated with negative affect such as feelings of sadness or 
anger. Within a controlled laboratory setting, person-specific stress-related scripts and 
exposure to drug-associated cues have been shown to increase drug craving and measures 
of salivary cortisol (Sinha, 2009). Furthermore, stress-related imagery has been used to 
induce drug craving in cocaine-dependent subjects within the confines of a magnetic 
resonance imaging scanner, revealing reduced activity in areas associated with control, 
and regulation of emotion and distress states, compared to healthy controls. In contrast, 
cocaine-dependent subjects exhibited stronger brain activation in areas associated with 




Studying Relapse in Animal models: The Reinstatement Procedure  
The value of studies of addiction in humans cannot be underestimated. However, 
there are numerous ethical considerations associated with exposing abstinent drug 
abusers to states likely to provoke relapse or drug naïve persons to illicit potentially 
dependency producing drugs. Furthermore, animal models of drug reinforcement and 
relapse offer distinctive advantages such as experimental control, ease of 
pharmacological manipulation, the ability to manipulate genetic factors, and the ability to 
investigate cellular processes. Thus, a combination of animal and human studies is 
needed to gain a broader understanding of drug relapse.  
Several models of relapse exist for rodents. These models typically focus on the 
recommencement or reinstatement of an operant behavior previously associated with 
drug self-administration (i.e., the reinstatement procedure; de Wit & Stewart, 1981) or the 
reinstatement of a preference for a place paired with the effects of a drug (the 
reinstatement of a conditioned place preference (CPP; Mueller & Stewart, 2000). In brief, 
the reinstatement of CPP involves training a rat to associate the contextual cues of a 
particular environment with a drug’s reinforcing effects to establish a preference for this 
environment over a distinctively different environment that was never paired with the 
drug. Consequently, this preference is extinguished by repeated exposure to the apparatus 
in the absence of the drug. Following extinction, triggers thought to be associated with 
drug relapse can be used to elicit a reinstatement of the preference for the previously 
drug-paired environment (Cruz, Leão, Marin, & Planeta, 2010; Lu et al., 2005). Whereas 
the CPP procedure requires “passive” exposure to drug through experimenter-initiated 
administration, the reinstatement of a behavior associated with self-administration 
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involves training an animal to perform an operant task such as lever pressing (de Wit & 
Stewart, 1981) or runway traversing (Ettenberg, 2009) to receive a drug reinforcer. Once 
this task is preformed to a criterion level the drug is removed and behavioral extinction of 
the operant task is learned to criterion.  
The popularity of the reinstatement model lies, in part, in its intuitive appeal. A 
reinstatement of drug seeking behavior or a drug CPP, under abstinent conditions, can be 
triggered by a re-exposure to the previously administered or related drugs (drug priming), 
cues associated with previous drug administration, and stress which are similar to factors 
which have been shown to precipitate relapse in humans (Epstein et al., 2006). With the 
exception of priming-induced reinstatement, which involves a single drug administration, 
animals are not re-exposed to the previously self-administered drug prior to reinstatement 
testing. Thus, both versions of the reinstatement model allow for the investigation of 
neuronal and environmental mechanisms associated with drug craving in the absence of 
the pharmacological effects of the drug.  
The majority of the results obtained from the reinstatement of CPP and the 
reinstatement of operant drug seeking behavior are in agreement. For instance, stress has 
been shown to reinstate operant responding associated with cocaine, amphetamine, 
morphine, and heroin self-administration (Buczek, Lê, Wang, Stewart, & Shaham, 1999; 
de Wit & Stewart, 1981; LeSage, Burroughs, Dufek, Keyler, & PenteL, 2004; Shaham et 
al., 1997) as well as the reinstatement of a preference for a place previously associated 
with morphine, cocaine, or nicotine administration (Der-Avakian et al., 2005; Leão, Cruz, 
& Planeta, 2009; Sanchez, Bailie, Wu, Li, & Sorg, 2003; Will, Watkins, & Maier, 1998). 
Despite the similarities between these models it has been suggested that both models 
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evaluate different aspects of reward and as a result different aspects of relapse. In the 
operant reinstatement model the performance of a behavior is maintained by the self-
administration of the drug. Thus, operant behavior is the result of the primary rewarding 
properties of drugs; whereas, CPP results from the incentive value of cues which have 
come to be associated with the passive (experimenter) administration of drug (see 
Aguilar, Rodríguez-Arias, & Miñarro, 2009). Human drug abusers are rarely exposed to 
drug passively; thus, the reinstatement of an operant behavior previously associated with 
drug self-administration may be more representative of the experience of relapse than the 
reinstatement of a CPP.   
Stress and Drug Seeking  
Most, if not all, models of addiction postulate that stress plays a significant role in 
the onset and maintenance of drug use (Brewer, Catalano, Haggerty, Gainey, & Fleming, 
1998; Matheny & Weatherman, 1998; Sinha, 2001). For instance, the stress coping model 
of addiction suggests that drug use during times of stress leads to the removal of an 
aversive state which enhances mood and serves to reinforce drug use (Khantzian, 1985; 
Sinha, 2001). Empirical studies of the initiation of drug use suggest a strong link between 
stressful childhood experiences such as abuse, neglect, and trauma and the use of illicit 
drugs. In one study of 8613 clients of a primary health care facility in California, a direct 
relationship between the number of aversive/stressful childhood events and dependency 
was found. In this study, individuals reporting 5 or more aversive childhood experiences 
were 7-10 times more likely to report addiction to, or problems with, illicit drugs (Dube 
et al., 2003). Moreover, amongst recovering drug addicts, particularly those with poor 
coping skills, stress is a commonly cited reason for relapse. In particular stress coping 
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styles such as positive thinking, negative thinking, and avoidance have been liked with 
relapse (Litman, Stapleton, Oppenheim, Peleg, & Jackson, 1984; Miller, Westerberg, 
Harris, & Tonigan, 1996).  
Unfortunately, it is not possible to expose rodents to the types of stressors 
generally experienced by human drug abusers. Thus, it is important to have a clear 
understanding of what stress is and how it can be applied in an animal model. A single all 
encompassing definition of stress is somewhat difficult to arrive at. However, a useful 
working definition of stress is the process involved in sensing and responding to physical 
or psychological events or stimuli which are perceived as threatening, harmful, or 
challenging (Lazarus & Folkman, 1984). In animal models of stress these events are 
typically pharmacological in nature or involve forced exposure to stimuli that in other 
circumstances would be avoided (Piazza & Le Moal, 1998). For instance, stressors such 
as tail pinch, electrical footshock, food restriction, and exposure to a dominant male have 
been shown to speed the acquisition of self-administration for a variety of drugs (Carroll, 
1985; Haney, Maccari, Le Moal, Simon, & Piazza, 1995). Once self-administration 
behavior has been acquired, stress has been shown to lead to an increase in the rate of 
responding for drug (Carroll, 1985; Kanarek & Marks-Kaufman, 1988; Miczek & 
Mutschler, 1996) and an increase in progressive ratio breakpoint, a measure of the 
motivation to take the drug (Shaham & Stewart, 1994).  
The Neuronal Correlates of Stress and Drug Seeking 
  While discussing the role of stress in the initiation, maintenance, and 
reinstatement of drug seeking it is important to briefly touch upon the physiological 
response to stress. In brief, exposure to a stressor causes an activation of the 
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hypothalamic-pituitary-adrenal axis (HPA) (Dunn & Berridge, 1990; Rivier & Plotsky, 
1986) which leads to cascade of events beginning with the release of corticotropin 
releasing factor (CRF) from the hypothalamus. CRF release triggers the secretion of 
adrenocorticotropic hormone (ACTH), a pituitary hormone capable of eliciting the 
production and release of corticosterone (cortisol in humans) from the adrenal cortex. 
The release of corticosterone into the bloodstream mobilizes a quick response, generally 
referred to as the ‘fight or flight response,’ in a threatening situation (Kosten & 
Ambrosio, 2002). In addition to HPA axis activation, stress also activates extra-
hypothalamic CRF pathways, which innervate limbic and forebrain regions such as the 
hippocampus, amygdala, bed nucleus of the stria terminalis (BNST), ventral subiculum 
(vSub), ventral tegmental area (VTA), nucleus accumbens (NAc), and prefrontal cortex 
(PFC) (Kosten & Ambrosio, 2002; Sinha, 2001).  
Evidence for HPA axis disregulation has been observed in both human and 
rodents exposed to drugs of abuse. Amongst individuals dependent upon opiates a 
reduction in ACTH and cortisol has been observed during drug taking (Facchinetti et al., 
1985; Ho et al., 1977). In contrast, an increase in CRF, ACTH, cortisol, norepinephrine, 
and epinephrine is observed during withdrawal (Adinoff et al., 1991; Ehrenreich et al., 
1997; Koob, 1997; Kreek & Koob, 1998; Mello & Mendelson, 1997; Vescovi, Coiro, 
Volpi, & Passeri, 1992) as well as a hyper-responsive HPA axis response during periods 
of abstinence (Culpepper-Morgan & Kreek, 1997; Schluger et al., 1998). Similarly, in 
rodents the acute delivery of morphine produces an activation of the HPA axis; however, 
with chronic drug administration the activation of the HPA axis is suppressed (Kreek & 
Koob, 1998).  
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There is ample evidence linking HPA activation to drug-associated behaviors. For 
example, inhibition of corticosterone synthesis by metyrapone or ardenalectomy has been 
shown to block the locomotor response to cocaine or morphine (Marinelli et al., 1994) 
and the stress-induced sensitization to the locomotor activating effects of amphetamine 
and morphine (Deroche et al., 1992a; Deroche, Piazza, Le Moal, & Simon, 1993; 
Marinelli, Le Moal, & Piazza, 1996). Similarly, repeated corticosterone administration 
sensitizes the locomotor response to amphetamine (Deroche, Piazza, Maccari, Le Moal, 
& Simon, 1992b). Finally, social isolation, thought to represent psychological stress, has 
been shown to facilitate the locomotor activating effect of morphine in intact but not 
adrenalectomized rats maintained at a stable level of plasma corticosterone (Deroche, 
Piazza, Le Moal, & Simon, 1994). These findings are of interest because individual 
differences in vulnerability to self-administer drug can be correlated with locomotor 
response to stress or acute drug injection (Deminiere, Piazza, Le Moal, & Simon, 1989; 
Piazza et al., 1991). Furthermore, in rodents not predisposed to self-administer 
amphetamine, corticosterone treatment was shown to increase the rewarding aspects of 
amphetamine and foster the development of self-administration (Piazza et al., 1991). 
The Neuronal Circuitry Involved in Stress-Induced Reinstatement of Drug Seeking 
Of the utmost importance for the current studies, is the finding that exposure to 
stress can lead to a reinstatement of previously extinguished drug reinforced behavior. 
Using the reinstatement model, a return to drug seeking has been shown following 
footshock (Shaham & Stewart, 1995) and acute 21-48h FD (Shalev et al., 2000; Tobin et 
al., 2009) stress. Moreover, administration of pharmacological stressors such as CRF 
(Erb, Petrovic, Yi, & Kayyali, 2006; Erb, Shaham, & Stewart, 1998; Shaham et al., 
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1997), or yohimbine, an α2 noradrenergic receptor agonist (Feltenstein & See, 2006; 
Shepard, Bossert, Liu, & Shaham, 2004), have also been shown to reinstate drug-seeking 
behavior. Similarly, using the CPP procedure it was shown that footshock-stress and 
forced swim-stress reinstate extinguished morphine and cocaine CPP (Lu, Ceng, & 
Huang, 2000; Redila & Chavkin, 2008.   
In contrast to a stress-induced increase in drug intake, CRF and not corticosterone 
appears to play a critical role in stress-induced reinstatement of extinguished drug 
seeking (Shalev, Erb, & Shaham, 2010). For instance intracerbroventricular (icv) infusion 
of α-helical CRF, a nonselective CRF receptor antagonist, has been shown to attenuate 
footshock-induced reinstatement (Shaham et al., 1997), acute FD-induced reinstatement 
(Shalev, Finnie, Quinn, Tobin, & Wahi, 2006), and footshock-induced renewal of a 
morphine CPP (Lu et al., 2005). Furthermore, stress-induced corticosterone release, from 
the adrenal cortex, is not necessary for footshock- (Erb et al., 1998; Shaham et al., 1997) 
or acute FD-induced reinstatement (Shalev et al., 2006), suggesting that it is the actions 
of extra-hypothalamic CRF that are important for stress-induced reinstatement. More 
specifically, CRF receptors in the BNST (Erb & Stewart, 1999), VTA, and median raphe 
nucleus are thought to be central in stress-induced reinstatement (see Shalev et al., 2010 
for a review of this literature). 
Additionally, it is worth noting that acute-FD-induced stress is dissociable from 
other forms of stress in that it combines both a pure stress effect and a disregulation of 
the homeostatic circuitry involved in the control of energy balance. For instance, leptin, 
an anorexigenic hormone secreted by peripheral adipose tissue in correlation with the 
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amount of stored fat, has been shown to block acute FD-induced reinstatement, but has 
no effect on footshock-induced reinstatement (Shalev, Yap, & Shaham, 2001).  
The Role of Dopamine (DA) in Drug Reinforcement  
 Clearly, the study of the “classical” stress-related pathways in the brain is central 
to understanding the role of stress in drug relapse. However, studies performed over the 
last decade have suggested a critical role for the neuronal circuitry implicated in reward 
and motivation in stress-induced reinstatement of drug seeking. The rewarding property 
of abused drugs depends, almost exclusively, on the ability of these drugs to elicit an 
enhanced DAergic response in the NAc (Di Chiara, Bassareo, Fenu, & De Luca, 2004). 
DA terminals in this region originate from DA cellbodies in the VTA which also project 
to the mPFC, amygdala, hippocampus, and ventral pallidum (VP) (Pierce & Kumaresan, 
2006). Activation of this pathway, known as the mesocorticolimbic DA pathway is 
critically involved in the detection and prediction of reward (Schultz, 2001; Schultz, 
Dayan, & Montague, 1997), as well as the motivation to gain reinforcement (Berridge, 
1996; Robinson & Berridge, 2003). Recently, however, this view of the 
mesocorticolimbic DA pathway as a singular contributor to reward and motivation 
function has been challenged. The nigrostriatal DA pathway, which originates in the 
substantia nigra (SN) that is anatomically adjacent to the VTA and is typically discussed 
in the context of motor function, was suggested to be importantly involved in reward and 
addiction (Wise, 2009).  
Psychostimulant drugs such as amphetamine or cocaine act directly on the 
mesocorticolimbic, and possibly nigrostriatal, pathway through their actions as indirect 
agonists at DA receptors. Amphetamine acts to increase the release of DA while cocaine 
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inhibits the actions of the DA transporter (DAT) allowing DA to stay in the synapse 
longer (Koob, 1992). Opiate drugs such as heroin act on DA neurons in a more indirect 
manner. These drugs increase DA release by acting on γ-Aminobutyric acid (GABA) 
terminals, which in turn exert an inhibitory effect on VTA and possibly SN DA neurons 
(Johnson & North, 1992; Wise, 2009). Removal of this inhibitory tone, by activation of 
opiate receptors located on inhibitory interneurons, increases NAc DA release. Finally, 
drug-induced NAc DA release, particularly in the NAc shell, may depend on response 
contingency. For instance, NAc shell DA release is potentiated in animals trained to self-
administer drug, compared to drug naïve animals and animals given non-contingent 
yoked drug administration, demonstrating a further distinction between the self-
administration and CPP models of reinstatement (Lecca, Cacciapaglia, Valentini, Acquas, 
& Chiara, 2007a; Lecca, Valentini, Cacciapaglia, Acquas, & Di Chiara, 2007b).  
Once released, the actions of DA in the brain are mediated by two distinct 
families of guanine nucleotide-binding proteins (G-protein) coupled receptors: The DA 
D1-like family of receptors and the DA D2-like family of receptors. The DA D1-like 
family of receptors includes the DA D1 and DA D5 receptors both of which are positively 
coupled to adenylate cyclase through an excitatory G-protein. Whereas, the D2-like 
family of receptors includes the DA D2, D3 and D4 receptor subtypes and are negatively 
coupled to adenylate cyclase through an inhibitory G-protein (Sokoloff & Schwartz, 
1995). The unique role of each of these DA receptor subtypes, in drug reinforcement, can 
be assessed by pharmacological activation or blockade using agonists or antagonists, 
respectively, or through genetic manipulations producing a change in the expression of a 
particular receptor subtype. Studies of this nature have demonstrated that rodents will 
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self-administer DA D1-like agonists suggesting that activation of these receptors is 
reinforcing (Self & Stein, 1992; Self, Belluzzi, Kossuth, & Stein, 1996).  Moreover, 
systemic administration of the DA D1 or D2  receptor antagonists, SCH 23390 and 
spiperone, respectively, leads to a compensatory increase in cocaine self-administration 
suggesting that antagonism of these receptors causes a reduction in the reinforcing value 
of cocaine (Corrigall & Coen, 1991). However, when given a choice rats will prefer to 
self-administer cocaine over a DA D1 or D2 receptor agonist suggesting that these 
compounds do not fully duplicate the reinforcing effects of cocaine (Manzardo, Del Rio, 
Stein, & Belluzzi, 2001). 
Interestingly, genetic studies of DA receptor knockout mice have revealed 
significant differences between in the function of DA D1 and DA D2 receptors. For 
instance DA D2, but not DA D1, receptor knockout mice continue to show cocaine self-
administration (Caine et al., 2002; 2007) suggesting a more direct role for DA D1 
receptors in the reinforcing effects of cocaine and perhaps heroin.  
The Role of the DA in the Reinstatement of Drug Seeking 
 In addition to its role in the reinforcing effects of drugs, DA has also been shown 
to play a role in drug craving during abstinent conditions. For instance, in abstinent 
opiate-dependent individuals, drug craving, triggered by a video of heroin related cues, is 
associated with an increase in striatal DA release and a reduction in D2 receptor 
availability compared to age and gender matched participants (Zijlstra, Booij, Van den 
Brink, & Franken, 2008). The role of the DA D1 receptor in drug craving has been less 
well studied; however, a role for this receptor is indicated in a reinstatement of drug 
seeking behavior in rodents, as detailed below.  
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Activation of the DAergic system is of great importance in priming- and cue-
induced reinstatement, in rodents. For instance, the DA agonists amphetamine and 
cocaine have been shown to trigger the reinstatement of drug-seeking behavior in animals 
trained to self-administer cocaine or heroin (de Vries, Schoffelmeer, Binnekade, Mulder, 
& Vanderschuren, 1998; de Wit & Stewart, 1981). Furthermore, systemic 
pharmacological blocking of DA D1 receptors, using SCH 23390 (Shaham & Stewart, 
1996) or intra-NAc blocking of DA D1 or D2 receptors, using SCH 23390 or raclopride, 
has been shown to attenuate cocaine and heroin priming-induced reinstatement of drug 
seeking  (Anderson, Bari, & Pierce, 2003; Anderson, Schmidt, & Pierce, 2006). 
Furthermore, blockade of the DA D1 or DA D2 receptor has been shown to attenuate 
discrete cue- (Cervo, Carnovali, Stark, & Mennini, 2003; Ciccocioppo, Sanna, & Weiss, 
2001) and context-induced reinstatement (Crombag, Grimm, & Shaham, 2002). Taken 
together these studies suggest a crucial role for DA transmission through the DA D1 and 
D2 receptors, in priming- and cue-induced reinstatement. 
However, the involvement of DA in stress-induced reinstatement of drug seeking 
is less clear. Footshock-induced reinstatement of heroin seeking is attenuated by systemic 
administration of the non-selective DA antagonist flupenthixol. Yet, systemic treatment 
with the selective DA D1 antagonist, SCH 23390, or the selective D2 antagonist, 
raclopride, has no effect on footshock-induced reinstatement (Shaham & Stewart, 1996). 
In contrast, we have recently demonstrated that systemic injection of SCH 23390 causes 
an attenuation of acute FD-induced reinstatement of heroin seeking. Interestingly, the 
doses used in our study were 10 fold lower than those shown to have no effect on 
footshock-induced reinstatement (Tobin et al., 2009). 
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As mentioned above, leptin attenuates acute FD-induced reinstatement but has no 
effect on footshock-induced reinstatement. Interestingly, leptin receptors are expressed 
within the VTA and leptin-responsive VTA DA neurons project to the NAc (Fulton et al., 
2006). Furthermore, leptin administration has been shown to reverse chronic food 
restriction-induced sensitization of lateral hypothalamic brain stimulation reward (BSR) 
(Fulton, Woodside, & Shizgal, 2000). Thus, leptin appears to play a critical role in 
nutritionally based changes in motivational state (Shalev et al., 2001). However, in what 
seems to be a contradicting finding, leptin-deficient mice show a diminished locomotor 
response to amphetamine and a marked reduction in DA release from NAc shell 
terminals (Fulton et al., 2006). It is therefore unclear, at this point, whether the 
attenuation of acute FD-induced reinstatement of heroin seeking, by central leptin 
injection, was mediated by the actions of leptin on the function of DA neurons. 
The Role of Glutamate in Drug Seeking 
 As discussed above, the DAergic system is critically involved in the acutely 
rewarding effects of abused drugs as well as in drug seeking under abstinent conditions. 
However, pharmacotherapies targeting the DA system cannot completely eliminate drug 
craving and relapse (Cornish & Kalivas, 2000; O'Brien, 2005; Spanagel & Kiefer, 2008). 
Furthermore, the pervasive nature of addiction as well as the propensity to relapse long 
after drug administration has ceased (see Bossert, Ghitza, Lu, Epstein, & Shaham, 2005; 
Jaffe, 1990; O'Brien & McLellan, 1996; Wallace, 1989) suggest that these behaviors 
might be driven by drug-induced long-term adaptations in the neuronal circuitry 
underlying reward and motivation (Kalivas, 2004). Thus, a considerable effort has been 
directed at identifying neuronal circuits that undergo long-term adaptations following 
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drug exposure (Nestler, 2001).   
Glutamate has been identified as a major regulator of the synaptic plasticity 
involved in learning and memory (Abraham, 2008; Maren & Baudry, 1995). 
Consequently, it has been suggested that drug-induced pathological changes in 
glutamaterigc synapses play a critical role in the development of addiction (Kalivas, 
2004; 2009; Wolf, 2002). The vast majority of research on the neural mechanisms 
underlying drug addiction has focused on the DAergic projection from the VTA to the 
NAc. Importantly, both of these structures also receive extensive glutamatergic input 
(Cooper, Klipec, Fowler, & Ozkan, 2006a; Gass & Olive, 2008; Geisler, Derst, Veh, & 
Zahm, 2007; Goto & O'Donnell, 2001; Groenewegen, Zee, & Kortschot, 1987; 
Omelchenko & Sesack, 2007; Sesack, Carr, Omelchenko, & Pinto, 2003; Yang & 
Mogenson, 1985). Moreover, drugs of abuse as well as drug-predictive cues have been 
shown to elicit the release of both DA and glutamate in the VTA (Gass & Olive, 2008; 
Wise, Wang, & You, 2008). Furthermore, the role of glutamate in the VTA seems to be 
tied to the added value provided by drug-associated cues, rather than drug reward itself. 
Thus, cocaine methiodide, an analogue of cocaine that does not cross the blood brain 
barrier, has no effect in drug naïve animals; but, in rats previously trained to lever press 
for cocaine it can trigger VTA glutamate release sufficient to reinstate extinguished 
cocaine-seeking behavior (Wise et al., 2008).  
The actions of glutamate are mediated by two distinct classes of glutamate 
receptors (GluR): ligand gated, ionotropic receptors (iGluR), and G-protein coupled, 
metabotropic (mGluR), receptors. These classes of receptors are functionally distinct. 
The iGluRs mediate fast excitatory neurotransmission; whereas, mGluRs are involved in 
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mediating less rapid synaptic processes (Conn & Pinn, 1997; Gass & Olive, 2008; Guo, 
Wang, Xiang, & Zhao, 2009). Both iGluR and mGluRs have numerous receptor subtypes. 
There are three groups of mGluRs (Group 1-3), which include the mGluR1-mGluR8 
receptors, and three families of iGluRs: α-amino-3-hydroxy-5-methylisoxazole-4-
propionic acid (AMPA), N-methyl-D-aspartate (NMDA) and kinate receptors, all 
composed of multiple subunits (Dingledine, Borges, Bowie, & Traynelis, 1999; Gass & 
Olive, 2008). Numerous studies have investigated the role of iGluRs in drug seeking 
behavior as it pertains to the reinstatement model. For instance, intra-NAc infusion of the 
AMPA glutamate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) 
blocked the reinstatement of cocaine seeking induced by systemic cocaine injection, NAc 
DA infusion and NAc AMPA receptor agonist infusion (Cornish & Kalivas, 2000). 
Similarly, intra-NAc shell infusion of the mGluR2/3 agonist LY379268, which decreases 
glutamate release, has been shown to attenuate context-induced reinstatement of heroin 
seeking (Bossert, Gray, Lu, & Shaham, 2006a), and injections of CNQX into the NAc 
core attenuated both heroin priming- and discrete cue-induced reinstatement of heroin 
seeking (LaLumiere & Kalivas, 2008). Additionally, systemic LY379268 has also been 
shown to attenuate cue- and context-induced reinstatement of sucrose seeking (Bossert, 
Poles, Sheffler-Collins, & Ghitza, 2006b).  
Taken together, these studies indicate a critical role for glutamate transmission in 
the reinstatement of extinguished drug seeking. Moreover, long-term changes in 
glutamate synapses following drug exposure may be critically involved in the persistent 
risk for relapse observed in drug addicts. With regard to changes in glutamate synapses 
following drug exposure, the vast majority of research has focused on changes in the 
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expression of iGluR subunits (see chapter 3). For example, the incubation of drug seeking 
behavior, a time-dependent increase in drug seeking behavior, which is thought to 
represent an intensification in drug craving over time, is associated with an increase in 
GluA2-lacking AMPA receptors in the NAc (Conrad et al., 2008). Similarly, cue-induced 
reinstatement of heroin seeking has been associated with a reduction in synaptic 
membrane AMPA receptor expression in the medial PFC (mPFC), and particularly the 
internalization of the GluA2 receptor subunit (Van den Oever et al., 2008).  
Drug Exposure-Induced Changes in Synaptic Plasticity 
Changes in the expression and trafficking of glutamate receptors and subunits are 
thought to be central to the regulation of synaptic plasticity, the activity-dependent 
strengthening or weakening of the connection between neurons (Malinow & Malenka, 
2002). Long-term potentiation (LTP), which is a sustained increase in the strength of 
transmission between neurons brought about by high frequency stimulation of the 
afferent neuron, is a particularity important form of synaptic plasticity, as it is thought to 
be the cellular correlate of learning and long-term memory (Malenka, 1994; Malinow & 
Malenka, 2002). The induction of LTP depends heavily on the activation of NMDA and 
AMPA glutamate receptors. In brief, high frequency stimulation causes a sustained 
activation of AMPA receptors, which allows sodium to enter the post-synaptic cell 
causing it to depolarize. Following this depolarization the blockade of NMDA calcium 
channels by magnesium is removed and calcium enters the cell. As calcium concentration 
increases, it leads to a cascade of biochemical events, resulting in a more efficient 
synapse  (Malenka, 1994; Malenka & Nicoll, 1999).  
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I have focused on synaptic plasticity within the glutamateric projection from the 
vSub to the NAc shell following heroin self-administration and subsequent acute FD-
induced reinstatement.  There are several reasons for the interest in this pathway. Firstly, 
both the NAc and vSub have been shown to play a role in the reinforcing aspects of 
drugs. As discussed above, most, if not all, drug of abuse facilitate the release of NAc DA 
and glutamate (Di Chiara & Imperato, 1988). Furthermore, inactivation of the NAc, with 
a mixture of the GABAA and GABAB receptor agonists muscimol and baclofen, or 
targeted blockade of the DA D1 receptor within this region, attenuate reinstatement of 
drug seeking behavior (Bossert, Poles, Wihbey, Koya, & Shaham, 2007; McFarland & 
Kalivas, 2001; McFarland, Davidge, Lapish, & Kalivas, 2004). Similarly, activation or 
transient inactivation of the vSub, a major source of output from the hippocampal 
formation, has been shown to increase amphetamine-induced locomotor activity (Riegert 
et al., 2004) and attenuate cocaine-priming induced reinstatement (Cooper et al., 2006a), 
respectively. Moreover, the vSub is an important regulatory input to the NAc.  Activation 
of the vSub by electrical stimulation or inactivation of this structure with tetrodotoxin 
(TTX) has been shown to increase or block, respectively, extracellular NAc DA release. 
Conversely, DA, through activation of post-synaptic DA D1 receptors, increases the drive 
of NAc neurons by vSub input (Goto & Grace, 2005a).  
Importantly, drugs of abuse can modulate synaptic plasticity within the vSub to 
the NAc pathway.  For instance, repeated cocaine treatment, leading to behavioral 
sensitization, has been shown to disrupt the induction of LTP within the NAc following 
tetanic stimulation of the vSub (Goto & Grace, 2005b). Furthermore, stress induced by 
acute (12h) withdrawal from chronic morphine administration has been shown to blunt 
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the induction of LTP in the vSub-NAc shell pathway, an effect which is absent after 4 
days of withdrawal (Dong, Cao, & Xu, 2007). The involvement of this pathway in acute 
FD-induced reinstatement is currently unknown and the subject of further investigation in 
the current thesis. 
The Relationship between DA, Glutamate, and Stress 
Until now, I have discussed the roles of DA and glutamate in the reinstatement of 
drug seeking separately; however, the interaction between these two neurotransmitter 
systems is critical for the development of addiction. At the level of the VTA, glutamate 
acts to increase the activity of DA cellbodies, which in turn results in an increase in NAc 
DA release (Suaud-Chagny, Chergui, Chouvet, & Gonon, 1992; Westerink, Kwint, & 
deVries, 1996). Similarly, an interaction between DA and glutamate in the NAc is 
indicated by the finding that DAergic projections from the VTA and glutamatergic 
projections from the mPFC and BLA to the NAc can, in some cases, terminate on the 
same medium spiny neurons (French & Totterdell, 2002; French, Hailstone, & Totterdell, 
2003; Sesack & Pickel, 1992). Furthermore, stimulation of regions which provide 
glutamatergic input to the NAc may presynaptically modulate DA by acting upon 
glutamatergic receptors in the NAc (Blaha, Yang, Floresco, Barr, & Phillips, 1997; 
Floresco, Yang, Phillips, & Blaha, 1998). Also, DA can act to modulate NAc glutamate 
release. For instance, intra-NAc infusion of the DA agonists, amphetamine or quinpirole, 
cause a dose dependent reduction in extracellular NAc glutamate, an effect that can be 
prevented by administration of the DA D1 or D2 receptor antagonists SCH 23390 or 
sulpiride, respectively (Kalivas & Duffy, 1997).  
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The relationship between DA and glutamate can be shaped by previous drug 
exposure. For example, repeated cocaine exposure has been shown to increase the 
behavioral response to intra-NAc infusion of the glutamate receptor agonist, AMPA, but 
only in rats having developed behavioral sensitization and not in rats that received the 
same cocaine exposure but have not developed behavioral sensitization (Pierce, Bell, 
Duffy, & Kalivas, 1996). On a related note, footshock stress, a common trigger for stress-
induced reinstatement, has been shown to facilitate the release of CRF in the VTA in both 
rats trained to self-administer cocaine and control rats trained to self-administer saline. 
However, a reinstatement of operant behavior and an elevation of VTA glutamate was 
only observed in cocaine-trained rats (Wang et al., 2005). Wang et al. (2005) also report 
that VTA infusion of α-helical CRF prevented reinstatement and VTA glutamate and DA 
release, suggesting that in cocaine-trained animals CRF acquired the ability to modulate 
VTA glutamate and subsequent DA release. Thus, the relationship between CRF, 
released by stress, glutamate, and DA appears to result from neuroadaptions occurring 
over the course of drug use.  
The effect of chronic heroin exposure on VTA glutamate release has been less 
well studied. However, systemic or intra-VTA administration of dizocilpine, a non-
competitive NMDA receptor antagonist, leads to an increase in the rate of heroin self-
administration and a rightward shift in the dose response curve, suggesting that glutamate 





Rationale of the Current Studies 
 The following thesis employed the reinstatement procedure to elucidate the 
neuronal mechanisms mediating acute FD stress-induced reinstatement of heroin seeking. 
To that end, three approaches have been taken. In chapter 1 the involvement of the DA 
D1 receptor, in particular regions of the mesolimbic DA system, in acute FD-induced 
reinstatement was investigated by local intracranial microinjections, of the D1 receptor 
antagonist SCH 23390. This approach has allowed us to identify areas where DA 
function is critical for the expression of acute FD-induced reinstatement and highlight 
differences between this circuitry and the circuitry mediating other forms of 
reinstatement. The goal in chapters 2 and 3 was to investigate how acute FD may act to 
modulate synaptic plasticity as a potential mechanism underlying reinstatement of drug 
seeking. In chapter 2, I present the investigation of acute FD- and heroin exposure-
associated changes in the induction of LTP, a model of learning and memory, in the 
pathway from the vSub to the NAc shell. This pathway has been shown to be involved in 
synaptic changes relating to both cocaine and morphine use, and may play a role in the 
perversion of normal learning apparent in heroin addiction. Finally, in the study presented 
in chapter 3, the technique of Western immunoblotting was used to measure the 
expression of GluA1, GluA2, and NR1 glutamate receptor subunits in rats that have been 
trained to self-administer heroin and subsequently exposed to an acute 21h FD-induced 
reinstatement test. Adaptations in glutamatergic synapses, and more specifically, changes 
in the expression of iGluR subunits, have been shown to underlie drug seeking during 
periods of abstinence. Collectively these studies will help to elucidate the neuronal 
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mechanisms involved in stress-induced reinstatement which may aid in the development 
of targeted interventions to prevent stress-induced relapse in human drug abusers. 
GENERAL METHODOLOGY 
Subjects 
 A total of 327 (chapter 1: n = 222, chapter 2: n = 42, chapter 3: n = 63) male Long 
Evans rats (Charles River, St. Constant, QC) were tested in squads of 10 over a period of 
several years. Prior to surgery rats were pair-housed in shoebox cages for approximately 
1 week to acclimate them to daily handling as well as facility light (chapters 1 & 3: 
reverse 12:12 h light-dark cycle; lights off at 9:30 a.m.; chapter 2: normal 12:12h light-
dark cycle; lights on at 8:30 am) and temperature (21 °C) conditions. Once the animals 
reached a bodyweight of approximately 350 g intravenous (IV) catheterization or a 
combination of IV catheterization and intracranial cannulation or electrode implantation 
was preformed. Following surgery, rats were singly housed for a 36-48h recovery period 
prior to being placed in operant chambers where they remained for the duration of 
experimentation (except for drug-naïve rats, see chapters 2 and 3). With the exception of 
acute FD-induced reinstatement tests, all rats had ad libitum access to food and water. 
Procedural approval was granted by the Concordia University Animal Care Committee 
and animals were treated in accordance with the Canadian Council on Animal Care. 
Surgery 
 To allow for drug self-administration and to minimize differences between drug-
naïve control animals and those administering heroin all rats were implanted with IV 
catheters. Catheters were constructed from Silastic tubing (Internal Diameter: 0.51 mm, 
Outer Diameter: 0.94 mm; Dow Corning, Midland, MI, USA) cut to a length of 12 cm. 
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During surgery animals in chapters 1 and 2 also received bilateral guide cannulae aimed 2 
mm above the NAc shell, NAc core, vmPFC, dmPFC or BLA (for specific details refer to 
chapter 1) or were implanted with a bipolar stimulating electrode into the vSub and a 
recording electrode into the NAc shell (for specific details refer to chapter 2).  
Rats were anesthetized with a mixture of xylazine and ketamine (10 + 100 mg/kg, 
i.p.) or with isoflurane (5-1.5%, see chapter 3) and given saline (2 ml, SC) to prevent 
dehydration. Once fully anesthetized, as confirmed by the absence of a reflex following a 
pinch to the hind paw, two incisions were made: one on the skull and one on the neck 
(approximately 1 cm above the ventral side of the shoulder blade). The jugular vein was 
isolated, cleaned of all surrounding tissue, and a small incision was made. Through this 
incision the bottom 3 cm of the catheter was inserted and secured in place with three silk 
sutures. The remaining portion of catheter was threaded subcutaneously to the skull, 
where it was attached to a modified 22-guage cannula (Plastics One Industries, Roanoke, 
VA). Depending on the experiment, guide cannulae (chapter 1) or electrodes (chapter 2) 
were inserted through burr holes drilled on the skull. Once in place, all cannulae or 
electrodes were mounted to the skull using jewelers’ screws and dental cement.  
 Following surgery rat were given penicillin (450,000 IU/rat) to prevent infection, 
and the analgesic buprenorphine (10 µg/kg; Schering-Plough Ltd., Welwyn Garden City 
Hertfordshire, UK) to relieve pain. Catheters were also flushed, on a daily basis, 






 Following approximately 48h recovery all non-drug-naïve animals were moved 
from their home cages, in the animal care facility, and placed in operant chambers 
(Coulbourn Instruments, Allentown, PA, USA; 29.0 cm x 29.0 cm x 25.5 cm) where they 
were individually housed for the duration of experimentation. Each chamber consisted of 
two Plexiglas walls, one front and one back, and two metal panel sidewalls. Two 
retractable levers, an ‘active’ drug-paired and an ‘inactive’ non-drug paired, were located 
on the right side wall approximately 11 cm above the floor. A cuelight was located above 
each lever, a tone emitter (2.9 KHz tone module, Coulbourn Instruments, Allentown, PA, 
USA) was located above the active lever and a houselight was positioned in the top 
center of the left sidewall. The floor of the operant chamber was composed of stainless 
steel rods to allow for the collection of waste into a removable tray filled with Betachip 
bedding. Each chamber was enclosed in a sound attenuating wooden compartment 
equipped with a fan for ventilation and external noise masking.  
 Responding on the active lever was paired with the delivery of 0.13 ml of heroin 
solution, inactivation of the houselight, activation of the tone module and illumination of 
a cuelight above the active lever. Drug infusions, active lever presses, and inactive lever 
presses were recorded using Graphic State Software and a personal computer connected 
to the operant chambers via linc boxes (Coulbourn Instruments, Allentown, PA, USA). 
To allow for drug infusions rats were attached to a liquid swivel (Instech Swivel 
Assembly, Med Associates, St. Albans, VT, USA) and pump (Harvard Apparatus, St. 
Laurent, QC, Canada) via Tygon tubing (Internal Diameter: 0.50 mm, Outer Diameter: 
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1.52 mm; Saint-Gobain Performance Plastics, Granville, NY, USA), shielded by a metal 
spring.  
Drugs  
 Heroin (diacetylmorphine HCL; National Institute for Drug Addiction, Baltimore, 
Maryland, USA) was dissolved in sterile saline to produce a stock solution of 5 mg/ml. 
This stock was further diluted with physiological saline and stored in 20 ml heroin 
syringes resulting in a concentration of 0.10 mg/kg/infusion.  
General Procedure 
 The experiments to be described in the following chapters employ the same basic 
procedure (specific details and exceptions will be described in each chapter). In all 
chapters, except chapter 1, experimental animals consisted of heroin-trained and heroin-
naive control rats. Heroin-naive rats remained in the animal care facility and were 
handled in an equivalent manner to heroin-trained rats, but were never exposed to the 
operant training chambers and never received heroin. Prior to the commencement of 
training, all heroin-trained animals were given one day of habituation, which consisted of 
placing the animals in their respective operant chambers for a period of approximately 
24h. During this time levers were not extended and no discrete drug-associates cues were 
present. Following habituation rats were trained to self-administer heroin (0.10 
mg/kg/infusion) for a minimum of 10 days. The nature of the training procedure differed 
across experiments. However, in all experiments the first 5 days of training consisted of 
three 3h sessions, separated by a 3h interval. In the experiments described in chapters 1 
and 3 the first session began shortly after the onset of the dark phase (approximately 
10:00 a.m.); whereas, in experiment 2 the first session began during the light phase and 
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started at approximately 1:00 p.m.  The beginning of the first session was marked by the 
insertion of both levers, the turning on of a houselight and the activation of the 
cuelight/tone complex located above the active drug-paired lever. This complex remained 
on for 30s or until the first active lever response.  Responding on the active lever resulted 
in a 5s drug infusion (0.10 mg/kg/infusion; volume 0.13 ml) and a 20s timeout period 
during which the houselight remained off, the cuelight/tone complex remained on and no 
further drug was available. At the end of each session the active lever was retracted but 
the inactive lever remained extended in order to increase the discrimination between the 
active and inactive lever.  
 Following self-administration training, the drug was removed and all animals 
entered a period of extinction. Extinction training followed the same procedure as self-
administration training except that active lever responding did not result in the delivery of 
heroin. In addition, unless noted otherwise, extinction training consisted of one 3h 
session per day. After a minimum of 4 extinction sessions, drug seeking was considered 
extinguished if responding on the previously active lever fell at or below an extinction 
criterion of 15 or 20 responses (per 3-h extinction session). At this point the animal was 
subject to reinstatement testing in a counterbalanced order while sated or following acute 
21 or 48h FD. In the experiments described in chapter 1, rats were intracranially infused 
with the DA D1 receptor antagonist SCH 23390, approximately 5-10 min prior to the 
commencement of reinstatement testing. In the experiments described in chapters 2 and 
3, rats received no special treatment prior to the test.  However, in these experiments the 
reinstatement test period was reduced to a single 2h session. The electrophysiological 
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recording or the decapitation and removal of the brain for later analysis was preformed 
immediately after this test (see specific details in each chapter). 
Histology 
 In order to verify cannulae and electrode placements rats were first overdosed 
with pentobarbital sodium (Euthanyl, 72-120 mg/rat, ip). Once unconscious, rats with 
guide cannulae (chapter 1) were infused with 0.5 ul of Evans Blue dye. The injector 
extended 2 mm below the tip of the guide cannulae. Following euthanasia, confirmed by 
the lack of a pulse, rats were decapitated and their brains were rapidly removed. Rats 
used in the experiments described in chapter 2 were overdosed with Euthanyl and 
transcardially perfused with phosphate buffered saline and 4% paraformaldehyde. In 
chapter 1, brains were soaked in 4% paraformaldehyde for approximately 48h; whereas, 
in chapter 3 brains were transferred from paraformaldehyde to a 30% 
sucrose+paraformaldehyde solution after 4h. Brains remained in 
sucrose+paraformaldehyde solution until sinking. Following fixation, brains were frozen 
with dry ice and stored at -80° C. Finally, brains were sliced using a cryostat and sections 
of 30 µm were placed on gel coated slides. Brain slices were treated with cresyl violet 
and coverslipped for placement verification. Slides were inspected and placement was 
determined by the most ventral portion of dye, in the case of guide cannulae, or the most 
ventral portion of tract, in the case of electrodes. Rats used in the experiments described 
in chapter 3 were rapidly decapitated and their brains were flash-frozen for 5s in 
isopenthane and stored at -80° C. Brains were later sliced on the cryostat and bilateral 
tissue punches (0.8-1.6 mm2) were collected from the BLA, dmPFC, NAc and VTA (see 
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THE ROLE OF THE DOPAMINE D1 RECEPTOR IN ACUTE FOOD 
















 The neurotransmitter DA has been heavily implicated in both the learning and 
rewarding aspects of drug use and the transition from controlled to compulsive drug 
seeking. Moreover, a role for DA has been firmly established with regard to both drug-
induced (priming) and drug cue-induced reinstatement of extinguished drug-seeking 
behavior, two variations of an animal model of relapse. Until recently, stress-induced 
reinstatement, in rodents, has been studied almost exclusively by using inescapable 
footshock stress. In this form of reinstatement DA is thought to play a somewhat limited 
role. However, our laboratory has recently demonstrated that systemic administration of 
the DA D1 receptor antagonist, SCH 23390, will attenuate acute FD-induced 
reinstatement of heroin seeking. In contrast, systemic injection of SCH 23390 has no 
effect on footshock-induced reinstatement. Thus, the current study was designed to 
elucidate the neuronal regions critical to the effect of SCH 23390 on acute FD-induced 
reinstatement of heroin seeking. In brief, rats were trained to self-administer heroin (0.1 
mg/kg/infusion) over a minimum of 10 days. Following training, heroin was removed 
leading to an extinction of responding. Next, rats were tested twice, under extinction 
conditions, for reinstatement: once following acute 21-48h FD and once under sated 
conditions. Prior to testing, SCH 23390 was administered into the NAc shell (0.0, 0.3, 0.6 
ug/side), NAc core (0.0, 0.3, 0.6 ug/side), BLA (0.0, 1.0, 2.0 ug/side), dmPFC; 0.0, 0.2, 
2.0 ug/side or vmPFC; 0.0, 2.0 ug/side. An attenuation of drug seeking behavior was seen 
in rats pre-treated with SCH 23390, at the highest dose, in the NAc shell, dmPFC, or 
BLA suggesting that acute FD-induced reinstatement is dependent upon activation of DA 
D1 receptors in these regions, but not, the NAc core or vmPFC.  
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INTRODUCTION 
Drug addiction is a devastating disease characterized, in part, by recurrent cycles 
of abstinence and relapse. Understanding this cyclicity, and more specifically, factors 
mediating the transition from a drug-free state to an active state of drug seeking is of 
particular importance in developing effective strategies to treat addiction. In humans, the 
study of relapse poses several ethical and practical concerns. Fortunately, relapse can be 
modeled, in animals, using the reinstatement procedure; a procedure in which animals 
have been found to return to extinguished drug seeking, under abstinent conditions, 
following a variety of manipulations. Studies employing the reinstatement procedure 
have consistently demonstrated a role for the neurotransmitter DA in drug seeking. 
Interestingly, DA has been heavily implicated in the acute rewarding effects of abused 
drugs as well as the learning of associations between drug effects and stimuli predicting 
drug availability or consumption (Spanagel & Weiss, 1999; Wise, 2004; 2008). With 
regard to the reinstatement of drug seeking, DA is critically involved in both drug 
priming- and cue-induced reinstatement (for examples see Bossert et al., 2005; de Wit & 
Stewart, 1983; Shalev, Grimm, & Shaham, 2002). However, the role of DA in stress-
induced reinstatement has yet to be fully elucidated.  
 Historically, research focusing on the effect of stress on the reinstatement of drug 
seeking behavior, has tended to utilize inescapable footshock stress to trigger drug-
seeking. These studies have revealed an attenuation of drug seeking following systemic 
administration of the mixed DA D1/D2 receptor antagonist flupenthixol, but not the 
selective DA D1 or DA D2 receptor antagonists SCH 23390 or raclopride, respectively 
(Shaham & Stewart, 1996). In contrast, systemic injection of SCH 23390, at a dose 
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substantially lower than that used by Shaham and Stewart (1996), has been shown to 
attenuate reinstatement in rats exposed to acute 48h FD stress (Tobin et al., 2009). This 
finding suggests that the role of DA in stress-induced reinstatement may be dependent 
upon the nature of the stressor used. Thus, while the neuronal circuitry involved in 
footshock-induced reinstatement has been thoroughly investigated, it cannot be assumed 
to be the same as the neuronal circuitry underlying acute FD-induced reinstatement. Here, 
the role of the DA D1 receptor in acute FD-induced reinstatement is studied by 
selectively blocking this receptor in the NAc shell, NAc core, BLA, dmPFC and vmPFC.  
The NAc and the Reinstatement of Drug Seeking 
The NAc is a central component of the mesolimbic DA pathway and receives a 
large DAergic input from the VTA. Mesolimbic DA, particularly DA release in the NAc, 
has been consistently linked to the attribution of reward value. For instance, microdialysis 
studies, measuring extracellular DA release in the NAc, have shown an increase in the 
release of DA following the presentation of rewarding stimuli such as specific foods, 
exposure to drugs of abuse, and following BSR (Di Chiara et al., 2004; Hernandez & 
Hoebel, 1988; Spanagel, Herz, & Shippenberg, 1990; Wise, Leone, Rivest & Leeb, 
1995). The majority of early dialysis studies do not distinguish between DA release in the 
NAc shell and NAc core. However, the dissociation between these structures is crucial 
since the NAc is a functionally heterogeneous structure. Anatomically, the NAc is poised 
to act as an interface between the limbic system, involved in regulating the desire to use 
drugs, and the motor system, involved in directing the behavioral output necessary to 
procure drugs. This interface is mediated by the NAc shell and NAc core, respectively 
(Groenewegen & Trimble, 2007; Mogenson, Jones, & Yim, 1980). Recently, it has been 
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demonstrated that conditioned stimuli associated with food increase extracellular DA 
release in the NAc core, but not the NAc shell; whereas, conditioned stimuli associated 
with morphine increase NAc shell, but not NAc core, DA release (Bassareo, Musio, & Di 
Chiara, 2011). Furthermore, rats have been shown to self-administer both DA agonists 
and psychostimulant drugs directly into the NAc shell, but not the NAc core (Carlezon & 
Wise, 1996; Ikemoto, Glazier, Murphy, & McBride, 1997; McKinzie, Rodd-Henricks, 
Dagon, Murphy, & McBride, 1999). In contrast, transient inactivation of the NAc core, 
but not NAc shell, with a combination of the GABAA and GABAB agonists muscimol and 
baclofen, respectively, has been shown to abolish both cue- and priming-induced 
reinstatement of cocaine seeking (Fuchs, Evans, Parker, & See, 2004; McFarland et al., 
2004). Whereas, transient inactivation of either the NAc shell or core has been shown to 
block footshock-induced reinstatement of cocaine seeking (McFarland et al., 2004). 
Similar to the findings with cocaine-trained animals, transient inhibition of the NAc core, 
but not shell, has been shown to attenuate cue-induced reinstatement of heroin seeking. In 
contrast, heroin priming-induced reinstatement of heroin seeking is attenuated by 
transient inhibition of the NAc shell or NAc core (Rogers, Ghee, & See, 2008). 
Collectively, these studies suggest that the neuronal circuitry mediating reinstatement 
may differ as a function of the reinstatement trigger and as a function of previous drug 
history.  
The BLA and Reinstatement of Drug Seeking 
The BLA is thought to be critically involved in the regulation of associative 
conditioning processes involved in learning the relationship between a stimulus and a 
reward. Such learning is central to the maintenance and reinstatement of drug seeking, as 
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it underlies the attribution of salience to cues paired with drug self-administration 
(Grimm & See, 2000; Kantak, Black, Valencia, Green-Jordan, & Eichenbaum, 2002; 
Meil & See, 1997). The role of the BLA in addiction has been most extensively 
investigated with regard to psychostimulant drugs. Studies of this nature have shown that 
lesioning or pharmacological inactivation of the BLA, but not the central amygdala, 
interferes with the acquisition of a cocaine or amphetamine CPP, and reduces responding 
for cocaine on a second order schedule of reinforcement (Fuchs & See, 2002; Hiroi & 
White, 1991). Both CPP and second order schedules of reinforcement are paradigms in 
which behavior is maintained largely by drug associated cues (Bossert et al., 2005; de 
Wit & Stewart, 1983; Shalev et al., 2002; Whitelaw, Robbins, & Everitt, 1996). In 
contrast, self-administration of cocaine on a fixed ratio (FR) schedule of reinforcement, is 
not effected by lesions of the BLA, suggesting that the BLA is not involved in the 
primary reinforcing aspects of cocaine (Meil & See, 1997). Furthermore, lesions of the 
BLA have been shown to have no effect on heroin self-administration under a continuous 
or second order schedule of reinforcement, suggesting that the BLA is not critically 
involved in maintaining heroin seeking (Alderson, Robbins, & Everitt, 2000).  
Despite these findings, the BLA appears to be crucially involved in the 
reacquisition of behaviors previously associated with cocaine and heroin self-
administration. For instance, cocaine seeking can be triggered, in abstinent animals, by 
electrical or pharmacological stimulation of the BLA (Hayes, Vorel, Spector, Liu, & 
Gardner, 2003; Ledford, Fuchs, & See, 2003). Similarly, lesioning or transient inhibition 
of the BLA has been shown to block cue- and context-induced reinstatement, but has no 
effect on cocaine priming- or footshock-induced reinstatement of cocaine seeking (Fuchs 
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et al., 2005; McFarland et al., 2004; Meil & See, 1997). In contrast to findings with 
psychostimulant drugs, inactivation of the BLA with TTX has been shown to abolish 
both cue- and drug priming-induced reinstatement of heroin seeking. Similarly, 
inactivation of the BLA blocks the facilitation of CPP following a single reconditioning 
exposure to heroin in the previously heroin-paired context (Rizos, Ovari, & Leri, 2005). 
Thus, the BLA may play a dissociable role in reinstatement depending upon the drug type 
(Fuchs & See, 2002).  
The mPFC and Reinstatement of Drug Seeking 
The mPFC is a central component in the regulation of the mesolimbic pathway. 
Pyramidal neurons in the mPFC send glutamatergic input to VTA DA neurons, which in 
turn project to the mPFC (Carr & Sesack, 2000; Floresco, West, Ash, Moore, & Grace, 
2003). Furthermore, DA within the mPFC, acts to regulate glutamatergic output to 
subcortical regions involved in regulating drug seeking, such as the NAc (Gulley & 
Stanis, 2010; Kalivas, Pierce, Cornish, & Sorg, 1998; Robinson & Berridge, 1993). This 
network of anatomical connections to and from the mPFC has been shown to regulate 
drug seeking. For instances, rats will self-administer cocaine, a DA agonist, directly into 
the mPFC, an effect which is blocked by a 6-hydroxydopamine (6-OHDA)-induced 
selective lesions of DA neurons, and is restored by DA infusion (Goeders & Smith, 
1986). Furthermore, administration of cocaine into the mPFC will reinstate cocaine 
seeking in rats previously trained to self-administer cocaine, suggesting that DA 
transmission in the mPFC is critical for drug seeking (Park et al., 2002).  
 In rodents, the mPFC can be subdivided into two functionally distinct regions: the 
dmPFC consisting of the cingulate and prelimbic cortices and the vmPFC consisting of 
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the infralimbic cortex and the dorsal peduncular nucleus. These regions have been 
proposed to play unique roles in drug seeking and extinction, respectively. For instance, 
discriminative stimuli previously paired with cocaine produce both a reinstatement of 
drug seeking behavior and induce Fos expression in the prelimbic and cingulate regions 
of the dmPFC; both of which are reversed by a systemic injection of the DA D1 receptor 
antagonist SCH 23390 (Ciccocioppo et al., 2001). Furthermore, targeted blockade of the 
DA D1 or D2 receptor at the border of the prelimbic and cingulate cortex, has also been 
shown to significantly reduce reinstatement of drug seeking following the administration 
of a cocaine prime (Sun & Rebec, 2005; but see Capriles, Rodaros, Sorge, & Stewart, 
2003 for contradicting findings).  Similarly, infusion of SCH 23390 in the prelimbic 
cortex attenuates heroin priming-induced reinstatement of drug seeking (See, 2009), as 
well as footshock-induced reinstatement of cocaine seeking (Capriles et al., 2003). 
Moreover, transient inactivation of the prelimbic cortex with TTX or a combination of 
muscimol and baclofen, blocks cue-, footshock-, and cocaine-priming-induced 
reinstatement of cocaine seeking (Capriles et al., 2003; McFarland et al., 2004; 
McLaughlin & See, 2003).   
In contrast, inactivation of the vmPFC, with muscimol and baclofen, immediately 
following extinction training or prior to reinstatement testing, impairs extinction learning 
and reinstates extinguished cocaine seeking, respectively. Thus, it has been suggested that 
the vmPFC is an inhibitory structure which facilitates the extinction of drug seeking 
(Peters, LaLumiere, & Kalivas, 2008; LaLumiere, Niehoff, & Kalivas, 2010). However, 
the inhibitory role of the vmPFC in drug seeking may not be consistent across drug 
classes. Recently, Bossert et al. (2011), demonstrated that inactivation of the infralimbic 
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cortex decreases context-induced reinstatement of heroin seeking; yet, inactivation of the 
infralimbic cortex has no effect on cue-induced reinstatement of cocaine seeking 
(McLaughlin & See, 2003). 
The Current Studies  
 Here, the role of DA transmission in acute FD-induced reinstatement was 
investigated in an effort to elucidate the neuronal circuitry underling this form of 
reinstatement. More specifically, the role of the DA D1 receptor in the NAc shell 
(Experiment 1), NAc core (Experiment 2), BLA (Experiment 3), dmPFC (Experiment 4) 
and vmPFC (Experiment 5) was investigated by localized administration of the D1 
antagonist SCH 23390. It was hypothesized that blockade of DA D1 receptors in the NAc 
shell and dmPFC would attenuate drug-seeking behavior. As discussed above, these 
structures have been extensively investigated for their role in addiction and more 
specifically the reinstatement of drug seeking under extinction conditions. The role of 
DA D1 receptors in the NAc core, BLA, and vmPFC in acute FD-induced reinstatement 
is less clear. Inactivation studies suggest that the NAc core, but not the BLA, plays a 
critical role in stress-induced reinstatement of psychostimulant drugs (McFarland et al., 
2004); whereas, the vmPFC has been shown to play an inhibitory role with regard to 
cocaine, but not heroin seeking. Furthermore, the role of DA transmission in these areas, 
as it relates to stress-induced reinstatement, has not been extensively investigated.  
Additionally, the vast majority of studies have investigated stress-induced reinstatement 
of cocaine seeking and relatively few studies exist focusing on the neural circuits 
involved in the reinstatement of heroin seeking. Finally, there are no studies addressing 




 A total of 222 (Experiment 1: n = 70; Experiment 2: n = 40; Experiment 3: n = 
45; Experiment 4: n = 47; Experiment 5: n = 20) male Long Evans rats (Charles River, 
St. Constant, QC) were tested in squads of 10 or less. As described previously, rats were 
pair-housed prior to surgery and given time to acclimate to daily handling and facility 
conditions. Once the animals reached a bodyweight of approximately 350 g, IV 
catheterization and intracranial cannulation surgeries were preformed. Following surgery, 
rats were given a recovery period and placed into the operant chambers for heroin self-
administration.  
Surgery 
 In brief, rats were implanted with IV catheters into the right jugular vein (see 
general methodology) and bilateral guide cannulae (22 gauge) were aimed 2 mm above 
the NAc shell (AP: +1.7, ML: +/- 3.7; 20°, DV: -5.8 from destination skull); NAc core 
(AP: +1.7, ML: +/- 2.5, 6° angel; DV: -5.5); BLA (AP: -2.5, ML: +/- 5.0, DV: -6.6); 
dmPFC (AP: +3.0, ML: +/- 1.5, 10°, DV: -1.7); and vmPFC (AP: +3.0, ML: +/- 1.3, 10°, 
DV: -3.0). Coordinates were based upon previous research and the atlas of Paxinos and 
Watson (2005). After the last reinstatement test rats were injected with a fatal dose of 
Euthanyl and infused with Evans Blue dye (0.3 ul/side) 2 mm below the guide cannulae 
to verify the location of drug delivery. Subsequently rat brains were removed, soaked in 
4% paraformaldehyde for approximately 48h, frozen with dry ice, and stored at -80 °C. 
For histology brains were sliced on a cryostat, mounted and stained for later placement 
verification.  
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Drugs & Microinjection Procedure  
 Heroin was diluted in saline to produce a stock solution (5 mg/ml). Stock heroin 
was further diluted with saline in 20 ml syringes to produce a final concentration of 0.1 
mg/kg/infusion. The DA D1 receptor antagonist SCH 23390 was diluted in sterile saline 
to produce the following region specific doses: NAc (shell and core): 0.0, 0.3 and 0.6 
μg/side; BLA 0.0, 1.0 and 2.0 μg/side; mPFC (dmPFC and vmPFC): 0.0, 0.2 and 2.0 or 
0.0 and 2.0 μg/side. These doses were chosen to reflect the range of doses used with the 
existing literature (for examples see: Anderson et al., 2003; Berglind, Case, Parker, 
Fuchs, & See, 2006; Bossert et al., 2007; Nair et al., 2011; See, 2009).  
 Microinjections were given 5-10 min prior to the start of reinstatement testing. 
Intracranial infusions were made using a syringe pump (Harvard Apparatus, Holliston, 
MA, USA) connected to a 10 ul Hamilton syringe. This syringe was attached via 
polyethylene-20 tubing to a 28-gauge injector, which was cut to extend 2 mm below of 
the guide cannulae. Injections for all regions of interest were made over 1 min and the 
injectors were left in place for 1 min following the infusion. For mock injections (see 
below) the syringe pump was run for 1 min and short injectors, not extending beyond the 
guide cannulae, were inserted into the guide cannulae but were not attached to the 
infusion pump.  
Experimental Procedure 
The following five experiments employed the procedure described previously in 
the general methodology section; however, there are several exceptions, which are noted 
below. Depending upon the experiment, animals were given one day of autoshaping 
before starting self-administration training. Autoshaping consisted of a single 1h session 
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during which the levers were not extended and heroin delivery was not contingent upon a 
response. During this session animals received 6 heroin infusions, each paired with the 
same cues as during training. Small methodological differences between experiments 
reflect procedural tweaking over the course of the project, meant to optimize the testing 
conditions.  
Training & Reinstatement Testing   
Experiment 1 & 2: Administration of the DA D1 receptor antagonist, SCH 23390, 
into the NAc shell or core 
           Animals were trained to self-administer heroin on an FR-1 schedule of 
reinforcement over a minimum of 10 days (days 1-5: three 3h sessions; days 6-10 one 3h 
session). Animals that demonstrated substantially lower active lever responding, relative 
to the others in their cohort, or showed an inability to distinguish between the active and 
inactive lever were given extra self-administration training sessions. Following training, 
rats were given a minimum of four 3h extinction sessions during which heroin syringes 
were removed but all the cues associated with heroin self-administration remained.  
Beginning on the third day of extinction and continuing throughout extinction 
training, rats received mock intracranial infusions. Upon reaching a criterion of 15 or 
fewer responses on the previously active lever, heroin seeking was considered 
extinguished and reinstatement testing commenced. Under extinction conditions, rats 
received two 3h reinstatement test sessions separated by a minimum of one extinction 
session and until the extinction criterion was met again. Prior to testing, rats were given a 
48h ‘off’ period during which time they were food deprived or sated in a counterbalanced 
order. For the ‘off’ period animals remained in the operant chamber but no extinction 
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session was run. Approximately 5-10 min before the start of each reinstatement test rats 
were infused with one of three SCH 23390 (0.0, 0.3 and 0.6 μg/side) doses into the NAc 
shell or core. For FD tests, food hoppers were removed from the operant chamber and 
returned at the end of the session.  
Experiment 3-5: Administration of the DA D1 Receptor Antagonist, SCH 23390, 
into the BLA, vmPFC or dmPFC 
Animals were trained to self-administer heroin on an FR-1 schedule of 
reinforcement for 5 days and then moved to an FR-3 schedule for the last 5 days of 
training. Animals that had difficulty in maintaining responding following the change in 
reinforcement schedule were given extra training days and in some cases returned to the 
FR-1 schedule until responding improved. As in self-administration training, the first day 
of extinction consisted of three 3h sessions; however, all subsequent extinction days were 
reduced to one 3h session. For reinstatement testing rats were assigned to one of two or 
three SCH 23390 dose groups.  (BLA: 0.0, 1.0 or 2.0 μg/side; dmPFC: 0.0, 0.2 or 2.0 
μg/side; vmPFC: 0.0 or 2.0 μg/side) and given an infusion into the BLA, dmPFC, or 
vmPFC 5-10 min prior to reinstatement testing. Each animal received two 
counterbalanced tests, one under sated conditions and one following 21h FD.  
Statistical Analysis 
The effect of DA D1 receptor antagonism in the NAc, BLA or mPFC on acute 
FD-induced reinstatement of heroin seeking was preformed using SPSS Software v. 
19.0.0 for Mac (IBM Inc., Armonk, New York, USA). A series of mixed factorial 
ANOVAs were preformed to investigate active and inactive lever responding following 
infusion of SCH 23390 into each region of interest.  Deprivation state (baseline, FD, 
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sated) was used as a within subjects factor and antagonist dose (vehicle, low, high or 
vehicle, high) was used as a between subjects factor for all ANOVAs. Following 
significant ANOVA results, pair-wise comparisons were conducted using Sidak corrected 
t-tests to control for multiple comparisons. All analyses were evaluated for significance at 
α = .05.  
RESULTS 
Experiments 1 & 2: Administration of the DA D1 receptor antagonist, SCH 23390, into 
the NAc shell or NAc core 
 Fifty animals were eliminated from the analysis of this data set. The reasons for 
these eliminations included: catheter failure or a failure to train (n = 15), sickness or 
death (n = 6), improper cannulae placements (nboth incorrect = 10; none correct  = 10; none shell & 
one core  = 7; ncannulae through ventricle  = 2). A failure to train was considered apparent if rats 
responded an average of 15 times, or less, during the last 5 training sessions (3h sessions) 
or an average of 20 times, or less, across all 10 training sessions.  Of the remaining 60 
rats, half had placements localized in the NAc shell (n = 30) and half had placements 
localized in the NAc core (n = 30) (see Figure 1).  
Training data did not differ between rats with placements located in the NAc shell 
or NAc core, across the 10 days of training, in terms of the number of heroin infusions,  
F(1, 58) = 2.61, p = .11, ηp
2 = .04, active lever responses, F(1,58) = 2.76, p = .10, ηp
2 = 
.05, or inactive lever responses, F(1, 58)  = 0.12 , p = .73, ηp
2 = .01, thus, the training data 




Figure 1.  
Anatomical position of microinjector tips targeting the NAc.  Top: closed circles indicate 
NAc shell placements (n = 30) and open squares indicate the NAc core (n = 30) 
placements. Images correspond to Figures 12-21 (2.76-1.44 mm from bregma) from the 
atlas of Paxinos & Watson (2005).  Figures are arranged from top to bottom with Figure 
12 being the bottom left and Figure 21 being the top right. Bottom: sample 






for the ‘active’ drug-paired lever over the ‘inactive’ non-drug paired lever throughout 
training. Following training, rats received a mean (+/-SEM) of 6.83 (+/- 0.36) days of 
extinction training prior to their first reinstatement test and an additional 4.12 (+/- 0.34) 
extinction days prior to their second reinstatement test. The rate of extinction did not 
differ with respect to guide cannulae placement for either of the reinstatement tests, Ftest1 
(1,58) = 0.21, p = .65, ηp
2 = .00; Ftest2 (1,58) = 2.70, p = .11, ηp
2 = .04.  
Rats with guide cannulae targeted at the NAc shell or NAc core differed 
substantially in terms of how the administration of the DA D1 receptor antagonist SCH 
23390 affected acute FD-induced reinstatement. Thus, these two placement groups are 
discussed separately for the remainder of the analyses. Prior to reinstatement testing rats 
were assigned to one of three antagonist dose groups (vehicle: nshell = 7, ncore = 9; low: 
nshell = 14, ncore = 8; high: nshell = 9, ncore = 13). For rats with guide cannulae correctly 
targeting the NAc shell there were no significant differences between the antagonist dose 
groups in any of the training variables: infusions (MVeh =18.69, SEM = 3.86; MLow = 
18.47, SE = 1.96; MHigh = 17.42, SEM = 2.18), F(2,27) = 0.07, p = .94, ηp
2 = .01, active 
lever responses (MVeh = 77.14, SEM = 27.96; MLow = 56.17, SEM = 10.81; MHigh = 41.04, 
SEM = 13.16), F(2,27) = 1.04, p = .37, ηp
2 = .07, or inactive lever responses (MVeh = 6.06, 
SEM = 2.91; MLow = 7.67, SEM = 2.61; MHigh = 3.33, SEM = 0.71), F(2, 27) = .86, p = 
.44, ηp
2 = .06, during the last 5 days of training. For rat with guide cannulae correctly 
targeting the NAc core there were also no significant differences observed in the number 
of infusions (MVeh =13.02, SEM = 1.65; MLow = 18.68, SEM = 2.23; MHigh = 18.05, SEM 
= 3.34), F(2,27) = 1.08, p = .35, ηp





Figure 2.  
Heroin self-administration for rats with guide cannulae located in the NAc. Data shown 
are the mean (+/- SEM) numbers of active lever presses, inactive lever presses and heroin 
infusions (0.1 mg/kg/infusion) for the 60 rats with confirmed placement in the NAc for 
the ten training days (T1-10; days 1-5: three 3h sessions, FR-1; days 6-10: one 3h 
session, FR-1) and the first extinction day (Ext 1). A significant difference existed 
between active and inactive lever responding on all training days and during extinction (p 
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1-3h session, FR-1 
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6.66; MLow = 51.40, SEM = 14.12; MHigh = 45.55, SEM = 15.78), F(2,27) = .25, p = .78, 
ηp
2 = .02, or inactive lever responses (MVeh = 3.51, SEM = 0.80; MLow = 15.50, SEM = 
11.63; MHigh = 3.62, SEM = 0.84), F(2, 27) = 1.46, p = .25, ηp
2 = .01, between antagonist 
dose groups for the last 5 days of training. 
Separate mixed factorial ANOVAs were preformed to evaluate the effect of SCH 
23390, infused into the NAc shell or NAc core, on acute FD-induced reinstatement of 
active or inactive lever responding. Analysis of the number of active lever responses in 
rats with guide canulae aimed at the NAc shell, revealed a significant effect of 
deprivation state, F(2, 54) = 16.96, p < .001, ηp
2 = .39, antagonist dose, F(2, 27) = 3.33, 
p = .05, ηp
2 = .19 and deprivation state X antagonist dose interaction, F(4, 54) = 3.53, p = 
.01, ηp
2 = .20 (see Figure 3A). Follow-up analyses revealed a significant increase in 
active lever responding in the FD condition (M = 35.03; SEM = 5.86) compared to both 
the baseline (M = 10.48; SEM = 0.73) and sated (M = 10.95; SEM = 1.50) conditions (ps 
< .01). A one-way ANOVA assessing active lever responding on the deprivation test day 
revealed a significant effect of antagonist dose, F(2, 27) = 3.68, p = .04, ηp
2 = .21. Pair-
wise comparisons revealed a significant reduction in responding in the high antagonist 
dose group relative to the vehicle group  (p  < .05). Next, separate one-way repeated 
measures ANOVAs were conducted for each antagonist dose group. These ANOVAs 
revealed a significant deprivation state effect in the vehicle, F(2,12) =17.00; p < .001, ηp
2 
= .74 and low, F(2,26) = 6.57; p = .01, ηp
2 = .33, dose groups but not in the high 
antagonist dose group, F(2,16) = .60, p = .56, ηp
2 = .07. For rats in the vehicle group 
significantly more active lever responding was observed on the FD test day than on the 
BL or sated days (ps <. 05).  A tendency toward increased active lever responding on the 
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FD test day relative to the BL (p = .08) and sated (p = .06) tests was also observed in the 
low antagonist dose group. Analysis of the number of responses on the inactive revealed 
no significant effect of antagonist dose, F(2,54) = 2.35, p = .11, ηp
2 = .08, deprivation 
state, F(2,27) = 2.36, p = .11, ηp
2 = .15, or deprivation state X antagonist dose 
interaction, F(4,54) = 0.78, p = .54, ηp
2 = .06. 
For the NAc core, a significant effect of deprivation state on active lever 
responding, F(2, 54)  = 19.99, p < .001, ηp
2 = .43, was observed. Further analyses 
revealed a significant increase in responding during the acute FD test (M = 36.46, SEM = 
5.80) relative to the baseline (M = 10.87, SEM = 0.47) and sated (M = 10.84, SEM = 1.97) 
conditions (ps < .001). However, there was no significant effect of antagonist dose, 
F(2,27) = 0.15, p = .86, ηp
2 = .01, and no significant deprivation state X antagonist dose 
interaction, F(4,54) = 0.47, p = .76, ηp
2 = .03 (see Figure 3B). Acute FD also significantly 
increased responding on the inactive lever responding, F(2, 54) = 10.09, p < .001, ηp
2 = 
.27. Further analysis of this effect showed that acute FD (M = 6.85, SEM = 1.30) caused a 
significant increase in inactive lever responding relative to both the baseline (M = 3.43, 
SEM = 0.58) and sated (M = 1.92, SEM = 0.34) conditions, ps < .05. Moreover, baseline 
inactive lever responding was also shown to be greater than responding on the sated test 
day, p < .05. Non-specific responding on the inactive lever is not an unexpected 
consequence of acute FD and the re-exposure to drug associated cues. However, it is 
clear that rats were able to differentiate between the levers, and preferred to respond on 
the previously active, drug-associated lever.  
In interpreting the effect of SCH 23390 on drug seeking behavior it is often 
















Figure 3.  
The effect of intra-NAc SCH 23390 infusion on acute FD-induced reinstatement of 
heroin seeking. Data are mean (+SEM) number of active (left) and inactive (right) lever 
responses made during baseline (BL), following 48h unlimited access to food (Sated) and 
following 48h FD for rats with placements into the NAc shell (A) or NAc core (B). 
Different groups of rats were used for each dose of SCH 23390 (Shell: Veh (0.0 µg), n = 
7; Low (0.3 µg), n = 14; High (0.6 µg), n = 9; Core: Veh, n = 9; Low, n = 8; High, n = 
13). * p < .01 when compared to BL and sated conditions, @ p < .05 when compared to 
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(Crombag et al., 2002). Thus, to ensure that the effect of intra-NAc shell SCH 23390 on 
acute FD-induced reinstatement was not due to a non-specific inhibition of motor 
activity, an ANOVA was preformed comparing the number of photocell beam breaks in 
the operant training chamber for rats in the vehicle (n = 4), low (n = 10) and 
high (n = 6) antagonist dose groups. The number of rats within each dose group differ 
from those presented above because of missing photocell data. Additionally, one rat was 
eliminated due to an excessive number of photocell beam breaks during the baseline 
period (9665 beam breaks). A mixed factorial ANOVA revealed no significant effect of 
deprivation state, F(2, 34) = 1.66, p = .21, ηp
2 = .09, deprivation state X antagonist dose 
interaction, F(4, 34) = 0.53, p = .71, ηp
2 = .06.  However, a significant antagonist dose 
effect was observed, F(2, 17) = 4.20, p = .03, ηp
2 = .31; however, somewhat contrary to 
expectations, this effect seems to be accounted for by a tendency toward an increase in 
motor activity in the high antagonist dose group (M = 1171.53; SEM = 130.92) relative to 
the vehicle (M = 683.33; SEM = 160.34, p = .09) and significantly more beam breaks 
relative to the low antagonist dose groups (M = 734.05; SEM = 101.41, p = .05), 
respectively (see Figure 4). Despite the lack of a significant interaction, a one-way 
ANOVA was preformed to assess the effect of antagonist dose only on the FD-test day. 
This analysis is justified for two reasons: 1. Locomotor behavior was not considered 
when assigning the rats to antagonist dose group, thus there is a large amount of 
variability in this measure which may mask an actual effect; 2. The FD-test day is the 
most critical day to assess the effect of the antagonist on motor behavior. This ANOVA 
revealed a significant effect of antagonist dose, F(2, 17) = 4.30, p = .03, ηp




Figure 4.  
Number of photocell breaks for rats with confirmed placements in the NAc shell during 
reinstatement. Data shown are mean (+SEM) number of photocell breaks on baseline 
(BL), sated and food deprived (FD) days for rats in the vehicle (n = 5), low (n = 10) and 
high (n = 5) SCH 23390 dose groups. * Indicates a significant difference relative to low 
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contrary to expectations, pair-wise comparisons showed that animals in the low 
antagonist group moved significantly less than those in high antagonist group, p < .05. 
Experiment 3: Administration of the DA D1 receptor antagonist, SCH 23390, into the 
BLA 
Of the initial 45 rats, 2 died before the completion of the experiment. 
Additionally, 2 rats were removed due to a failure to train, 2 rats were removed because 
the guide cannulae location could not be verified, and 16 rats were excluded due to 
injector tip placement. Finally, 1 rat was treated as an outlier based upon responding on 
the acute FD test day (reinstatement day active lever responding = 165; z-score = 4.27) 
and the data for this rat were not considered. Thus, 24 rats (see Figure 5) were considered 
in the following analyses of the effect of intra-BLA SCH 23390. Of the 13 rats excluded 
due to injector tip location, 4 had only one injector tip located within the BLA, whereas 
the remaining 9 had both cannulae located near, but outside of the BLA. These 9 rats 
were treated as anatomical controls. As seen in Figure 6, rats with guide cannulae 
targeting the BLA were able to distinguish between the active and inactive lever. On the 
last day of training the mean +/- SEM number of infusions, active, and inactive lever 
responding were 28.87 +/- 3.78, 165.11 +/- 39.64, and 12.42 +/- 2.77, respectively.  
For tests of reinstatement, rats were assigned to one of three antagonist dose 
groups (nVeh = 10; nLow = 7, nHigh = 7) such that there were no significant differences 
between the groups in terms of the average number of infusions (MVeh = 20.32, SEM = 
2.09; MLow = 37.63, SEM = 10.64; MHigh = 47.46, SEM = 19.68), F(2,21) = 1.58, p = .23, 
ηp
2 = .13, active (MVeh = 94.12, SEM = 10.90; MLow = 256.48, SEM = 96.94; MHigh = 
80.71, SEM = 30.51), F(2,21) = 1.33, p = .29, ηp







Figure 5.  
Anatomical position of microinjector tips for rats with guide cannulae targeting the BLA. 
Top: confirmed BLA placements (n = 24) are indicated by closed circles; anatomical 
control placements (n = 8) are indicated by squares. Images correspond to Figures 52-56  
(-2.28 to -2.76 mm from bregma) from the atlas of Paxinos & Watson (2005).  Figures 
are arranged from top to bottom with Figure 52 being the bottom left and Figure 56 being 




Figure 6.  
Heroin self-administration for rats with guide cannulae located in the BLA. Data shown 
are the mean (+/- SEM) numbers of active lever presses, inactive lever presses and heroin 
infusions (0.1 mg/kg/infusion) for the 24 rats with confirmed placement in the BLA for 
the ten training days (T1-10; days 1-5: three 3h sessions, FR-1; days 6-10: three 3h 
sessions, FR-3) and the first extinction day (Ext 1). A significant difference existed 
between active and inactive lever responding on all training days and during extinction (p 
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SEM = 1.91; MLow = 27.70, SEM = 10.47; MHigh = 17.91, SEM = 6.79), F(2,21) = 1.33, p 
= .29, ηp
2 = .11, across the last five days of training. Following training, rats received an 
average of 9.50 (SEM = 0.80) days of extinction training before the first reinstatement 
test and 2.54 (SEM = 0.54) days of extinction training before the second reinstatement 
test. 
A repeated measures ANOVA preformed to evaluate the effect of SCH 23390 
infusion into the BLA on acute FD-induced reinstatement revealed a significant effect of 
deprivation state, F(2, 42) = 15.69, p < .001, ηp
2 = .43, antagonist dose, F(2, 21) = 4.96, 
p = .02, ηp
2 = .32 and deprivation state X antagonist dose interaction, F(4, 42) = 3.21, p = 
.02, ηp
2 = .23 (see Figure 7). Follow-up pair-wise comparisons revealed a significant 
increase in active lever responding in the FD condition (M = 24.10; SEM = 2.38) 
compared to both the baseline (M = 11.27; SEM = 1.70) and sated (M = 11.50; SEM = 
1.70) conditions (ps < .001). A one-way ANOVA of active lever responding on the FD 
test day revealed a significant effect of antagonist dose, F(2, 24) = 4.91, p = .02, ηp
2 = 
.32. Further analyses revealed a significant and a tendency toward significant reduction in 
responding in the high (p < .05) and low (p = .06) antagonist dose groups, respectively, 
relative to the vehicle group. However, there was no difference in responding between 
the low and high antagonist groups. Separate one-way repeated measures ANOVAs 
investigating the effect of deprivation state for each antagonist dose revealed a significant 
deprivation effect in the vehicle, F(2,18) =17.77, p < .001, ηp
2 = .66, and high, F(2,12) = 
8.81; p = .004, ηp
2 = .59, but not low, F(2,12) = 0.93; p = .42, ηp
2 = .13, antagonist dose 
groups.  Further analyses revealed significantly more responding on the active lever on 









































Figure 7.   
The effect of intra- BLA SCH 23390 infusion on acute FD-induced reinstatement of 
heroin seeking. Data are mean (+SEM) number of active (left) and inactive (right) lever 
responses made during baseline (BL), following 21h FD or sated condition for rats with 
confirmed placements in the BLA (A) and anatomical control rats (B). Different groups 
of rats were used for each dose of SCH 23390 (BLA: Veh (0.0 µg), n = 10; Low (1.0 µg), 
n = 7; High (2.0 µg), n = 7; Control: Veh, n = 1; Low µg, n = 2; High, n = 6). * p < .05 
compared to BL and sated conditions, @ p < .05 compared to Veh group under FD 
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groups. For the high antagonist dose group there was a significant increase in active lever 
responding on the FD test relative to the sated test (p <. 05). For the inactive lever, a 
significant effect of deprivation state was also observed, F(2, 42) = 5.31, p < .01, ηp
2 = 
.20. This effect was accounted for by significantly less responding in the sated condition 
(M = 1.40; SEM = 0.38) relative to the baseline (M = 2.42; SEM = 0.46) and food 
deprived condition (M = 3.56; SEM = 0.70), ps < .05. No significant effect of antagonist 
dose, F(2, 21) = 0.27, p = .78, ηp
2 = .03, or antagonist dose X deprivation state was 
observed, F(4, 42) = 1.00, p = .42, ηp
2 = .09.   
For the 9 rats with injector tips located outside, but within approximately 1 mm, 
of the BLA there was 1 rat from the vehicle group, 2 rat from the low antagonist group 
and 6 rats from the high antagonist group. As seen in Figure 7, there was a significant 
effect of deprivation state, F(2,16) = 10.92, p < .01, ηp
2 = .57, with rats responding more 
on the active lever on the FD test (M = 48.78; SEM = 11.24) than on the baseline day (M 
= 10.22; SEM = 0.88) or sated conditions (M = 10.44; SEM = 2.66), ps < .05. Due to the 
small number of subjects from the low and high antagonist dose groups, the effect of 
antagonist dose and antagonist dose by deprivation state interaction was not investigated. 
Rather, a planned comparison was preformed to compare responding on the FD test day 
for anatomical control rats administered with the high antagonist (M = 33.33; SEM = 
10.38) and rats with confirmed placements in the BLA administered with the vehicle (M 
= 34.00; SEM = 4.56). The results of this comparison showed no significant difference 
between the rats, t (14) = -0.07, p = .95. Additionally, no significant effect of deprivation 
state was observed for inactive lever responding for anatomical control rats, p > .05. 
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Figure 8.  
Number of photocell breaks for rats with confirmed placements in the BLA during the 
reinstatement test. Data shown are the mean (+ SEM) number of photocell breaks on 
baseline (BL), sated and food deprived (FD) days for rats in the vehicle (n = 6), low (n = 

































As previously discussed, the inhibition of drug seeking behavior observed in the 
current experiment may be the result of motor suppression. To investigate this possibility 
an ANOVA was preformed comparing the number of moves for a subset of rats from the  
vehicle (n = 6), low (n = 6) and high (n = 5) antagonist dose groups on each test day. The 
discrepancy in subject numbers is due to missing photocell data. The results of this 
ANOVA showed no significant effect of deprivation state, antagonist dose or antagonist 
dose X deprivation state interaction on photocell beam breaks, ps > .05. 
Experiments 4 & 5: Administration of the DA D1 receptor antagonist, SCH 23390, into 
the dmPFC and vmPFC 
Of the 67 rats originally placed in the operant chambers 45 were included in the 
following analyses. Two rats were removed during training due to sickness, two rats were 
eliminated due to catheter failure, three rats were eliminated due to a failure to train and 
the others were eliminated following inspection of injector tip placement (see Figure 9). 
As expected, training data did not differ between rats with placements located in the 
dmPFC and vmPFC, across the 10 training days, in terms of the number of heroin 
infusions, F(1, 43)  = .98, p = .33, ηp
2 = .02, number of active lever responses, F(1,43) = 
.33, p = .57, ηp
2 = .01, or number of inactive lever response, F(1, 43)  = .48 , p = .49, ηp
2 = 
.01. Thus, training data for experiments 4 and 5 were combined. As can be seen in Figure 
10, rats showed a clear preference for the ‘active’ drug-paired lever over the ‘inactive’ 
non-drug paired lever throughout training. Rats received on average (+/- SEM) 8.00 (+/- 








Figure 9.  
Anatomical position of microinjector tips targeting the mPFC. Top: approximate 
anatomical position of microinjector tips for rats with guide cannulae targeting the 
dmPFC (n = 31; closed circles) and the vmPFC (n = 14; open squares). Images 
correspond to Figures 9-13 (3.72 -2.52 mm from bregma) from the atlas of Paxinos & 
Watson (2005).  Figures are arranged from lowest to highest from top left to bottom right. 
Bottom: sample photomicrographs of a dmPFC (right) and vmPFC (left) placements. 
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2.51 (+/- 0.33) extinction sessions prior to their second reinstatement test. There was no 
difference in the rate of extinction observed across experiments, ps > .05.  
Rats did, however, differ in their reinstatement of heroin seeking following SCH 
23390 infusions, depending on the region. Thus, the data for rats with guide cannulae 
targeting the dmPFC and vmPFC are discussed separately. Prior to tests of reinstatement,  
 rats with guide cannulae targeting the dmPFC were assigned to one of three antagonist 
dose groups (vehicle: n = 11; low: n = 10; high: n = 10) in such a way that there were no 
differences between the groups in terms number of infusions received (MVeh = 27.11, 
SEM = 3.94; MLow = 23.94, SEM = 4.14; MHigh = 31.10, SEM = 4.14), F(2, 28) = .75, p = 
.48, ηp
2 = .05, active lever responses, (MVeh = 143.20 SEM = 30.95; MLow = 121.94, SE = 
32.46; MHigh = 158.62, SE = 32.46), F(2, 28) = .32, p = .73, ηp
2 = .02, in active lever 
responding, (MVeh = 18.14,SEM = 3.04; MLow = 16.42, SEM = 3.19; MHigh = 7.96, SE = 
3.19), F(2, 28) = 3.00, p = .07, ηp
2 = .18, during the last 5 days of training. Rats with 
guide cannulae targeting the vmPFC were assigned to either a vehicle (n = 8) or high (n = 
6) antagonist dose group. No significant differences between number of infusions, (Mveh 
= 23.35, SE = 4.67; MHigh = 20.30, SEM = 5.39, F(1, 12) = 0.17, p = .69, ηp
2 = .01, 
number of active lever responses, (MVeh = 133.00, SEM = 29.45; MHigh =100.30, SE = 
34.11, F(1, 12) = 0.53, p = .48, ηp
2 = .04, or number of inactive lever responses, (MVeh = 
15.75, SEM = 7.09; MHigh = 23.00, SEM = 8.18, F(1, 12) = 0.44, p = .56, ηp
2 = .04, were 
observed across the last 5 days of training, p < .05. 
For rats with guide cannulae targeting the dmPFC, a repeated measures ANOVA, 
investigating active lever responding during the reinstatement testing revealed a 
significant effect of deprivation state, F(2, 56) = 24.25, p < .001, ηp
2 = .46, antagonist  
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Figure 10.  
Heroin self-administration for rats with guide cannulae located in the mPFC. Data shown 
are the mean (+/- SEM) numbers of active lever presses, inactive lever presses and heroin 
infusions (0.1 mg/kg/infusion) for the 45 rats with confirmed placement in the mPFC for 
the ten training days (T1-10; days 1-5: three 3h sessions, FR-1; days 6-10: three 3h 
sessions, FR-3) and the first extinction day (Ext 1). A significant difference existed 
between active and inactive lever responding on all training days and during extinction (p 
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dose, F(2,28) = 4.18, p = .03, ηp
2 = .23 and deprivation state X antagonist dose 
interaction, F(4,56) = 3.91, p < .01, ηp
2 = .22 (see Figure 11A). 
 Follow-up pair-wise comparisons revealed a significant increase in active lever 
responding in the FD condition (M = 47.92; SEM = 6.73) compared to both the baseline 
(M = 13.16; SEM = 0.79) and sated (M = 12.76; SEM = 1.70) conditions, ps < .001. A 
one-way ANOVA assessing active lever responding on the FD test day revealed a 
significant effect of antagonist dose, F(2, 28) = 4.21, p = .03, ηp
2 = .23. Pair-wise 
comparisons revealed a significant reduction in responding in the high antagonist dose 
group relative to the vehicle antagonist dose group  (p  < .05). Separate one-way repeated 
measures ANOVAs were conducted for each antagonist dose across deprivation 
conditions. These ANOVAs revealed a significant deprivation state effect in the vehicle, 
F(2,20) = 8.83; p = .01, ηp
2 = .47 and low dose, F(2,18) = 20.71; p = .01, ηp
2 = .70, 
groups; but not in the high antagonist dose group, p > .05. Moreover, for both the vehicle 
and low-dose groups, follow-up analyses revealed significantly more responding on the 
active lever on the FD test day than on the BL or sated days, ps < .05. A mixed factorial 
ANOVA investigating responding on the inactive lever showed no significant effect of 
deprivation state, antagonist dose or deprivation state X antagonist dose (ps > .05).  
As expected, deprivation state had a significant effect on active lever responding 
in rats with guide cannulae targeting the vmPFC, F(2, 24) = 8.82, p < .001, ηp
2 = .42 (see 
Figure 11B). This effect is accounted for by significantly more responding on the FD test 
(M = 44.25; SEM = 10.40) than the baseline (M = 10.20; SEM = 0.95; p < .05) and a 
tendency toward significantly more responding on the FD test than the sated test (M = 









Figure 11.  
The effect of intra-PFC SCH 23390 infusion on acute FD-induced reinstatement of heroin 
seeking. Data are mean (+SEM) number of active (left) and inactive (right) lever 
responses made during baseline (BL), following a 21h sated period, and following 21h of 
FD for rats with placements in the dmPFC (A) or vmPFC (B). Different groups of rats 
were used for each dose of SCH 23390 (dmPFC: Veh (0.0 µg), n = 11; Low (0.2 µg), n = 
9; High (2.0 µg), n = 11; vmPFC: Veh (0.0 µg), n = 8; High (2.0 µg), n = 6). * p < .05 
when compared to BL and sated conditions, @ p < .01 compared to the Veh and Low 
antagonist groups on the FD test day, + p < .05 relative to responding in the vehicle group 
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was no effect of antagonist dose, F(1, 12) = 1.18, p = .30, ηp
2 = .09, or deprivation state 
X antagonist dose interaction, F(2, 24) = .18, p = .84, ηp
2 = .02, for active lever 
responding.  
With regard to inactive lever responding there was no significant effect of 
deprivation state, F(2, 24) = 1.38, p = .27, ηp
2 = .10, or antagonist dose, F(1, 12) = .83, p 
= .38, ηp
2 = .06; however, a significant deprivation state X antagonist dose interaction 
was observed, F(2, 24) = 4.47, p = .02, ηp
2 = .27. Analysis of this interaction revealed 
significantly more responding by the vehicle group on the baseline day  (M = 5.31; SE = 
1.43) relative to the sated (M = 1.00; SEM = 1.13) and FD test (M = 1.63; SEM = 0.77) 
days, ps < .05. 
 As previously discussed, the inhibition of drug seeking behavior observed in the 
current experiment may be the result of motor suppression. To investigate this possibility 
an ANOVA was preformed comparing the number of moves for a subset of rats with 
cannulae aimed at the dmPFC from the vehicle (n = 6), low (n = 6), and high (n = 5) 
antagonist dose groups on each test day. As mentioned above, the discrepancy in subject 
numbers is the result of missing photocell data. Additionally, one rat was eliminated due 
to an excessive number of photocell beam breaks the day prior to the stated test (6993 
responses). The results of this ANOVA showed no significant effect of deprivation state, 
antagonist dose or antagonist dose X deprivation state interaction on photocell beam 




Figure 12.  
Number of photocell breaks for rats with confirmed placements in the dmPFC during 
reinstatement tests. Data shown are the mean (+ SEM) number of photocell breaks on 
baseline (BL), sated and food deprived (FD) days for rats in the vehicle (n = 5), low (n = 




































The results of the current series of experiments expand upon previous data from 
our laboratory demonstrating an attenuation of acute FD-induced reinstatement following 
systemic injection of the DA D1 receptor antagonist SCH 23390 (Tobin et al., 2009). The 
current findings suggest a critical role for DA transmission, acting on the D1 receptor in 
the NAc shell, dmPFC and BLA, in the reinstatement of heroin seeking following acute 
21-48h FD. Interestingly, however, administration of SCH 23390 into the NAc core or 
vmPFC had no effect on drug seeking, suggesting a lack of involvement for DA D1 
receptors in these regions in acute FD-induced reinstatement. 
 Prior to discussing the relevance of the current findings, it is important to address 
potential methodological caveats. One such caveat relates to the role of DA in the 
initiation of movement. Thus, in the current series of experiments treatment with SCH 
23390 may have reduced responding on the reinstatement test because of a non-specific 
inhibition of motor performance rather than a change in the motivation to seek heroin  
(Crombag et al., 2002). It is worth noting here that intra-BLA administration of the high 
SCH 23390 dose appeared to result in a reduction in active and inactive lever responding 
during the sated as well as FD test day. Also, a decrease in inactive lever responding, 
following antagonist administration, was observed in some experiments (see results). 
However, antagonist doses were drawn from previous research in which motor effects 
were not reported. Furthermore, as described above, photocells were placed in the center 
of the operant chambers and the number of beam breaks observed, a reflection of general 
locomotion, was not found to differ as a function of SCH 23390 dose. Finally, inactive 
lever responding is generally low in reinstatement studies and as such may not be an 
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appropriate measure of a non-specific motor impairment (Crombag et al., 2002; Shalev, 
et al., 2002). 
 A second potential caveat involves the length of the reinstatement test as it relates 
to the effective time for SCH 23390 treatment. The half-life of SCH 233390, when 
injected systemically, is approximately 30 min (Bourne, 2001); whereas, in the current 
studies we used a 3h reinstatement test. Thus, test session length may have “diluted” the 
effect of SCH 23390. This possibility seems rather unlikely. Three hours is a standard 
test-session length within the reinstatement literature, and has been used previously in 
studies in which SCH 23390 was infused locally and shown to block drug seeking (for 
example see Bossert et al., 2007). Furthermore, as reported here, SCH 23390 
significantly attenuated acute FD-induced reinstatement when injected into the NAc 
shell, dmPFC, or BLA, under the same test conditions.  
Finally, Caine et al. (1995) have suggested that due to the lipophilic nature of 
SCH 23390, intracranial infusion of this drug can be problematic and result in the spread 
of the drug away from the site of infusion. Thus, the effects observed here may be related 
to the actions of SCH 23390 in regions other than those targeted. This possibility seems 
unlikely given that no effect on acute FD-induced reinstatement was observed when SCH 
23390 was infused into the NAc core, vmPFC, or near the BLA.  
The Role of NAc DA D1-like Receptors in Acute FD-induced Reinstatement of Heroin 
Seeking 
As expected, antagonism of the DA D1 receptor in the NAc shell resulted in an 
attenuation of acute FD-induced reinstatement. In contrast, administration of SCH 23390 
into the NAc core had no effect. These findings coincide with the previous demonstration 
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that blockade of the DA D1 and D2 receptor in the NAc core with the non-selective DA 
antagonist fluphenazine had no effect on footshock-induced reinstatement of cocaine 
seeking (McFarland et al., 2004). Moreover, SCH 23390 administered into the NAc shell, 
but not NAc core, has been shown to attenuate cocaine priming- (Anderson et al., 2003), 
and context-induced reinstatement of heroin seeking (Bossert et al., 2007). Thus, the lack 
of involvement for DA D1 receptors in the NAc core in acute FD-induced reinstatement 
is not unexpected.  
Previously, McFarland et al. (2004) have suggested that the NAc core forms a 
central component in the circuitry underlying all forms of reinstatement. In support of 
this suggestion, transient inactivation of the NAc core, with muscimol and baclofen, has 
been shown to attenuated priming-, cue-, and footshock-induced reinstatement of cocaine 
seeking (Fuchs et al., 2004; McFarland et al., 2004; McFarland & Kalivas, 2001). 
Importantly, McFarland et al. (2004) have also demonstrated that footshock stress leads 
to an increase in extracellular glutamate, but not DA, in the NAc core during cocaine-
seeking reinstatement test. Thus, these researchers conclude that it is the glutamatergic 
input from the dmPFC cortex to the NAc core, and not DA transmission in the core, that 
is critical for footshock stress-induced reinstatement of drug seeking. The current results 
lend support to their conclusion, and extend it to the effects of acute FD stress on the 
reinstatement of heroin seeking. 
In contrast, SCH 23390 administration into the NAc core, but not shell, has been 
shown to block discrete-cue-induced reinstatement of heroin seeking (Bossert et al., 
2007). In addition, transient inactivation of either the NAc core or shell has been shown 
to block both cocaine priming- and footshock stress-induced reinstatement of cocaine 
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seeking (McFarland et al., 2004; McFarland & Kalivas, 2001). These findings suggest a 
dissociation between the role of the NAc shell and NAc core which may be based upon 
the nature of the reinstatement trigger. Furthermore, the disparate role of the NAc core in 
the above studies may be attributable to the nature of NAc core manipulations. Here a 
role for the NAc shell, and not core, in the reinstatement of drug seeking was 
demonstrated by selectively blocking DA D1 receptors with SCH 23390, a procedure that 
is qualitatively different from complete inactivation. This dissociation was clearly 
demonstrated by Yun et al. (2004) who report a difference in discriminative stimulus-
induced reinstatement of sucrose seeking following intra-NAc infusion of SCH 23390, 
TTX or a combination of AMPA and NMDA receptor antagonists (CNQX and AP-5). In 
rats treated with SCH 23390, a substantial reduction in responding to the discriminative 
stimulus was observed; whereas, general inactivation via glutamate receptor antagonism 
or TTX infusion was shown to increase the rate of non-cued responding on the active 
lever and total inactive lever responses, suggesting disinhibition of non-relevant 
behaviors. 
To the best of my knowledge there have been no published studies investigating 
NAc shell DA following acute FD-induced reinstatement. However, it has been shown 
that 7-10 days of restricted feeding (rats restricted to 70-80% of body weight) results in a 
decrease in extracellular NAc DA, as measured by microdialyisis (Pothos, Creese, & 
Hoebel, 1995). The authors suggest that this decrease in DA release may signify a 
starvation-induced, “withdrawal-like”, shift in motivational state leading to the 
performance of behaviors that will result in the increased release of DA (Pothos et al., 
1995). Unfortunately, there is no information in this study about the placement of the 
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probes within the NAc, limiting the ability to generalize these findings to the current data. 
Moreover, acute FD stress may differ from chronic food restriction with regard to NAc 
DA. Exposure to acute stressors such as restraint, footshock, and tail pinch have been 
shown to increase NAc DA (Abercrombie, Keefe, DiFrischia, & Zigmond, 2006; 
Imperato, Mele, & Scrocco, 1992) in the NAc shell but not the NAc core (Kalivas & 
Duffy, 1995).  
Although the current FD manipulation is considered an “acute” manipulation 
compared to chronic food restriction, it is nevertheless different from other acute 
stressors, as it is prolonged and might allow for some neuronal and physiological 
adaptations to occur. It is therefore unclear, as yet, how 21-48h FD stress affects NAc DA 
release during the reinstatement test. Nevertheless, my findings suggest that NAc shell 
DA, acting through the DA D1 receptor, is involved in mediating the expression of acute 
FD-induced reinstatement.  
Here, the role of the DA D1 receptor was investigated specifically; however, these 
findings do not preclude a role for other DA receptors, particularly DA D2-like receptors 
in acute FD-induced reinstatement. For instance, systemic administration of the DA D1 
or DA D2 receptor antagonists, SCH 23390 or raclopride, respectively, has been shown 
to attenuate cocaine seeking behavior, in a renewal paradigm (Crombag et al., 2002) . 
Furthermore, a cooperative effect of DA D1 and D2 receptors, in the NAc shell, is 
suggested by reports that rats will self-administer a mixture of SKF 38393, a DA D1 
receptor agonist, and quinpirole, a DA D2 receptor agonist, into the NAc shell, but will 
not administer these agonists separately at equimolar concentrations (Ikemoto et al., 
1997). Similarly, co-administration of DA D1 and DA D2 receptor agonists, into the NAc 
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shell, has been shown to reinstate extinguished cocaine seeking at doses which had no 
effect on behavior when administered alone (Schmidt & Pierce, 2006). Furthermore, 
antagonism of the DA D1 or DA D2 receptors prior to the administration of a DA D2 or 
D1 receptor agonist, respectively, has been shown to block the reinstatement of cocaine 
seeking (Bachtell, Whisler, Karanian & Self, 2005; Schmidt & Pierce, 2006). Finally, 
administration of the DA D3 receptor antagonist, SB-277011A into the NAc, at the 
border of the shell and core, has been shown to block footshock-induced reinstatement of 
cocaine seeking (Xi et al., 2004). However, it is important to note that we have 
previously shown no significant effect for systemic administration of DA D2 or D3 
receptor antagonists on acute FD-induced reinstatement of heroin seeking (Tobin et al., 
2009).  
The Role of mPFC DA D1-like Receptors in Acute FD-induced Reinstatement of Heroin 
Seeking 
A role for DA D1 receptors in the dmPFC, in acute FD-induced reinstatement of 
heroin seeking, is not surprising given that this region has been shown to be involved in 
stress-induced reinstatement and other forms of drug seeking behavior. Thus, reversible 
inactivation studies, using muscimol and baclofen, have revealed a critical role for the 
dmPFC cortex in priming-, cue-, and footshock-induced reinstatement of heroin and 
cocaine seeking (McFarland et al., 2004; Rogers et al., 2008). These findings also agree 
with those of Park el al. (2002) who reported that injections of a DA agonist (cocaine) 
into the mPFC DA can reinstate cocaine seeking, and that this effect can be blocked by 
administration of the glutamate AMPA receptor antagonist CNQX into the NAc shell. It 
is unfortunate, though, that Park et al. (2002) did not dissociate between injections of 
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cocaine into dmPFC and vmPFC. Recently, however, SCH 23390 infusion, into the 
prelimbic cortex has been shown to block priming- and cue-induced reinstatement of 
heroin seeking (See, 2009; Zavala, Weber, Rice, Alleweireldt  & Neisewander, 2003). 
More importantly, stress-induced reinstatement is also associated with DA 
transmission in the mPFC. For instance, exposure to a brief footshock stress (10 min) has 
been shown to result in a prolonged (> 60 min) increase in DA in the prelimbic cortex 
(McFarland et al., 2004). The same study also demonstrated complete blockade of 
footshock-induced reinstatement of cocaine seeking following intra-dmPFC injection of 
the mixed DA receptor antagonist, fluphenazine. These results are consistent with the 
findings of Capriles et al. (2003), who have reported that injections of SCH 23390, but 
not the DA D2 receptor antagonist, raclopride, into the prelimbic cortex attenuates 
footshock stress-induced reinstatement of cocaine seeking.  
These studies, and my findings, strongly support the hypothesis that the dmPFC 
cortex is an important component of a common pathway by which all reinstatement and 
relapse triggers act to promote drug seeking (Peters, Kalivas, & Quirk, 2009), and that 
DA transmission in the dmPFC is critically involved in this effect (Bossert et al., 2005; 
McFarland et al., 2004).  
The Role of BLA DA D1-like Receptors in Acute FD-induced Reinstatement of Heroin 
Seeking 
 The data presented here suggest a role for DA D1 receptors in the BLA in acute 
FD-induced reinstatement. The BLA, like the NAc and mPFC, receives a stress 
responsive DAergic projection from the VTA (Inglis & Moghaddam, 1999; Stevenson & 
Gratton, 2003). In addition to mediating the behavioral response to stress, the BLA is also 
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critically involved in the attribution of salience to environmental stimuli (Davis, 1992; 
Pierce & Kalivas, 1997; Stevenson & Gratton, 2003). Thus, transient inactivation or 
excitotoxic lesions of the BLA have been shown to interfere with cue-induced 
reinstatement of cocaine and heroin seeking (Fuchs & See, 2002; Meil & See, 1997; 
Rogers et al., 2008). However, intra-BLA infusion of the DA agonists amphetamine or 
cocaine does not lead to the development of a CPP (O'Dell, Sussman, Meyer, 
Neiswander, 1999), nor does lesioning of the BLA affect ongoing cocaine self-
administration (Meil & See, 1997). Thus, the BLA is thought to be involved in the 
conditioned incentive properties, but not the primary reinforcing aspects, of drug use 
(Meil & See, 1997). 
In contrast, transient inactivation of the BLA fails to attenuate footshock stress-
induced reinstatement of cocaine seeking (McFarland et al., 2004). Yet, here acute FD-
induced reinstatement is attenuated by intra-BLA infusion of SCH 23390. Thus, it 
appears that the role of the BLA in stress-induced reinstatement is dependent on the 
nature of the stressor. This conclusion, however, needs to be considered with some 
caution, since the current study and that of McFarland et al. (2004) differ in several ways. 
In McFarland et al. (2004) rats were trained to self-administer cocaine; whereas, in the 
current study they were trained to self-administer heroin. Previously, inactivation of the 
BLA has been shown to attenuate heroin, but not cocaine priming-induced of drug 
seeking (Fuchs & See, 2002; McFarland & Kalivas, 2001; Rogers et al., 2008). 
Furthermore, as discussed above and elsewhere (Bossert et al., 2007), transient inhibition 
of a discrete brain area may result in different behavioral outcomes compared to 
specifically targeting a particular neurotransmitter system. Thus, it is unclear what effect 
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SCH 23390 infusion, into the BLA, would have on footshock-induced reinstatement of 
cocaine, or other drug, seeking.  
Conclusion 
 The findings of the current study expand upon previous findings demonstrating an 
attenuation of acute FD-induced reinstatement following a systemic injection of the DA 
D1 receptor antagonist SCH 23390 (Tobin et al., 2009). Here a critical role for DA 
transmission in the NAc shell, dmPFC, and BLA, in acute FD-induced reinstatement of 
heroin seeking is demonstrated. The neuronal circuitry by which these brain areas interact 
has yet to be elucidated, but nevertheless, some speculation on possible neural circuitry 
underling acute FD-induce reinstatement is offered in the general discussion of this 
thesis. 
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A STUDY OF LONG-TERM ADAPTATIONS IN THE VENTRAL SUBICULAR-
NUCLEUS ACCUMBENS SHELL PATHWAY FOLLOWING HEROIN SELF-




















Long-term exposure to drugs of abuse, such as heroin, can result in the 
development of drug addiction. Importantly, extensive experience with drugs is 
associated with an enduring vulnerability to relapse during times of abstinence. This 
enduring vulnerability is thought to be the result of maladaptive changes in neuronal 
pathways that occur as a result of chronic drug use. In particular, drugs of abuse have 
been shown to exert a profound effect on the mesolimbic DA pathway, including the 
NAc, a major target for VTA DA neurons. Furthermore, stress, a common trigger for 
drug relapse in humans, has been shown to induce synaptic adaptations in the 
hippocampus of opiate-dependent rodents. In the current experiment I focus on changes 
in synaptic plasticity in the pathway from the vSub to the NAc shell. The vSub is a 
primary output region for the hippocampal formation and sends an excitatory 
glutamatergic projection to the NAc shell. Adaptations in the vSub-NAc shell pathway 
have been implicated in opiate withdrawal in passively drug-exposed animals. However, 
opiate-induced changes in the vSub-NAc shell pathway, and potential modulation of this 
pathway by stress, following heroin self-administrating have not been explored. Here, 
male Long Evans rats were implanted with a stimulating electrode into the vSub and a 
recording electrode into the NAc shell, and then trained to self-administer heroin (0.10 
mg/kg/infusion) for a minimum of 10 days. Following training, rats received at least 4 
days of extinction training during which time heroin was unavailable. Under extinction 
conditions, rats were subjected to 48h of FD or given unrestricted access to food and 
tested for the reinstatement of drug seeking. Field excitatory postsynaptic potentials 
(fEPSPs) were recorded following self-administration training, extinction training, and 
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the reinstatement test. In addition, immediately following the 2h reinstatement test, LTP 
was induced using high-frequency stimulation (200 Hz). In the heroin-trained rats, acute 
FD resulted in a significant reinstatement of heroin seeking. No differences in fEPSPs 
size were observed, relative to a drug-naïve control group, over the course of drug 
training or extinction. However, LTP was blocked in FD rats compared to sated rats, 
regardless of drug history. Finally, in heroin-trained rats, a significant inverse correlation 
was observed between LTP magnitude and heroin seeking during the reinstatement test. 
The current results suggest that FD can alter plasticity in the vSub-NAc shell pathway, 

















Most, if not all drugs of abuse directly, or as in the case of opiates, indirectly act 
to stimulate the release of DA within the mesolimbic pathway (Bear & Malenka, 1994; 
Di Chiara & Imperato, 1988; Koob, Sanna, & Bloom, 1998; Nestler, 2001). This property 
is shared with non-drug rewards; but, unlike natural rewards, drug-induced DA release 
does not habituate over time. This lack of habituation leads to an abnormal strengthening 
of the relationship between the effects of a drug and drug associated cues (Di Chiara, 
2002; Hansel & Linden, 2001). With repeated drug use, long-lasting adaptations occur in 
the mesocorticolimbic DA pathway and other reward relevant regions. Such adaptations 
are critical for the development of drug addiction, a condition characterized by 
compulsive drug seeking and relapse following periods of drug abstinence (Koob & 
Volkow, 2010; Martin, Grimwood, & Morris, 2000; Robinson & Berridge, 2000; Wise, 
2004). 
 Of particular importance for the current study is the role of the NAc in the 
reinstatement of drug-seeking behavior, a model of drug relapse. The NAc serves as a 
critical integrator of motivational input from the limbic system and the motor control 
circuitry required to guide behavioral output associated with the procurement of drugs 
(Kalivas, 2009; Kauer & Malenka, 2007; Mogenson et al., 1980; Nicola, Surmeier, & 
Malenka, 2000; Zahm, 1999). In addition to modulatory DAergic input, from the VTA, 
the NAc also receives excitatory glutamatergic input from a variety of sources including 
the vSub, a primary output region for the hippocampal formation that provides spatial and 
contextual information (Cooper, et al., 2006a; Goto & O'Donnell, 2001; Groenewegen et 
al., 1987; Saal, Dong, & Bonci, 2003; Yang & Mogenson, 1985).  
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Previous research has shown that exposure to drugs of abuse can modulate 
synaptic transmission at excitatory NAc inputs, including the vSub input to the NAc 
(Dong et al., 2007; Goto & Grace, 2005b; Thomas, Beurrier, Bonci, & Malenka, 2001). 
Understanding these changes is of crucial importance in understanding specific synaptic 
plasticity mechanisms that may underlie a return to drug seeking under abstinent 
conditions. The vast majority of studies addressing specific changes in synaptic plasticity 
over the course of drug use have tended to focus on psychostimulant-induced effects (see 
exceptions below). Thus, it is unclear what, if any, neuroadaptations occur within the 
vSub-NAc shell pathway following heroin self-administration and subsequent exposure 
to stress. The current study is designed to investigate changes within this pathway in 
rodents trained to self-administer heroin and subsequently tested for acute FD-induced 
reinstatement of heroin seeking, a model of stress-induced relapse.  
Understanding Synaptic Plasticity  
Synaptic plasticity refers to the ability of synapses to undergo activity dependent 
changes in synaptic strength. The vast majority of work on synaptic strength in the 
mammalian brain has focused on LTP and long-term depression (LTD) at excitatory 
synapses; however, both can also occur at inhibitory synapses (Kauer & Malenka, 2007). 
LTP and LTD refer to a sustained increase or decrease, respectively, in the strength of 
connection between neurons brought about by coincident activity of pre- and post-
synaptic neuronal elements resulting in the facilitation or inhibition of chemical 
transmission that can last for weeks, or months in vivo (Bear & Malenka, 1994; Madison, 
Malenka, & Nicoll, 1991; Sesack & Grace, 2010).  
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 LTP is a particularity important model of activity-dependent synaptic plasticity as 
it is considered to be a cellular correlate of long-term memory and learning in general 
(Bliss & Collingridge, 1993; Kauer & Malenka, 2007; Malenka, 1994; Malinow & 
Malenka, 2002; Martin, Chen, Hopf, Bowers, & Bonci, 2006; Thomas et al., 2001). The 
mechanisms mediating the induction of LTP have been studied extensively and numerous 
hypotheses, as well as differing forms of LTP, have been proposed (Baudry & Lynch, 
2001; Thomas et al., 2001). In brief, the most widely studied form of LTP relies upon 
glutamaterigic receptors, particularly the NMDA receptor (Kauer & Malenka, 2007; 
Martin et al., 2006). Under normal conditions, stimulation of the post-synaptic neuron 
causes the activation of AMPA receptors. Such activation allows sodium ions to enter the 
neuron, which produces a short-term depolarization known as an excitatory postsynaptic 
potential (EPSP). With repeated high-frequency stimulation, as is the case for a tetanic 
stimulation, each successive EPSP contributes to the depolarization produced by the 
previous EPSP, a process known as EPSP summation (Cornish, Duffy, & Kalivas, 1999; 
Madison et al., 1991; Wang, Xu, Wu, Duan, & Poo, 2003). Given sufficient 
depolarization of the neuron, the blockade of NMDA calcium channels by magnesium 
ions is removed allowing an influx of sodium and calcium ions into the cell. As calcium 
concentration in the cytosol increases, protein kinase enzymes such as 
calcium/calmodulin-dependent protein kinase II (CaMKII), protein kinase C (PKC), and 
mitogen-activated protein kinase (MAPK) become activated (Baudry & Lynch, 2001; 
Blaha et al., 1997; Floresco et al., 2003; Kauer & Malenka, 2007; Sweet & Neill, 1999; 
Sweatt, 2001; Malenka, 1994). These protein kinases are critically involved in the 
phosphorylation of existing AMPA receptors and the insertion of new AMPA receptors 
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into the post-synaptic membrane (Esteban et al., 2003; Lee et al., 2003; Legault & Wise, 
2001). Such changes ensure that future stimulation of the synapse leads to a greater post-
synaptic response. Furthermore, late potentiation of the postsynaptic response is 
associated with changes in protein transcription and gene expression; the end result of 
which is a long lasting change in the efficiency of a synapse, or LTP (Black, Green-
Jordan, Eichenbaum, & Kantak, 2004; Kauer & Malenka, 2007).  
In contrast, an increase in NMDA receptor-dependent calcium influx, which does 
not reach the threshold for the induction of LTP can result in a short-term potentiation 
(STP) or a LTD. Unlike LTP, STP is not long lasting and electrophysiological effects 
return to baseline levels over a period of 5-20 min (Malenka & Nicoll, 1999; Vorel, Liu, 
Hayes, Spector & Gardner, 2001). LTD, on the other hand, refers to a long-lasting change 
in synaptic plasticity, which may depend upon similar mechanisms to LTP (Bear & 
Malenka, 1994; Dong et al., 2007). LTD, particularly within the cerebral cortex, has been 
implicated in motor learning (Goto & Grace, 2005a; Hansel & Linden, 2001) and may 
also serve as one of several processes that weaken specific synapses in order to amplify 
those that have been strengthened by LTP (Martin et al., 2000; Yang & Mogenson, 
1984). 
Synaptic Plasticity Within the Mesolimbic DA pathway 
As alluded to previously, drug abuse can be viewed as a form of aberrant learning 
and as such, drugs of abuse have been shown to modify synaptic strength within the 
mesolimbic DA pathway. In particular, synaptic plasticity within the VTA has been 
implicated in the early behavioral response to drugs of abuse (Cooper, Moore, Staff, & 
Spruston, 2003; Kauer & Malenka, 2007). For instance, Saal et al. (2003) has shown an 
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increase, in vitro, in the ratio of AMPA receptor mediated synaptic currents to NMDA 
receptor mediated synaptic currents, indicating an increase in excitatory synaptic 
transmission on DA neurons in the VTA, 24h after a single in vivo administration of 
cocaine, amphetamine, morphine, nicotine or ethanol. Similarly, Ungless et al. (2001) has 
shown that a single in vivo cocaine exposure induces LTP of AMPA receptor mediated 
currents at excitatory synapses onto VTA DA neurons, in vitro, 24h and 5 days, but not 
10 days, after the drug exposure, indicating that cocaine and possibly other drugs or 
stress-induced synaptic potentiation in the VTA is transient in nature (Ungless et al., 
2001). Finally, vivo cocaine exposure resulted in a blockade of LTP and an enhancement 
of LTD, at the these synapses, indicating that LTP and cocaine-induced synaptic 
potentiation share similar mechanisms (Sandi & Pinelo-Nava, 2007; Ungless et al., 
2001). 
 Changes in synaptic plasticity which result in stronger excitatory synapses on 
VTA DA neurons may lead to changes in the release of DA downstream of the VTA (de 
Quervain, Roozendaal, & McGaugh, 1998; Kauer & Malenka, 2007). One region of 
particular importance is the NAc. The majority of neurons within the NAc are 
GABAergic medium spiny neurons. In addition to modulation by VTA DAergic input 
these neurons also receive excitatory glutamatergic input from a number of cortical and 
subcortical regions such as the PFC, entorhinal cortex, amygdala, and vSub, as well as 
inhibitory GABAergic input from regions such as the VP and VTA (Conboy & Sandi, 
2010; Sesack & Grace, 2010). Moreover, the VP and VTA constitute the major efferent 
targets of NAc neurons. Thus, changes in the efficiency of synapses onto medium spiny 
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neurons in the NAc are likely to feedback into further changes within the mesolimbic DA 
system (Herman et al., 1995; Kauer & Malenka, 2007; Thomas et al., 2001).  
In contrast to findings in the VTA, a single administration of cocaine has been 
shown to have no effect on the ratio of AMPA to NMDA receptor mediated excitatory 
postsynaptic currents in the NAc in vivo. However, 5 days of chronic cocaine 
administration followed by a withdrawal period and a challenge dose of cocaine causes a 
significant reduction in the ratio of AMPA to NMDA receptor mediated excitatory 
postsynaptic currents at PFC afferents synapsing onto NAc shell medium spiny neurons. 
Furthermore, a significant reduction in the induction of LTD was observed in cocaine-
treated animals suggesting that this reduction in synaptic plasticity was due to 
mechanisms shared with LTD (Herman et al., 1995; 1998; Thomas et al., 2001). 
Similarly, cocaine self-administration has been shown to inhibit the induction of LTD in 
both the NAc shell and core following 1-day of abstinence, but only in the NAc core 
following 21 days of abstinence. In contrast, LTD was inducible in yoked rats receiving 
equivalent amounts of cocaine, rats self-administering food, and drug-naïve rats, 
suggesting that cocaine self-administration may produce long-lasting neuroadaptations in 
the NAc, particularly in the NAc core, which are distinct from those induced by the basic 
pharmacological effects of the drug or from operant responding for non-drug reward 
(Herman et al., 1995; 1998; Martin et al., 2006). Importantly, persistent adaptations in 
glutamate receptors resulting from changes in synaptic plasticity may contribute to drug 
seeking behavior under abstinent conditions. For instance, Cornish et al. (1999) have 
demonstrated that AMPA receptor activation in the rat NAc will reinstate extinguished 
cocaine seeking; whereas, the AMPA/kainate receptor antagonist CNQX, but not the DA 
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receptor antagonist ﬂuphenazine, blocks cocaine priming-induced reinstatement of 
cocaine seeking (Cornish & Kalivas, 2000). 
Synaptic Plasticity in the vSub-NAc Shell Pathway in Response to Drug Exposure 
 As previously mentioned, the NAc shell receives glutamatergic input from the 
vSub. Moreover, stimulation of the vSub, with NMDA, has been shown to increase the 
number of spontaneously firing DA cells within the VTA, an effect which is abolished by 
intra-NAc infusion of the glutamate receptor antagonist kynurenic acid or intra-VP 
infusion of the GABAA and GABAB agonists baclophen and musimol, suggesting that the 
vSub activates VTA DA neurons through a vSub-NAc shell-VP-VTA pathway (for a 
detailed description of this pathway see Floresco et al., 2003; Nettles et al., 2000). 
Additionally, electrical stimulation of the vSub causes an increase in DA oxidation 
currents, a measure used to assess DA terminal efflux, in the NAc (Blaha et al., 1997; 
Herman et al., 1998). Moreover, the reinforcing effects of vSub self-stimulation are 
enhanced following NAc amphetamine infusion suggesting a relationship between NAc 
DA tone and the influence of the vSub on motivated behavior (Sweet & Neill, 1999). 
Additionally, intra-NAc infusion of glutamate receptor antagonists block the increase in 
DA efflux observed in the NAc following vSub stimulation, suggesting that the vSub 
input to the NAc shell may act upon glutamate receptors to presynaptically modulate DA 
release (Blaha et al., 1997; Canteras & Swanson, 1992; Cullinan, Herman, & Watson, 
1993). Furthermore, inactivation of the vSub with TTX blocks extracellular NAc DA 
release (Legault & Wise, 2001; Liu & Liang, 2009). Finally, inhibition of the vSub with 
lidocaine attenuates cocaine priming- and cue-induced reinstatement of drug seeking 
(Foy, Stanton, Levine, & Thompson, 1987; Shors, Seib, Levine, & Thompson, 1989; Sun 
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& Rebec, 2003; also see Black et al., 2004 for a discussion of the importance of drug 
training history) whereas, stimulation of the vSub causes a reinstatement of cocaine-
seeking behavior under extinction conditions (Taepavarapruk & Phillips, 2003; Vorel et 
al., 2001). 
 Despite the observed role for the vSub in drug seeking behavior there is a paucity 
of research investigating the relationship between this structure and synaptic plasticity 
within the NAc shell as it relates to animal models of addiction. Thus, there appear to be 
no studies investigating LTP, in the vSub-NAc shell pathway, within the context of the 
reinstatement model. There are, however, several studies that suggest the potential 
importance of this pathway in neuroplastic changes induced by drugs of abuse. For 
instance, Dong et al. (2007) has shown an impairment in the induction of LTP within the 
vSub-NAc shell following 12 days of experimenter administered morphine and 2, but not 
4, days of drug withdrawal. Furthermore, Goto and Grace (2005b) showed that synaptic 
plasticity at vSub inputs in the NAc was disrupted in rats sensitized to experimenter 
administered cocaine. Moreover, these researchers suggest that phasic DA release, within 
the NAc, facilitates vSub inputs to the NAc, via DA D1 receptors, shifting the balance of 
NAc input away from PFC input. Furthermore, mesolimbic DA transmission has been 
shown to exert a modulatory influence over the vSub input to the NAc. For instance, 
electrical trains delivered to the VTA prior to stimulating the vSub, reduce the excitation 
of NAc DA by vSub stimulation (Saal et al., 2003; Yang & Mogenson, 1984).  
The Role of the vSub in Stress Responsivity 
 Since LTP is thought to represent a cellular correlate of learning and memory, it is 
important to briefly touch on the effect of stress on learning. Studies of this nature have 
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shown that stress can impair or facilitate learning and memory depending upon the 
procedure (Kim & Diamond, 2002; Kourrich, Rothwell, Klug, & Thomas, 2007; 
Rothwell, Kourrich, & Thomas, 2011; Sandi & Pinelo-Nava, 2007). For instance, de 
Quervain et al. (1998) have shown that exposure to footshock stress 30 min prior to a 
Morris water maze retention test significantly impairs performance. Furthermore, these 
authors show that administration of metyrapone, which blocks corticosterone synthesis, 
blocks stress-induced memory impairments. In addition, in non-stressed rats 
administration of corticosterone prior to the test induces an impairment in memory 
retention. In contrast, Conboy and Sandi (2010) show that cold-temperature stress 
facilitates learning in a Morris water maze. These authors demonstrated that mice trained 
in colder water (22 °C) have increased post-training corticosterone levels and increased 
post-training learning relative to mice trained in warmer water (30 °C).   
 Related to these findings, the vSub has been shown to play a substantial role in 
stress integration. For instance, lesions of the vSub have been shown to have no effect on 
basal corticosterone level or the circadian pattern of corticosterone release (Herman et al., 
1995). However, lesions of this structure increase CRF mRNA and CRF peptide 
expression in the paraventricular nucleus of the hypothalamus (PVN), increase restraint 
stress-induced CRF release, increase the depletion of PVN CRF following restraint or 
open field stress and increase ACTH response to a novel auditory stress while having no 
effect on HPA axis driven negative feedback (Herman et al., 1995; 1998; Nettles et al., 
2000).  
Collectively these studies suggest that the vSub acts to inhibit the actions of the 
HPA axis (Herman & Mueller, 2006). However, projections from the vSub have been 
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shown to innervate the BNST and amygdala, and it may be the case that the vSub 
influences stress responsivity through GABAergic projections from these structures to the 
PVN (Canteras & Swanson, 1992; Cullinan et al., 1993; Dworkin, Goeders, & Smith, 
1985). Moreover, the vSub has been shown to interact with BNST in the formation of an 
aversive memory (Liu & Liang, 2009), suggesting a functional link between these 
structures which could potentially play a role in stress-induced reinstatement of drug 
seeking. As discussed in the general introduction, the effects of acute FD on the 
reinstatement of drug seeking are likely mediated by the actions of extra-hypothalamic 
CRF, particularly acting within the BNST (Dong et al., 2007; Donny, Bigelow, & Walsh, 
2006; Erb & Stewart, 1999; Erb et al., 1998; Nettles et al., 2000). 
Similarities Between Drugs and Stress with Regard to Synaptic Plasticity  
 As mentioned previously there is a limited amount of research focusing on 
synaptic plasticity within the vSub-NAc shell pathway in the context of drug-related 
effects. Dong et al. (2007) has demonstrated that acute withdrawal (12h) from 12 days of 
experimenter administered morphine impairs the induction of LTP within the vSub-NAc 
shell pathway; however, LTP induction is restored following 4 days of withdrawal. 
Moreover, stress-induced by 30 min on an elevated plus maze enabled low frequency 
stimulation (1 Hz), that was ineffective in non-stressed rats, to produce an LTD within 
the vSub-NAc shell pathway, following 12h but not 4 days of withdrawal.  
 Additionally, stress and drugs of abuse have been shown to produce similar 
changes in synaptic plasticity within the mesolimbic DA system. As mentioned above, a 
single exposure to a variety of abused drugs results in an increase in synaptic strength at 
VTA synapses, as indicated by an enhanced ratio of AMPA/NMDA receptor mediated 
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synaptic currents. Furthermore, there is an increase in the ratio of AMPA/NMDA 
receptor mediated synaptic currents, in the VTA, 24h after a single cold water forced 
swim stress suggesting that stress and drugs induce similar neuroplastic changes (Saal et 
al., 2003). Additionally, two days of cold water forced swim stress and novelty increase 
the ratio of AMPA/NMDA receptor mediated synaptic currents on excitatory 
glutamatergic synapses within the NAc. However, this effect is only observed on medium 
spiny neurons in the NAc shell and not in the NAc core (Campioni, Xu, & McGehee, 
2009; Rothwell et al., 2011). Furthermore, repeated in vivo administration of cocaine has 
been shown to enhance NAc excitatory synaptic transmission following a protracted 
withdrawal period. However, if cocaine is administered during this withdrawal period, a 
reversal of potentiation and synaptic depression is observed (Kourrich et al., 2007). 
Similarly, a reinstatement of CPP following a priming injection of cocaine or a forced 
swim stress is associated with a reduction in synaptic strength within the NAc shell. 
Thus, triggers associated with the reinstatement of drug seeking, such as drug-priming 
and stress, appear to demonstrate a common form of synaptic plasticity in the NAc, 
particularly within the NAc shell (Rothwell et al., 2011). 
However, it is worth noting that in the studies above, which discuss synaptic 
plasticity at excitatory synapses, within the NAc, with the exception of Dong et al. 
(2007), the stimulating electrode was targeted at fibers projecting from the PFC to the 
NAc, not from the vSub to the NAc.  
The Current Study 
Despite the demonstrated involvement of the NAc shell and the vSub in drug 
seeking behavior, there are relatively few studies investigating changes in synaptic 
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plasticity in the vSub-NAc shell pathway following opiate use. One notable exception is 
the study of Dong et al. (2007) in which rodents were administered morphine twice a day 
for a period of 12 days. In this study an impairment in the induction of LTP within the 
vSub-NAc shell pathway was observed following 12h, but not 4 days, of withdrawal. 
Here we expand upon the results of Dong et al. (2007) by investigating changes in the 
vSub-NAc shell pathway following heroin self-administration, extinction, and exposure 
to acute FD, a stressor known to reliably reinstate drug seeking (Shalev et al., 2000). 
Acute FD stress is functionally distinct from other forms of stress in that it represents a 
challenge to metabolic homeostasis. Thus, it is unclear what, if any, effect acute FD will 
have on synaptic plasticity in the vSub-NAc shell pathway. However, given that 
experimenter administered morphine and subsequent withdrawal impairs the induction of 
LTP in the vSub-NAc shell, an impairment in LTP within this pathway is expected in rats 
trained to self-administer heroin. Furthermore, acute stress and drugs of abuse have been 
shown to have similar effects on synaptic plasticity; thus an impairment in the induction 
of LTP following acute FD stress is expected. However, in rats with a history of both 
drug self-administration and acute FD-induced reinstatement it is expected that stress will 
reverse the effects of previous drug exposure which should allow for the induction of 
LTP in previously drug-trained rats. 
METHODS 
Subjects 
 Subjects consisted of 63 male Long Evans rats (Charles River, St Constant, QC, 
Canada) weighing 350-450 g at the start of experimentation. Prior to surgery rats were 
given 1 week to habituate to daily handling and facility light (normal 12:12 h light-dark 
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cycle, lights on at 8:00 a.m.; lights off at 8:00 p.m.) and temperature conditions (21C).  
Following IV catheterization and electrode implantation surgery and 1-2 weeks recovery, 
rats were transferred to self-administration chambers or remained in the animal care 
facility. With the exception of tests for acute FD-induced reinstatement (see below), food 
and water were available ad libitum. All experimental procedures were approved by the 
Concordia University Animal Research Ethics Committee.  
Surgery 
 Rats were implanted with bipolar electrodes under anesthesia  
(xylaxine+ketamine, 10+100 mg/kg, IP or inhaled Isoflurane 5%-1.5%). Bipolar 
electrodes were constructed from two segments of Teflon-coated stainless steel twisted-
wire (125 um tips separated by 1.0 mm). Electrode leads were connected to gold-plated 
Amphenol pins and lowered through burr holes into the vSub (AP: -6.5 mm, ML: 5.0 
mm, DV: 5.5-6.0 mm) and the NAc shell (AP: +1.6 mm, ML: +1.0, DV: 5.5-7.3 mm). 
The vertical position of both the stimulating electrode (vSub) and recording electrode 
(NAc shell) was adjusted to optimize the amplitude of field EPSPs (fEPSP) in the NAc 
shell. Once both electrodes were lowered to the target location an electrical stimulation, 
in most cases 1000 uA, was delivered to the vSub, and the NAc shell response was 
observed. Electrodes were adjusted to ensure the largest peak amplitude and a 15-25 ms 
response latency (see traces below). In addition to the electrodes, two stainless-steel 
screws were placed in the contralateral skull and served as reference electrode and as a 
ground. Finally, electrode leads, and wires from the reference and the ground screws 
were inserted into a 9-pin Macintyre connector and the connector was secured to the skull 
using jewelers’ screws and dental cement.  
 93 
 Immediately prior to, or 1 week following electrode implantation, an IV silastic 
catheter (Dow Corning, Midland, MI) was inserted into the right jugular vein as 
described previously in the general methodology. 
Apparatus  
 Following recovery from surgery, rats assigned to the heroin-training groups were 
moved from the animal care facility to operant self-administration chambers. These 
chambers are described in the general methodology; however, for this experiment the 
inactive lever was not retractable. Rats that remained in the animal care facility were 
singly housed in standard shoebox cages throughout experimentation. 
 For electrophysiological recordings rats were placed in a 30.0 X 60.0 X 30.0 cm 
Plexiglas chamber. Between testing sessions the floor, plastic grill flooring, and all walls 
were cleaned with 70% ethanol to minimize odor from the previous rat. fEPSPs were 
recorded from the NAc Shell using Datawave Software (DataWave Technologies, 
Loveland, CO, USA).  
Drugs 
 As described in the general methodology, heroin (diacetylmorphine HCL) was 
dissolved in physiological saline. However, as a result of different infusion pumps being 
used in this experiment, the volume of heroin delivered per infusion was reduced by 
approximately half; thus, the drug syringe concentration was increased to account for this 
difference. 
Procedure  
 The behavioral portion of this study consists of three phases: heroin self-
administration training, extinction training, and reinstatement testing. These phases are 
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described in detail (see general methodology). Therefore, only procedural modifications 
and a brief procedural description are noted here. Additionally, prior to, and during each 
of these phases, electrophysiological recording were made at regular intervals. Control 
animals were treated in a similar manner with regard to daily maintenance and 
electrophysiological procedures. 
 Heroin Training, Extinction Training & Reinstatement 
   Following electrode implantation and IV catheterization surgery rats were 
assigned to one of four training and reinstatement conditions: heroin self-administration 
and acute FD (Her-FD), heroin self-administration and sated (Her-Sated), drug-naïve and 
acute FD (Naïve-FD) and drug-naive and sated (Naïve-Sated). All drug-naïve rats 
remained in the animal colony and were never exposed to heroin.    
 For animals in the heroin self-administration conditions, training was conducted 
over a period of 10-14 days. Throughout training, rats received three 3-h drug sessions 
beginning at 1:00 p.m.  Following training the heroin syringes were removed and rats 
underwent a period of extinction training. Rats were given three-3h extinction sessions on 
the first day and one session thereafter. Once an extinction criterion of 15 or less active 
lever responses (per 3-h session) was reached, rats were tested for reinstatement of drug 
seeking, under extinction conditions. Rats were given one reinstatement test, which was 
preceded by a 48h ‘off’ period during which time no extinction sessions were conducted 
and rats were either food deprived or had unrestricted access to food.  
 Electrophysiology 
  For each rat, monopolar and bipolar electrophysiological responses were 
recorded. Thus, in cases where I was unable to obtain a bipolar recording, a monopolar 
 95 
recording was used. However this recording was compared to the reference to reduce 
interference. Electrical stimuli were generated using a digital to analog channel (50 kHz) 
and a stimulus isolation unit (A-M Systems, Model 2200). NAc shell responses were 
amplified, digitized at 1024 Hz, and stored for analysis.  
 Prior to, and throughout all experimental phases, rats received input/output tests to 
monitor synaptic responses, fEPSP, in the NAc shell, evoked by stimulation of the vSub 
(see data analysis). Input/output tests consisted of removing the rat from the operant 
chamber, placing it in the electrophysiological chamber, and attaching the Macintyre plug 
to a lead. For the input/output test rats received 5 stimulus sweeps consisting of three 
pulse intensities (100, 500, and 1000 uA). Following the reinstatement tests, LTP was 
induced using high-frequency stimulation consisting of 10 trains, separated by an inter-
train interval of 2 s, with 20 pulses at 200 Hz per train (Dong et al., 2007). In order to 
optimize the induction of LTP, response intensities were adjusted for each rat, such that 
60% of the maximal response was evoked prior to the delivery of the train.  
Data Analysis  
 To assess the effect of acute FD on the reinstatement of heroin seeking behavior, a 
series of ANOVAs were preformed using deprivation state (sated or FD) as a between 
subjects factor and day (baseline or test day) as a within subjects factor.  
Electrophysiological responses were analyzed using DataWave Software 
(DataWave Technologies, Loveland, CO, USA). For the analysis of input/output tests and 
the induction of LTP, standardized rather than raw data was assessed. This was done for 
ease of comparison and is a standard practice. For the input/output test, raw fEPSP 
amplitude was standardized to the highest intensity response, which was observed at 
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1000 uA, on the second baseline recording day, conducted prior to the start of heroin 
training. Changes in the input/output test were assessed using separate repeated measures 
ANOVAs for the heroin-trained animals and for the drug-naïve rats. For these ANOVAs, 
day was used as a within subjects comparison and deprivation state (sated or FD) was 
used as a between subjects factor. Analyses were performed on input/output data from the 
following days: two days of baseline recordings (prior to drug self-administration; BL1 
and BL2), early self-administration (SA days 1-2), mid-self-administration (SA days 2-
4), late self-administration (SA days 8-12), the first extinction day (Ext 1), the last 
extinction day before the 48h “off” period (Ext-Pre), and immediately prior to the LTP 
test (Test). In cases where an animal had multiple input/output tests, during a given time 
point, the most internally consistent response was chosen. For drug-naïve rats, data from 
the two days of baseline recordings (BL1 and BL2), the day before the 48h “off” period 
(Pre-Test) and immediately prior to the induction LTP (Test) were analyzed. 
 Furthermore, since the most interesting day with regard to the input/output tests is 
immediately before the induction of LTP, an additional ANOVA was preformed on the 
input/output data at this time using drug history (heroin or drug-naive) and deprivation 
state (sated or FD) as between subjects factors.  
For LTP, raw fEPSP amplitude measures were standardized to the average of the 
10 min prior to the delivery of the stimulus train. % fEPSP amplitude was used for all 
statistical analyses. Additionally, LTP magnitude was assessed by comparing the average 
% fEPSP amplitude for the last 10 min of recording to the average % fEPSP for the 10 
min baseline period using a repeated measures ANOVA. Drug history (heroin or drug-
naive) and deprivation state (stated or FD) were considered between subjects factor and 
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time (baseline or final 10 min) was considered a within subjects factor. To assess the 
relationship between acute FD-induced reinstatement and the magnitude of LTP, a drug 
seeking score was computed using the following formula: Test day active lever 
responding – baseline active lever responding. Drug seeking score was correlated with 
average % fEPSP amplitude during the last 10 min using a Pearson’s product moment 
correlation. For all comparisons significance was evaluated at p < .05 and all significant 
ANOVA results were followed-up by Sidak corrected t-tests. 
RESULTS 
 Six rats did not survive the surgeries, 3 were removed due to the lose of a 
headcap, 1 rat was removed from the self-administration group due to a leaky catheter, 2 
rats were removed due to a failure to train (defined as less than 15 active lever responses 
over 3h on the last day of training), 1 rat was removed because of a procedural error, and 
22 rats were removed because of an overly variable or poor electrophysiological response 
to stimulation. Thus, the final number of rats in each of the experimental conditions was: 
HER-FD n = 6; HER-Sated n = 5; Naive-FD n = 9 and Naive-Sated n = 8.  
Behavioral Performance 
 As demonstrated in Figure 1, rats showed a clear preference for the active, drug-
paired lever over the inactive non-drug-paired lever. On the last training day the mean 
(+/- SEM) number of infusions, active lever responses and inactive lever responses were 
48.81 (+/- 10.41), 109.91 (+/-18.93) and 28.91 (+/-12.88), respectively. Following 
training rats received a mean of 7.40 (SEM = 1.06) extinction days and a 48h “off” 
period. An effort was made to match heroin-trained rats to the sated and FD conditions 





Mean (+/- SEM), number of active lever presses, inactive lever presses and infusions (0.1 
mg/kg/infusion) for the 11 rats trained to self-administer heroin. Rats were trained to self-
administer heroin over a minimum of 10 training days (T1-10; three-3h session per day) 
and the first extinction day (Ext 1). A significant difference existed between active and 

































F(1, 9) = 0.21, p = .66, ηp
2 = .06, active lever responding (MSated =160.93, SEM = 7.70; 
MFD =138.93, SE = 5.16), F(1, 9) = 5.98, p = .04, ηp
2 = .40, and inactive lever (MSated = 
24.96, SEM = 0.77; MFD =23.51, SE = 1.78, F(1, 9) = 0.48, p = .51, ηp
2 = .05 based on the 
mean of the last 5 days of training. However, as can be seen above, since some animals 
were removed at a later phase of the experiment, the groups are not well matched. 
 A mixed factorial ANOVA investigating active lever responding during the 
reinstatement phase revealed a significant effect of day (baseline or Test), F(1, 9)  = 
11.77, p < .01, ηp
2 = .57, a significant effect of deprivation state (sated or FD), F(1, 9)  = 
10.75, p = .01, ηp
2 = .54, and a significant day X deprivation state interaction, F(1, 9)  = 
10.49, p = .01, ηp
2 = .54 (see Figure 2A). Follow-up analyses, to investigate the 
interaction between day X deprivation state revealed a significant increase in responding 
on the active lever compared to the baseline extinction session in the FD rats, and a 
significantly higher rate of response in the FD rats compared to the sated ones on the test 
day, ps < .05. This is despite the higher response rate on the active lever for the sated 
group during self-administration training. For the responses on the inactive lever, there 
was no significant effect of day, F(1, 9)  = 0.01, p = .91, ηp
2 = .01, deprivation state, F(1, 
9)  = 0.20, p = .67, ηp
2 = .02 or day X deprivation state interaction, F(1, 9)  = 1.00, p = 
.34, ηp
2 = .10 (see Figure 2B). 
Electrophysiology 
The data from the input/output tests include the two days of baseline recordings, 
early self-administration, mid-self-administration, late self-administration, the first 




Figure 2.  
The effect of an acute 48h FD on heroin seeking in abstinent animals. Data are mean (+/-
SEM) number of active (A) and inactive lever (B) responses made during the baseline 
(BL) extinction session and following 48h unlimited access to food (Sated, n = 5) or food 
deprived (FD, n = 6). * p < .05 relative to the baseline condition. @ p < .05 compared to 















































to the LTP test are displayed in Figure 3A. For drug-naïve rats, baseline recordings, the 
day before the 48h sated or FD period and immediately prior to the LTP test are  
displayed in Figure 3B. As is apparent in Figure 3, there was no significant effect of 
time, F(7,56) = 0.53, p = .81, ηp
2= .06, deprivation state, F(7,56) = 1.75, p = .22, ηp
2= 
.18, or time X deprivation state interaction, F(1,8) = 1 .75, p = .22, ηp
2= .18 across 
input/output tests for rats trained to self-administer heroin. Similarly, for drug-naïve rats 
there was no significant effect of time, F(3, 45) = 1.24, p = .30, ηp
2= .08, deprivation 
state, F(1,15) = 1.43, p = .25, ηp
2= .09, or time X deprivation state interaction, F(3,45) = 
1.45, p = .25, ηp
2= .09. An additional ANOVA preformed on the test day also revealed no 
significant effect of drug history, F(1, 24) = 0.81, p = .38, ηp
2= .03, deprivation state, 
F(1, 24) = .55, p = .47, ηp
2= .02, or drug history X deprivation state interaction, F(1, 24) 
= 2.82 p = .13, ηp
2= .10.   
In order to assess any differences in LTP across conditions, a repeated measures 
ANOVA was preformed as described above. This ANOVA revealed a significant effect 
of time, F(1, 24) = 13.93, p < .001, ηp
2= .37, a significant time X deprivation state 
interaction, F(1,24) = 4.78, p = .04, ηp
2= .17, and a tendency toward a significant effect of 
deprivation state, F(1,24) = 4.05, p = .06, ηp
2= .15 (see Figure 4). Further analyses 
revealed no significant difference between food deprived and sated animals during the 
baseline period (MFD = 100.67, SEM = 0.30; MSated = 100.10, SEM = 0.26), p > .05. 
However, only animals in the sated condition had a significant increase in % fEPSP 
amplitude during the last 10 min of recording (M = 126.86, SEM = 6.54), compared to the 
baseline average, p < .05. Thus, animals exposed to acute FD showed no significant 
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change in % fEPSP amplitude, while sated animals showed an approximately 26% 
facilitation (see Figure 5).  
Despite the apparent difference between groups in terms of the immediate 
response to the stimulus train, there was no significant difference between groups in 
terms of length of time to return to baseline, as measured by the first time point at, or 
exceeding 100% fEPSP amplitude following the stimulus pulse (MNaive-Sated = 4.31 min, 
SEM = 1.36; MNaive-FD = 4.61 min, SEM = 1.98; MHeroin-Sated = 10.20, SEM = 3.36; MHeroin-
FD = 4.83 min, SEM = 2.76), F(3,24) = 1.25, p = .21, ηp
2= .14. Finally, as shown in  
Figure 6, the magnitude of LTP decreased, within heroin-trained rats, as drug seeking 





Figure 3.  
Input/Output tests recording across experimental days for heroin-trained (A) and drug-
naïve rats (B) animals, that were tested under sated or food deprived (FD) conditions. All 






















































Figure 4.  
% fEPSP amplitude relative to baseline. Data are mean (+SEM) % fEPSP amplitude 
standardized to the mean of the baseline period. Data are shown in 2.5 min segments 
consisting of the average of 5 recording points over the course of a 10 min baseline and 
48 min of recording after the stimulus train delivery. BL1-4 correspond to the 4 baseline 
































































































































Mean (+SEM) % fEPSP amplitude expressed as the percent change from baseline for the 
average of the last 10 min of recording. Bars correspond to the mean (+SEM) for sated 
rats (heroin-trained and naïve sated; white) and food deprived (heroin-trained and naïve 
food deprived, FD; black) rats. * significantly greater than baseline, p < .05. Additionally, 
a sample traces from the baseline (left trace) and final 10 min of recording (right trace) 
are shown for a sample FD rat (dashed line) and a sample sated (solid line) rat. Traces 
were created using a mean of 5 traces from each time period. Calibration: Vertical scale 
































Figure 6.  
Scatterplot and trend line demonstrating the relationship between LTP magnitude (the 
average of the last 10 min of recording during the LTP test) and drug seeking behavior 
(Active lever responding on the test day – Active lever responding on the baseline day 
prior to the food deprivation or sated test). Rats that were food deprived on the test day 
are indicated by diamonds, and sated rats are indicated by circles. A significant 
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DISCUSSION 
 The main finding of the current study is that acute FD impairs the ability of a 
high-frequency stimulation to induce LTP in the vSub-NAc shell pathway. This 
impairment in LTP induction was seen in both heroin-trained and drug-naïve food 
deprived rats. Furthermore, there was no impairment in the induction of LTP in heroin-
trained sated rats, indicating that a period of acute FD, and not drug history, is associated 
with a reduction in the induction of LTP. In addition, drug exposure also appears to have 
no effect on synaptic plasticity in the vSub-NAc shell pathway during heroin self-
administration training and extinction, as evidenced by the lack of change in the 
input/output tests. Finally, amongst heroin-trained rats, a significant inverse correlation 
was found between drug seeking on the reinstatement test day and LTP magnitude. Thus, 
rats that showed higher levels of reinstatement of heroin seeking also showed impaired 
LTP.  
The Lack of Effect for Drug Self-Administration Training on Synaptic Plasticity 
 The finding that previous drug history was not associated with changes in 
synaptic plasticity, as measured by input/output tests and the induction of LTP, is 
somewhat surprising. Previously, it has been shown that drug administration and 
subsequent withdrawal can impair the induction of LTP in the vSub-NAc pathway in 
animals that have been chronically treated with morphine. This impairment was evident 
24h after the last morphine infusion. However, 4 days after the last infusion of morphine 
LTP was induced to a similar degree in morphine-withdrawn and saline-treated rats 
(Dong et al., 2007). In contrast, in adolescent rats administered the cannabinoid 
CB1/CB2-receptor agonist WIN55,212-2 for a period of 2 weeks, an impairment in the 
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induction of LTP in the vSub-NAc pathway was evident 24h and 10 days, but not 30 
days, after the last drug infusion (Abush & Akirav, 2012). Thus, it may be the case that 
drug training and the subsequent withdrawal-induced impairment in LTP induction is 
sensitive to the type of drug administered, the age of the animal, and the length of the 
withdrawal period. In the current study, I attempted to induce LTP in adult rats which 
were without drug for nearly 10 days prior to the reinstatement test. Given the design of 
the current experimental procedure, an earlier LTP test would not have been possible. 
 Alternatively, it may be the case that procedural differences account for the fact 
that an impairment in the induction of LTP was not observed in heroin-trained sated rats.  
In the current study animals were trained to self-administer heroin and then exposed to a 
period of behavioral extinction prior to a reinstatement test. In contrast, the vast majority 
of the relevant electrophysiological studies involve animals that have received 
experimenter-administered, non-response-contingent drug delivery. Numerous studies 
have shown that these two procedures are not equivalent even when time of drug delivery 
and drug dose are held constant. For instance, among human cocaine users the 
cardiovascular effects of cocaine are more pronounced following yoked as compared to 
self-administered drug (Donny et al., 2006). Similarly, increased mortality is observed in 
yoked rodents given cocaine at the same time and dose as their self-administering 
counterparts (Dworkin et al., 1985). In addition to general physiological differences 
resulting from yoked and self-administered drug, there are also substantial differences in 
how these two routes of administration affect the brain. NAc DA release, which is 
strongly associated with abuse potential and the reinforcing value of abused drugs, is 
higher following response contingent cocaine delivery than non-response contingent 
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cocaine delivery (Hemby, Co, Koves, Smith, & Dworkin, 1997; Lecca et al., 2007a). 
Moreover, changes in dendritic spine density following morphine exposure differ as a 
function of brain region and mode of drug administration. Thus, following 22 days of 
self-administered or experimenter administered morphine, and a one-month withdrawal 
period, a decrease in spine density was observed in numerous brain regions, including the 
NAc shell. However, this decrease was significantly greater in animals having previously 
self-administered morphine. Furthermore, a decrease in spine density in the CA1 and 
dentate gyrus of the hippocampus was only observed in animals that self-administered 
morphine (Robinson, Gorny, Savage, & Kolb, 2002). These differences in spine density 
may be interpreted as drug-induced changes in synaptic reorganization, which may 
underlie some of the long-term effects associated with opiate drug use.  
Exposure to drug abstinence versus extinction of drug seeking may also have 
differing effects on synaptic plasticity. To the best of my knowledge there have been no 
studies investigating these differences within the vSub-NAc shell pathway. However, 
previous studies have demonstrated differential changes in the NAc following extinction 
or abstinence. For instance, inactivation of the dmPFC, which projections to the NAc 
core, blocks the reinstatement of cocaine seeking, in rodents which have undergone 
extinction training, but has no effect on cocaine seeking in rodents which have been 
exposed to 2-3 weeks of abstinence (Fuchs, Branham, & See, 2006; McLaughlin & See, 
2003). Further evidence for extinction training-induced plasticity was recently presented 
by Knackstedt and colleagues (2010) who report a blunting of LTD elicited in the NAc 
core by PFC stimulation in extinguished, but not abstinent, cocaine-trained rats; however, 
in contrast they show a reduction in LTP in both extinguished and abstinent rats.   
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The Relationship between FD and Synaptic Plasticity 
Interestingly, acute FD, but not previous drug history, was shown to prevent the 
induction of LTP within the vSub-NAc pathway. The impairment in the induction of LTP 
following stress is not entirely unexpected, although the effect of stress on synaptic 
plasticity is complicated. Stressors such as restraint, restraint + tail shock, and 
inescapable footshock have been shown to impair the induction of LTP in the 
hippocampal CA1 region (Joëls, Krugers, & Karst, 2007; Joëls & Krugers, 2007), which 
projects to the vSub. However, Diamond et al. (1992) have shown an inverse relationship 
between hippocampal synaptic plasticity, as measured by hippocampal primed burst 
potentiation, and corticosterone. Thus, it may be the case that mild stressors potentiate the 
induction of LTP while more severe stressors impair the induction of LTP (Joëls et al., 
2007). Additionally, stress exposure and drug exposure have been shown to have similar 
effects on synaptic plasticity in the NAc, particularly the NAc shell. For example, stress 
exposure, in cocaine-administered mice, resulted in reduced excitatory synaptic strength 
in the NAc, and the effect was mirrored by re-exposure to cocaine which also induced 
reinstatement of CPP (Rothwell et al., 2011). 
To the best of my knowledge the only study addressing the role of stress in 
modulating synaptic plasticity within the vSub-NAc pathway is that of Dong et al. 
(2007). In rats repeatedly treated with morphine or saline and abstinent for 12h, stress 
(exposure to an elevated platform) facilitated the induction of LTD in the NAc following 
low frequency (1 Hz) stimulation of the vSub. However, prolonged abstinence (4 days) 
impaired LTD in the stressed rats. Similarly, in the current study, the effects of FD on 
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LTP, in heroin-trained rats, was found following a prolonged extinction period (an 
average of 7.40 days), plus a 48h “off” period.  
Importantly, Dong et al. (2007) did not investigate the effects of stress on LTP in 
the vSub-NAc pathway following prolonged withdrawal, making the generalization of 
their findings to the current study difficult. In addition, acute FD differs from other forms 
of stress in two main ways. First, “acute” FD is a relatively long lasting and perhaps a 
more severe form of stressor. Thus, it may be the case that the neuronal response to a 
brief stressor, such as 30 min exposure to elevated platform, is different than that 
produced by 48h without food. Second, acute FD differs from other forms of stress in that 
its effects are complex and include additional brain systems to the “classic” stress-
responsive systems. For example, it has been shown that acute FD-induced reinstatement, 
but not footshock stress-induced reinstatement, of heroin seeking can be attenuated by 
administration of the anorexigenic hormone leptin (Shalev et al., 2001). I am unaware of 
any reports on the effects of leptin in the vSub-NAc shell pathway, and studies on the 
involvement of leptin in synaptic plasticity present conflicting data.  For instance, leptin 
administration, in vitro, has been shown to result in either a facilitation or reversal of the 
expression of LTP in CA1 pyramidal neurons, when applied at a similar dose range 
(Moult, Milojkovic, & Harvey, 2009; Oomura et al., 2006).  
The Significance of an Impairment in the Induction of LTP Following Acute FD  
Prior to assessing the significance of the impairment in LTP observed following 
acute FD-induced reinstatement it is important to mention that a potentiation of % fEPSP 
amplitude was observed in non-FD rats and that the same stimulation protocol has been 
shown to induce a similar magnitude of LTP in drug naïve rats, rats exposed to a single 
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morphine injection, and rats repeatedly exposed to morphine but given 5 days of 
abstinence (Dong et al., 2007). Thus, the currently observed impairment in the induction 
of LTP is not due a non-effective procedure.  
Numerous researchers have demonstrated an impairment in the induction of LTP, 
mainly within hippocampal synapses, following a variety of stressors (i.e., restraint, 
restraint + footshock, sleep deprivation) (Campbell, Guinan, & Horowitz, 2002; Foy et 
al., 1987; Kim et al., 1996). However, there are very few studies investigating synaptic 
plasticity following stress in regions outside of the hippocampus (see examples above). 
Moreover, few if any, of the reports on plasticity in the NAc and the vSub-NAc shell 
pathway were performed in awake, behaving animals. Thus, the results described above 
were obtained in vitro (e.g., Rothwell et al. 2011), or in anesthetized animals (e.g., Dong 
et al. 2007).  Consequently, the current finding of a reduction of LTP in the vSub-NAc 
pathway are cautiously interpreted based on the results of studies on the effect of stress 
on synaptic plasticity in the hippocampus.  
Within the hippocampal literature, stress-induced impairments in LTP have been 
associated with two time dependent processes: a rapid non-genomic process and a slower 
genomic process (see Joëls et al., 2007). Within minutes of stress-exposure, rapid non-
genomic processes leading to an impairment in the induction of LTP occur within the 
hippocampus. This process is thought to rely on the actions of glucocorticoids at 
mineralocorticoid receptors, which enhances the probability of glutamate release 
facilitating glutamate transmission and producing an endogenous form of LTP, which 
prevents further induction of LTP by tetanic stimulation. Furthermore, stress responsive 
genes in the hippocampus, and perhaps elsewhere, are transcriptionally regulated by 
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glucocorticoids acting at both mineralocorticoid and glucocorticoid receptors leading to a 
prolonged change in the properties of neurons (de Kloet, Karst, & Joëls, 2008; Joëls et 
al., 2007; Karst et al., 2005; Venero & Borrell, 1999).  
Here, we demonstrate an impairment in the induction of LTP which is highly 
correlated with acute FD-induced reinstatement, suggesting that acute FD induces an 
‘LTP-like’ effect which simultaneously impairs the induction of LTP by high-frequency 
stimulation (“saturation effect”), and facilitates drug seeking. This interpretation is 
supported by the findings of Campioni et al (2009), which demonstrated a glucocorticoid 
receptor-dependent stress-induced increase in synaptic strength in the NAc, in mice. 
However, as mentioned previously in this thesis, acute FD-induced reinstatement 
is not dependent upon a stress-induced increase in adrenal corticosterone release (Shalev, 
et al., 2006). On the other hand, it is important to note that Shors et al. (1990) showed 
that adrenalectomy did not hinder the ability of stress to impair the induction of LTP in 
the hippocampus. Furthermore, in rats exposed to controllable and uncontrollable 
footshock, corticosterone is increased to a similar extent; yet, stress-induced impairment 
in the induction of LTP was only observed in rats unable to control the shock (Shors et 
al., 1989). Conversely, intra-hippocampal CRF infusion has been shown to produce a 
long-lasting enhancement of synaptic efficacy in the dentate gyrus, as indicated by an 
increase in population spikes and an increased fEPSP amplitude and slope. Moreover, 
intra-hippocampal infusion of the CRF antagonist, α-helical CRF, caused a dose 
dependent reduction in LTP-induced by tetanic stimulation (Wang, Wayner, Chai & Lee, 
1998).  Therefore, it can be suggested that CRF-induced synaptic plasticity and the 
induction of LTP via a tetanic stimulus-train involve similar mechanisms. Thus, stress-
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induced CRF release, rather than corticosterone, appears to results in the induction of 
‘LTP-like’ process within the dentate gyrus, and possibly the vSub synapses on the NAc 
shell.  
The Significance of an Impairment in the Induction of LTP Following Acute FD: Caveat  
While it is likely that acute 48h FD induces an ‘LTP-like’ effect which blocks the 
induction of LTP by tetanic stimulation (see above), there is one rather important caveat 
to consider. Throughout experimentation, input/output tests were performed, whereby the 
vSub was stimulated and responding in the NAc shell was recorded. Had acute FD 
induced an ‘LTP-like’ state, then an increase in the % fEPSP amplitude following acute 
FD would be expected due to an increase in synaptic strength within this pathway. 
Interestingly, I did not observe an increase in % fEPSP amplitude in drug-naïve FD rats 
prior to the induction of LTP; however, responding in this group is not statistically 
significantly different from any of the other conditions. In addition, no effect across the 
input/output measuring times was observed, which is unusual. As mentioned previously, 
synaptic plasticity is altered following drug self-administration, withdrawal, and 
extinction; yet, at no point were changes in the response of the NAc shell to vSub 
stimulation observed. The flattened nature of the input/output tests may indicate a lack of 
sensitivity in this measure, possibly due to low subject numbers and the high variability 
in the data set that is typical to recordings made in non-anesthetized rats, making the 
findings of the input/output data less informative.  
Given previous findings, I suggest that acute FD stress, like other forms of stress, 
induces an ‘LTP-like’ effect which leads to a “saturation” of the LTP response which 
inhibits the induction of LTP. An important concern is how to interpret a potential ‘LTP-
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like’ effect in food deprived rats. Shors and Matzel (1997) have suggested a role for LTP 
in attention to stimuli. Thus, the presence of an ‘LTP-like’ state in rats that are acutely 
food deprived can increase the salience of environmental cues. In previously heroin-
trained rats, this increase in salience may trigger a return to drug seeking when drug-
associated cues are presented under acute FD conditions. Alternatively, it may be the case 
that the endogenous LTP generated by acute FD induces amnesia for the previously 
learned extinction contingency (Diamond, Park, & Woodson, 2004). 
Concluding Remarks 
In the current experiment the role of the vSub-NAc pathway in acute FD-induced 
reinstatement was investigated by electrically stimulating the vSub and recording the 
response in the NAc shell. This pathway was chosen because of the modulatory influence 
exerted by the vSub over the mesolimbic DA system. Furthermore, an impairment in the 
induction of LTP within this pathway has been observed in rats experiencing the stress of 
early withdrawal from repeated morphine administration (Dong et al., 2007).  
Given the above findings, it was expected that previous heroin training would 
impair the induction of LTP. Instead, previous drug history was shown to have no effect 
on LTP, while acute FD was shown to impair the induction of LTP regardless of drug 
history. I cautiously conclude that the impairment in the induction of LTP observed in the 
current experiment might be due an acute FD-induced ‘LTP-like’ state which results in 
an impairment in subsequent LTP-induction. The mechanism through which such LTP 
triggers the reinstatement of heroin seeking is unclear; however, it is possible that acute 
FD interferes with extinction learning thereby triggering a return to the previously well 
learned behaviors, in this case drug seeking. 
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GLUTAMATERGIC RECEPTOR EXPRESSION FOLLOWING HEROIN SELF-
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The study of addiction has tended to focus on the neurotransmitter DA. However, 
drugs of abuse also modulate the release of glutamate, particularly within brain regions 
associated with drug reinforcement, such as the mesocorticolimbic DA pathway. 
Glutamate transmission has been implicated in most, if not all, forms of synaptic 
plasticity and is likely to underlie the persistent vulnerability to relapse observed in drug 
addicts. Similarly, in rodents, glutamate agonists and antagonists have been shown to 
trigger or block, respectively, the reinstatement of extinguished drug seeking, a model of 
human drug relapse. Thus, in the current study I investigated changes in the AMPA 
GluA1 and GluA2, and the NMDA NR1 receptor-subunits, in rats trained to self-
administer heroin and drug naïve rats. Following a minimum of 10 days of heroin self-
administration (0.1 mg/kg/infusion), drug seeking was extinguished by removing the 
drug. Under extinction conditions rats were tested for acute 21h FD-induced 
reinstatement or remained sated. Immediately following the end of a 2h reinstatement 
test, brains were removed and Western Immunobloting was preformed on tissue from the 
dmPFC, NAc, VTA and BLA. Drug naïve rats were treated in a similar manner. The 
results of this study revealed a tendency toward a reduction in GluA2 and NR1 
expression in the PFC and NAc, respectively, of heroin-trained food deprived rats, 
compared to heroin-trained sated rats, as well as a significant increase in GluA2 
expression in the VTA of heroin-trained sated rats compared to drug-naïve sated rats. 
Finally, FD increased GluA2 expression, in the BLA, in drug-naïve but not heroin-trained 
rats. Thus, heroin self-administration and acute FD may act jointly or in isolation to 
modulate iGluR subunit expression, a critical component of synaptic plasticity. It is 
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therefore concluded that adaptation in glutamate synapses might be involved in acute FD-

























Traditionally, the study of addiction has tended to focus on the role of DA. A 
reason for this is that most, if not all, drugs of abuse facilitate the release of DA in the 
NAc, an effect which is directly linked to the rewarding value of these substances (Di 
Chiara & Imperato, 1988; Di Chiara et al., 2004; Herman et al., 1995). However, 
repeated drug use leads to an enhanced motivation to administer the drug and a decreased 
ability to adapt behavior in response to non-drug related environments and stimuli 
(Kalivas, LaLumiere, Knackstedt, & Shen, 2009). This persistence in drug seeking and 
the vulnerability to relapse long after the acute effects of drug taking have waned, suggest 
that drug use results in long-term changes in the neuronal circuitry mediating drug-
seeking (Kalivas, 2004; Wolf, 2002).  
Glutamate has been shown to play a central role in plasticity within the brain, 
including drug-induced neuroplasticity (Kalivas, 2004; 2009; Wolf, 2002). In fact, 
addiction has been characterized as a form of pathological synaptic plasticity resulting, at 
least in part, from drug-induced changes in glutamate synapses (Gass & Olive, 2008; 
Kalivas & Volkow, 2005; Kalivas:2009; McEntee & Crook, 1993). Such changes result 
in the abnormal strengthening of neuronal pathways that are involved in mediating the 
effects of abused drugs. Thus, in the current chapter, changes in the expression of GluRs 
subunits, within regions of the mesocorticolimbic DA pathway, are investigated 
following heroin self-administration, extinction, and acute FD-induced reinstatement, a 
rodent model of stress-induced relapse. Here, it is expected that heroin self-
administration, and subsequent drug removal, will lead to enduring changes in GluR 
subunit expression that contribute to the propensity to reinstate drug seeking under 
 121 
abstinent conditions. Furthermore, as demonstrated in chapter 2, acute FD can induce 
changes in synaptic plasticity; thus, it is expected that acute FD will also modulate GluR 
subunit expression. The direction of these changes (ie., upregulation or downregulation) 
and whether or not there is an interaction between a history of heroin self-administration 
and acute FD stress may differ depending on the region of interest and the role of this 
region in drug seeking.  
The Nature of Glutamate Receptors 
 Glutamate is one of the most abundant excitatory neurotransmitters, in the 
mammalian brain, mediating as much as 70% of synaptic transmission in the central 
nervous system (Fonnum, 1984; Gass & Olive, 2008; Headley & Grillner, 1990). Once 
released into the synaptic cleft glutamate can exert its effect by binding to one of two 
classes of receptors: iGluRs and mGluRs. These receptors differ in terms of both their 
location and function. The iGluRs are ligand gated ion channels that mediate fast 
excitatory neurotransmission and are located primarily on the head of the postsynaptic 
spine (Gass & Olive, 2008; Guo et al., 2009). In contrast, mGluRs, which are located 
both pre- and postsynaptically (Gass & Olive, 2008) are directly coupled to second 
messengers via excitatory G-proteins and thus modulate less rapid synaptic processes 
(Conn & Pinn, 1997; Gass & Olive, 2008; Guo et al., 2009).  
Each class of GluR encompasses numerous receptor subtypes. For instance, there 
are three groups of mGluRs (Group 1-3), which include the mGluR1-mGluR8 receptors 
(Gass & Olive, 2008). Furthermore, there are three iGluR receptor families: AMPA, 
NMDA and kainite, each of which is composed of a number of subunits (Dingledine, et 
al., 1999; Gass & Olive, 2008).  
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AMPA receptors are protein complexes that form ligand-gated ion channels 
composed of a variety of four non-covalently bound subunits termed GluA1-4 
(Dingledine et al., 1999; Gass & Olive, 2008; Guo et al., 2009). NMDA receptors, like 
AMPA receptors, are heterotetrameric protein complexes that form ligand-gated ion 
channels and are composed of three different receptor subtypes: NR1, NR2 and NR3. 
There are a variety of different forms of each of these subunits. For instance, there are 
eight different NR1 subunits generated by alternative splicing from a single gene, four 
different NR2 subunits (A, B, C and D) and two NR3 subunits (A and B) (Dingledine et 
al., 1999). However, unlike, the AMPA receptor, the NMDA receptor requires co-
activation by both glutamate, which binds the NR2 subunit and glycine, which binds to 
the NR1 and NR3 receptor subunits, to function. The exact composition of the NMDA 
receptor is somewhat debated. However, NR1 is an obligatory receptor subunit with most 
researchers assuming the classical NMDA receptor is composed of two NR1 and two 
NR2 subunits of the same or different subtypes (Dingledine et al., 1999). Similar to 
NMDA and AMPA receptors, kainite receptor are tetrameric protein complexes that form 
ligand-gated ion channels composed of various subunits termed GluA5-7, KA1, and KA2 
(Dingledine et al., 1999; Pinheiro & Mulle, 2006). For the purpose of the current 
experiment only AMPA and NMDA receptor subunits will be considered. This is because 
AMPA and NMDA receptors have been extensively investigated for their role in synaptic 
plasticity. For a review on the function of kainite receptors see Pinheiro and Mulle (2006). 
 As previously mentioned, AMPA receptors are composed of subunits which are 
assembled together to produce an ion channel (Dingledine et al., 1999; Gass & Olive, 
2008; Guo et al., 2009). Each AMPA receptor subunit contains a glutamate binding site, 
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and once activated, these sites allow the ion channel to become permeable to a variety of 
cations including calcium, sodium, and potassium.  Activation of AMPA receptors 
contributes to the depolarization of the postsynaptic membrane and the activation of 
NMDA receptors by the subsequent removal of the ion-channel blockade by magnesium. 
Removal of this blockade allows an influx of ions, particularly calcium into the cell (Gass 
& Olive, 2008). This rise in calcium has been linked to both LTP and LTD. LTD occurs 
when magnesium ions are only partially displaced and less calcium is allowed to enter the 
cell (Derkach, Oh, Guire, & Soderling, 2007). 
Glutamate Transmission and Psychoactive Drugs 
 The study of addiction has revealed many parallels between addiction and learning 
and memory. As such, numerous theories postulate that addiction is a disorder of 
‘overlearning’ whereby, with repeated drug use, drug seeking becomes automatic and 
contexts and cues associated with drug taking become more salient (Gass & Olive, 2008). 
Thus, as in learning and memory, drugs of abuse induce forms of synaptic plasticity. 
Consequently, there has been a great deal of research investigating changes in AMPA and 
NMDA receptors following drug exposure.  
Drug-Induced Sensitization 
  The first experiments to demonstrating a role for glutamate in drug addiction 
focused on the role of glutamate in the induction of behavioral sensitization, an animal 
model of the intensification of craving observed in human drug addicts (Wolf, 1998). 
Behavioral sensitization, which is typically studied with regard to psychostimulant drugs 
such as cocaine or amphetamine, refers to the augmentation of a motor-stimulant 
response following repeated drug exposure (Steketee & Kalivas, 2011).  
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Studies of this nature have showed that daily pretreatment with the NMDA 
receptor antagonist MK-801 blocks cocaine- and amphetamine-induced behavioral 
sensitization (Karler, Calder, Chaudhry, & Turkanis, 1989), an effect which seems to be 
mediated largely by the actions of glutamate in the VTA. For instance, repeated intra-
VTA infusion of the NMDA receptor antagonist 3-(R-2-carboxypiperazin-4-yl)-propyl-1-
phosphonic acid has been shown to block the induction of behavioral sensitization 
following repeated intra-VTA infusions of amphetamine (Cador, Bjijou, Cailhol, & 
Stinus, 1999). Moreover, two days of intra-VTA infusion of L-trans-pyrollidine-2,4-
dicarboxylic acid, a glutamate reuptake inhibitor, leads to the development of  a 
sensitized locomotor response to a single injection of amphetamine, an effect which can 
be blocked by administering an NMDA receptor antagonist (Aked, Coizet, Clark, & 
Overton, 2005). Additionally, lesions of the mPFC, but not amygdala, have been shown 
to block both behavioral sensitization and the facilitation of VTA glutamate release 
following repeated amphetamine administration (Cador et al., 1999), suggesting an 
important role for the glutamatergic projection from the mPFC to the VTA in behavioral 
sensitization.  
Drug-Reinforced Behaviors  
  Drugs of abuse function as ‘instrumental reinforcers’ in that they increase 
the frequency of behaviors associated with their acquisition. As such, drugs facilitate self-
administration and foster a preference for places associated with their administration 
(Everitt & Robbins, 2005). The literature regarding the role of glutamate in drug-self 
administration and CPP is somewhat mixed in nature. For instance, reducing glutamate 
transmission via intra-VTA administration of the NMDA antagonist LY235959 (Kenny, 
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Chartoff, Roberto, Carlezon, & Markou, 2009) or the mGluR agonist LY379268 has been 
shown to decrease nicotine and cocaine self-administration (Baptista, Martin-Fardon, & 
Weiss, 2004; Liechti, Lhuillier, Kaupmann, & Markou, 2007). However, intra-VTA 
administration the non-competitive NMDA receptor antagonist dizocilpine increases the 
rate of heroin self-administration; whereas, the competitive NMDA receptor antagonist 
AP-5 or the non-competitive NMDA receptor antagonist, ketamine, dose dependently 
blocks heroin self-administration. Similarly, intra-VTA infusion of the AMPA/kainite 
receptor antagonist 6,7-dinitroquinoxaline-2,3-dione (DNQX) significantly reduces 
heroin self-administration (Xi & Stein, 2002). The interpretation of these findings is 
somewhat difficult, since it is not clear if the changes in drug intake are compensatory to 
the changes in the rewarding value of the drug. Thus, an increase in drug-intake could be 
explained by either an increase in its rewarding value, or by a compensatory response to 
reduced value.  
With regard to CPP, both the NMDA antagonist AP-5 and the AMPA antagonist 
CNQX, have been shown to induce a mild CPP. In contrast, AP-5 and CNQX block the 
development and expression of morphine CPP as well as the development of cocaine 
CPP when injected into VTA (Harris & Aston-Jones, 2003; Harris, Wimmer, Byrne, & 
Aston-Jones, 2004). Similarly, systemic injection of the non-competitive NMDA receptor 
antagonist MK-801 has been shown to block the induction of CPP when given prior to 
training injections of cocaine but have no effect when given acutely before the CPP test. 
In contrast icv infusion of the AMPA/kainite receptor antagonist DNQX, blocks the 
expression, but not acquisition, of cocaine CPP. Thus, at least for cocaine, it appears that 
specific GluRs, most likely in the VTA, mediate different aspects of CPP. More 
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specifically, NMDA receptors mediate the primary rewarding properties of cocaine (as 
assessed by the acquisition of CPP); whereas, non-NMDA receptors are important for the 
expression of behavior elicited by stimuli previously associated with drug reinforcement 
(as assessed by the expression of CPP) (Cervo & Samanin, 1995). Here, it is also 
important to remember that the actions of glutamate in the VTA may be region specific. 
For instance, CNQX, administration into the anterior VTA has been shown to block the 
rewarding effects of morphine in a CPP paradigm and heroin in a self-administration 
paradigm; whereas, CNQX administration into the posterior VTA blocks the locomotor 
effect of opiates but has no effect on the rewarding properties of either drug (Shabat-
Simon, Levy, Amir, Rehavi, & Zangen, 2008). 
Synaptic Plasticity in Glutamate Synapses 
The activation of AMPA and NMDA receptors as well as the trafficking of these 
receptors is highly related to their subunit composition (Collingridge, Isaac, & Wang, 
2004; Derkach et al., 2007). For instance, the presence or absence of the GluA2 receptor 
subunit is critical in determining the calcium permeability of AMPA receptors. AMPA 
receptors containing the GluA2 receptor, the majority of AMPA receptors in the brain, 
are highly impermeable to calcium due to the presence of arginine in the ion pore channel 
(Derkach et al., 2007; Gass & Olive, 2008; Hollmann, Hartley, & Heinemann, 1991; 
Vandenberghe, Robberecht, & Brorson, 2000).  
Furthermore, phosphorylation of AMPA receptor subunits and trafficking of 
AMPA receptor subunits to and from the membrane plays an important role in the 
regulation of the AMPA receptor functioning. For instance, the GluA1 receptor subunit 
can be phosphorylated at three serine residues: serine (Ser) 831, Ser 845 and Ser 818 
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(Santos, Carvalho, Caldeira, & Duarte, 2009). In mice lacking these phosphorylation sites 
there are deficits in the induction of both LTP and LTD (Lee et al., 2003). Moreover, the 
induction of LTP increases phosphorylation of GluA1 at Ser831 (Mammen, Kameyama, 
Roche, & Huganir, 1997).  
In the absence of stimuli capable of inducing synaptic plasticity, AMPA receptors 
undergo continual cycling, a process of regulating the density of these receptors at the 
plasma membrane. However, following the activation of NMDA receptors the cycling of 
AMPA receptors is altered in a manner which is dependent upon subunit composition. 
For instance, the GluA1 receptor subunit is critically involved in the insertion of AMPA 
receptors into the plasma membrane during LTP (Derkach et al., 2007; Hayashi et al., 
2000).  
Drug-induced Adaptations in Glutamatergic Synapses 
 Research investigating changes in the functioning of the glutamatergic system, 
following drug use, has revealed substantial neuroadaptations in the mesocorticolimbic 
pathway. For instance, a reduction in basal extracellular glutamate is observed in the NAc 
core of rats trained to self-administering cocaine, cocaine-yoked rats, and rats treated 
with cocaine to induce behavioral sensitization, relative to drug naïve rats (McFarland, 
Lapish, & Kalivas, 2003; Pierce et al., 1996). In contrast, a reduction in basal NAc core 
glutamate is not observed in rats trained to self-administer heroin or in heroin yoked rats 
(LaLumiere & Kalivas, 2008). The reason for the dissociation between heroin and 
cocaine in terms of NAc glutamate is unclear. However, systemic administration of N-
acetylcysteine, a prodrug for the amino acid cysteine, which is involved in the regulation 
of extracellular glutamate, has been shown to restore the cocaine-induced reduction in 
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NAc glutamate and prevent both cocaine and heroin priming-induced reinstatement 
(Zhou et al., 2008).  
 Numerous changes in iGluR subunit expression have also been noted following 
the discontinuation of drug use. For example, Ghasemzadeh et al. (1999) used in situ 
hybridization and real time-PCR to investigate changes in iGluR subunit expression 
following a week of consecutive cocaine injections, 3 weeks of abstinence, and a single 
priming injection of cocaine. In cocaine-naïve rats, a single cocaine injection produced a 
reduction in GluA3, GluA4, and NR1 mRNA in the NAc, and a reduction in NR1 mRNA 
in the dorsal striatum and VTA. However, in the previously cocaine exposed rats, cocaine 
injection increased GluA3 and GluR2 mRNA in in the NAc and PFC, respectively (also 
see (Ghasemzadeh et al., 1999) for findings with regard to mGluRs). In contrast, 
Fitzgerald and colleagues (1996), used immunoblotting to show an increase in the 
expression the GluA1 and NR1 subunits in the VTA, but no changes were found in the 
levels of GluA1, GluA2/3 or NR1 protein in the NAc, 1 day after the termination of 
chronic cocaine administration.  
 Changes in iGluR expression have also been observed following opiate drug 
exposure. For instance, 6 days of chronic morphine, via a morphine pellet, has been 
shown to increase the expression of NR1 and NR2 NMDA receptor subunits in NAc 
(Bajo, Crawford, Roberto, Madamba, & Siggins, 2006). Similarly, 48h with a morphine 
pellet increases NR1 and NR2 receptor subunit expression in the NAc, and decreases 
NR1 expression in the mPFC and hippocampus (Murray, Harrison, Grimwood, Bristow, 
& Hutson, 2007). In contrast, 10 days of intermittent morphine injection, but not 5 days 
of continuous exposure to morphine, results in an elevation in GluA1 receptor subunit 
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expression in the VTA (Fitzgerald et al., 1996). Furthermore, morphine sensitization 
followed by a 7-day abstinence period has been shown to decrease GluA2 and increase in 
NR1 and NR2 receptor subunit mRNA in the amygdala (Sepehrizadeh, Bahrololoumi 
Shapourabadi, Ahmadi, Hashemi Bozchlou, Zarrindast, & Sahebgharani, 2008a; 
Sepehrizadeh, Sahebgharani, Ahmadi, Shapourabadi, Bozchlou, & Zarrindast, 2008b).  
Importantly, most of the studies described above investigated drug-exposure and 
abstinence-induced changes in the expression of GluRs subunits in animals that have 
experienced passive administration, rather than self-administration, of the drugs. 
However, as detailed below, similar changes in the expression of GluRs subunits have 
been observed in abstinent animals following self-administration training. 
The Role of Glutamate in the Reinstatement of Extinguished Drug Seeking 
Studies investigating the reinstatement of drug seeking behavior consistently 
demonstrate a role for NAc glutamate transmission. For example, in rats trained to self-
administer cocaine, a decrease in basal extracellular NAc glutamate is observed during 
drug abstinence. However, when exposed to cocaine, during abstinence, there is an 
augmentation of NAc glutamate release, relative to drug naïve animals, and a 
reinstatement of drug seeking (McFarland et al., 2003). Thus, drug-induced changes in 
glutamatergic transmission may, at least in part, mediate the propensity to relapse to drug 
seeking. As further evidence for the role of glutamate transmission in reinstatement, 
Cornish and Kalivas (2000) have demonstrated the reinstatement of cocaine seeking-
behavior following systemic injection of cocaine or intra-NAc infusion of DA or AMPA. 
The more interesting aspect of this study is that intra-NAc infusion of the mixed DA 
receptor antagonist fluphenazine blocked DA-induced reinstatement; whereas, the AMPA 
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receptor antagonist CNQX, but not the NMDA receptor antagonist 3-(2-
carboxypiperazin-4-yl) propyl-1-phosphonic acid, blocked cocaine- and intra-NAc DA or 
AMPA-induced reinstatement.  
With regard to the role of specific GluR subunits in the reinstatement of drug 
seeking, the GluA1 subunit has received a considerable amount of attention. Infusion of 
antisense oligonucleotides, directed against mRNA for the GluA1 subunit, into the NAc 
shell or core, causes an approximately 36% reduction in the expression of the GluA1 
subunit and a pronounced reduction in cocaine priming- and AMPA-induced 
reinstatement (this effect is more pronounced in the NAc shell) (Ping, Xi, Prasad, Wang, 
& Kruzich, 2008). Similarly, Anderson et al. (2008) has demonstrated that the 
reinstatement of cocaine-seeking behavior is associated with an increase in GluA1 
phosphorylation on Ser831 and enhanced cell-surface expression of GluA1-containing 
AMPA receptors in the NAc shell, but not NAc core. Furthermore, these authors found 
that cocaine priming-induced reinstatement could be attenuated by intra-NAc shell 
administration of the viral vector AAV10-GluR1- C99, which impairs the transport of 
GluA1-containing AMPA receptors to the cell surface.   
Glutamate neurotransmission is also involved in the reinstatement of heroin 
seeking behavior. Microdialysis studies have shown an increase in extracellular NAc core 
glutamate release in rodents trained to self-administer heroin and subsequently tested for 
cue- and priming-induced reinstatement (LaLumiere & Kalivas, 2008). Furthermore, 
heroin priming and cue-induced reinstatement of heroin seeking is blocked by intra-NAc 
core infusion of the AMPA/kinate receptor antagonist CNQX; whereas, contextual cue-
induced reinstatement of heroin seeking is attenuated by inhibition of glutamate 
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transmission in the NAc shell or VTA by infusion of the mGluR receptor agonist 
LY379268 (Bossert et al., 2006a; Bossert, Liu, Lu, & Shaham, 2004; LaLumiere & 
Kalivas, 2008). Furthermore, re-exposure to cues previously associated with heroin self-
administration has been shown to produce a downregulation of the GluA2 receptor 
subunit in the mPFC. This downregulation is associated with a nearly 25% reduction in 
AMPA/NMDA current ratio, a measure of synaptic depression. Furthermore, blockade of 
clathrin-dependent GluA2 endocytosis, in the mPFC, prevents mPFC synaptic depression 
and reduces heroin priming and the heroin cue-induced reinstatement (Van den Oever et 
al., 2008). 
Rationale for the Current Studies 
To the best of my knowledge there are currently no studies investigating changes 
in iGluRs following heroin self-administration and subsequent acute FD-induced 
reinstatement. However, there are several reasons to expect that the expression of the 
AMPA receptor subunits GluA1 and GluA2, as well as the NMDA receptor subunit NR1, 
will be modulated following acute FD-induced reinstatement of heroin seeking. As 
discussed above, drug self-administration and subsequent reinstatement tests modulate 
glutamatergic neurotransmission and the expression of iGluRs. Furthermore, in drug 
naïve rats, 10 days of repeated restraint stress or 10 days of unpredictable stress increase 
VTA GluA1 and VTA GluA1 and NR1 receptor subunit expression, respectively 
(Fitzgerald et al., 1996). Therefore it was hypothesized that if acute FD-induced 
reinstatement of heroin seeking is mediated, at least in part, by adaptations in 
glutamatergic synapses, specific changes in iGluRs subunits in the heron-trained, food 




 Subjects consisted of 42 male Long Evans rats (Charles River, St Constant, QC, 
Canada) run in two experimental replications and weighing 300-421 (M = 358.59, SEM = 
3.90) g at the start of experimentation. Prior to and post-surgery animals were housed 
under constant temperature (21C) and on a reverse 12h/12h light/dark cycle (lights off at 
9:30 am). Following IV catheterization rats were randomly assigned to one of two heroin 
self-administration groups or to one of two drug-naïve groups  (see below).  
Surgery 
 All rats were implanted with an IV silastic catheter (Dow Corning, Midland, MI) 
into the right jugular vein, as previously described in the general methodology.  
Apparatus  
 Following recovery from surgery, rats assigned to the heroin-training groups were 
moved from the animal care facility to the operant chambers, described in detail in the 
general methodology, for the duration of experimentation. Drug-naïve rats remained in 
the animal care facility and were singly housed in standard shoebox cages throughout 
experimentation.  
Drug 
 As described in previously, heroin (diacetylmorphine HCL) was dissolved in 
physiological saline and delivered at a concentration of 0.1 mg/kg per infusion. 
Procedure 
Heroin Self-administration Training, Extinction Training & Reinstatement 
The behavioral portion of this study consists of three phases: heroin self-
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administration training, extinction training, and reinstatement testing. These phases are 
described in detail in the general methodology; however, there are some procedural 
modifications. Following IV catheterization surgery rats were assigned to one of four 
training and reinstatement conditions: heroin self-administration and acute FD (Her-FD), 
heroin self-administration and sated (Her-Sated), drug-naïve and acute FD (Naïve-FD) 
and drug-naive and sated (Naïve-Sated). Drug-naïve animals were handled daily in a 
similar manner to those in the operant chambers except they were never exposed to 
heroin or the drug-training environment.   
For animals in the heroin self-administration groups, training was conducted over 
a period of 10 days. Throughout the training phase, rats received three 3-h drug (days 1-5, 
FR-1; days 6-10, FR-3) sessions beginning shortly after at the onset of the dark phase 
(approximately 10 am). Following training the heroin syringes were removed and rats 
underwent a period of extinction training. Beginning on the second extinction day, 
session length was reduced to one-3 h session/day. Once an extinction criterion of 15 or 
less active lever responses (per 3-h session) was reached, rats were tested for 
reinstatement of drug seeking, under extinction conditions. Each rat was given one 2h 
reinstatement test, which was preceded by 21h of FD or 21h stated. Immediately 
following the end of the 2h reinstatement test, rats were removed from the operant 
chamber and decapitated. Brains were removed and flash frozen in isopentane for 5s 
before being transferred to a -80°C freezer for storage. Rats in the colony were food 
deprived or remained sated and were killed at the same time as rats which had been 




Brains were removed from a -80°C freezer and placed in a cryostat set to  -13°C. 
After approximately 1h in the cryostat, brains were mounted, and two 500 µm slices, 
corresponding to each of the regions of interest were taken. Over dry ice, a blunted 18G 
needle was used to take bilateral tissue punches 0.83 mm in diameter from the BLA, NAc 
and VTA and two 0.83 mm bilateral tissue punches were taken from the dmPFC. All 
areas were identified using the atlas of Watson and Paxinos (see Figure 1). Tissue 
punches were prepared for analysis by adding 75 ul of lysis buffer (10 mM Tris-HCl, pH 
7.5, 2% SDS, Complete Mini Protease Cocktail Inhibitor (Roche Diagnostics, Laval, QC, 
Canada) to each set of punches and sonicating each of the samples. Following 
centrifuging (10, 000 RPM) the supernatant was collected and protein quantification was 
preformed using the BCA protein assay reagent kit (Pierce, Rockford, IL, USA). Based 
upon this quantification each supernatant was aliquoted into vials with 15 µg of protein 
and frozen at – 80°C. Prior to immunoblotting aliquots were removed from the freezer, 
placed on ice and prepared for immunoblotting by adding 6 ul of sample treatment buffer 
(Invitrogen Life Technologies, Burlington, ON, Canada), 2.4 ul of reducing agent 
(Invitrogen Life Technologies, Burlington, ON, Canada) and distilled water to ensure a 
consistent volume across aliquots. All samples were heated to 70°C for 10 min and 
loaded into individual lanes of 4-12% Bis Tris gels (Invitrogen Life Technologies, 






Western Immunoblot Punches. Displayed above are the starting point and location of the 
dmPFC (top left), NAc (top left), BLA (top right) and VTA (bottom center) punches. For 
each region, with the exception of the dmPFC, two 500 µm thick, 0.83 mm in 
circumference bilateral punches were taken. For the dmPFC an additional set of punches 







Precision Plus Protein Western C Standard (BioRad, Mississauga, ON, Canada) loaded. 
Electrophoresis was run using the electrophoresis insert of the XCell SureLock Mini-Cell 
System (Invitrogen Life Technologies, Burlington, ON, Canada) set to run at 200 V for 
50 min with a running buffer consisting of 5% NuPage MOPS SDS (20X) in distilled 
water (Invitrogen Life Technologies, Burlington, ON, Canada).  Additionally, 500 ul of 
NuPage antioxidant (Invitrogen Life Technologies, Burlington, ON, Canada) was added 
to the inner chamber of the electrophoresis cell prior to the start of running. Following gel 
electrophoresis, protein was transferred to a nitrocellulose membrane (0.45 um pore size; 
Invitrogen Life Technologies, Burlington, ON, Canada) using the Xcell II Blot Module 
component of the SureLock Mini-Cell System and a transfer buffer consisting of distilled 
water, 10% methanol, 5% NuPage transfer buffer (20X) and 0.1% antioxidant.  
Membranes were blocked for 1h in milk (5% milk in tris-buffered saline + tween 
(.5%), TBS-T) and incubated overnight at 4°C in 5% milk TBS-T and the primary 
antibodies for GluA1 (1:1000), GluA2 (1:1000) or NR-1 (1:1000) and the loading control 
tubulin (1:1000 or 1:4000). All primary antibodies were purchased from Millipore, 
(Temecula, CA, USA). Following incubation in the primary antibody, membranes were 
washes several times in TBS-T and incubated with a secondary antibody to the primary 
antibodies and loading control (anti-beta actin; 1:5000, Abcam, Cambridge, MA, USA) 
and a secondary antibody to the standard (Strep Tactin-HRP conjugate; 1:5000, BioRad 
Mississauga, ON, Canada).  
Following secondary antibody incubation protein was visualized by exposing 
Kodak Biomax or HyBlot CL film (Sigma Aldrich, Oakville, ON, Canada or Harvard 
Apparatus, Saint-Laurent, QC, Canada, respectively), to membranes treated with Western 
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Lightning Reagents (PerkinElmer Life Sciences, Inc., Boston, MA, USA).  
Data Analysis 
Behavioral Data 
The effect of test condition (21h FD or sated) on heroin seeking behavior 
was assessed using SPSS Software v. 19.0.0 for Mac (IBM Inc., Armonk, New York, 
USA). A repeated measures ANOVA was performed using Day (Baseline (day prior to 
reinstatement test) or Test Day) as a within subjects factor and Deprivation State (FD or 
Sated) as a between subjects factor. Significant effects were followed up with Sidak 
corrected t-tests comparisons. All analyses were evaluated for significance at α = .05.  
Western Immunoblotting 
Optical density was measured for the band migrating at the approximate 
molecular weight for each GluR subunit (GluA1: 106 kDa; GluA2: 108 kDa; NR1: 120 
kDa) antibody and the tubulin (50 kDa) antibody using ImageJ software (National 
Institute of Health, Bethesda, Maryland, USA). In brief, a rectangular selection 
approximately double the height of the protein band in the first lane was drawn around 
each of the glutamate or tubulin bands within each gel. Protein expression was then 
analyzed, within each rectangle by looking at peak band intensity, determined as the area 
under the curve, relative to the film background. The measure resulting from this analysis 
was divided by the total protein expression across the bands of interest for each gel to 
give a measure of % GluR subunit expression or % tubulin expression per gel. Finally, % 
GluR subunit expression was divided by the % tubulin expression to correct for 
differences in protein loading across the samples. This final result was divided by the 
mean GluR subunit expression in the control (Naive-Sated) group (Miller, 2010). This 
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final step was preformed to allow for ease of visual comparison in figures. This method 
of quantification was chosen to account for differences in the running of gels, primary 
incubation time, and exposure time.  
As mentioned previously, a great deal of research has shown a change in the 
expression of GluR subunit expression following chronic drug use. In order to test the 
hypothesis that heroin self-administration, in the current experiment, produced similar 
changes, a planned comparison assessing GluR subunit expression in the Her-Sated and 
Naive-Sated rats, was preformed for each of the regions investigated. Furthermore, stress 
has also been shown to alter the expression of GluR subunits. Consequently, a major 
focus in this study was to assess the effect of acute-FD stress on GluR subunit expression 
in rats trained to self-administer heroin as compared to drug-naïve rats. Thus, two 
planned comparisons were conducted to compare the effect of FD in heroin-trained rats 
(Her-FD compared to Her-Sated) and in drug naïve (Naïve-FD compared to Naïve-
Sated). Additionally, since glutamate was expressed as a function of tubulin, to control 
for differences in loading, the above planned comparisons were repeated for % control 
tubulin expression. All comparisons were evaluated at α = .05. 
RESULTS 
 Of the 42 rats that received intravenous catheterization surgery, 20 rats were 
assigned to self-administer heroin and 22 rats were assigned to remain in the colony and 
remain heroin naive. Furthermore, 10 rats in the heroin group were assigned to the food 
deprived condition (Her-FD) and 10 rats were assigned to the sated condition (Her-
Sated). Of the rats assigned to the Her-Sated condition one rat was removed due to a 
failure to train, defined as an average of less than 20 responses on the ‘active’ drug-paired 
 139 
lever, throughout training. Thus, the total number of rats included in the Her-Sated group 
is 9. For the drug-naïve rats, 10 rats were assigned to the Naïve-Sated group and 12 rats 
were assigned to the Naïve-FD group.  
Behavioral Data 
 As demonstrated in Figure 2, rats showed a clear preference for the ‘active’ drug-
paired lever over the ‘inactive’ non-drug paired lever throughout training. On the last 
training day the mean (+/- SEM) number of infusions, active lever responses, and inactive 
lever responses were 38.32 (7.45), 294.37 (126.70) and 19.21(6.20), respectively. 
Following training, rats experienced a mean of 11.79 (SEM = 1.92) extinction days prior 
to the reinstatement test.  
For the purposes of reinstatement testing, rats that were assigned to either the 
HER-FD group or the HER-Stated group were matched in terms of infusions (MFD = 
37.18, SEM = 8.54; MSated = 34.71, SEM = 4.77), F(1,17) = 0.06, p = .81, ηp
2 = .01, active 
lever responding (MFD = 247.08, SEM = 94.44; MSated = 210.22, SEM = 40.31), F(1,17) = 
0.12, p = .73, ηp
2 = .01, and inactive lever responding (MFD = 21.56, SEM = 6.96; MSated = 
17.87 SEM = 5.61), F(1,17) = 0.17, p = .69, ηp
2 = .01, during the last 5 days of training.  
Repeated measures ANOVA performed on the number of active lever responses 
made during the baseline and test days revealed a significant effect of day with rats 
responding more on the reinstatement test day (M = 41.90; SEM = 10.73) than on the 
baseline day (M = 11.37; SEM = 0.82), F(1,17) = 8.24, p = .01, ηp




Mean (+/- SEM), number of active lever presses, inactive lever presses, and heroin 
infusions. Rats were trained to self-administer heroin (0.1 mg/kg/infusion) over a 10-day 
training period (days 1-5: three 3h sessions, FR-1; days 6-10: three 3h sessions, FR-3). 
Also shown is the number of active and inactive lever responses for the first day of 
extinction. A significant difference existed between active and inactive lever responding 





























3-3h, FR-1 sessions 




The effect of acute food deprivation (FD) on the reinstatement of heroin seeking 
behavior. Data are mean (+SEM) number of active (left) and inactive (right) lever 
responses made during baseline (BL) and following 21h FD or unlimited access to food 
(Sated) for rats trained to self-administer heroin for 10 days and subsequently given 
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effect of deprivation state was also observed, with food deprived rats (M = 39.60; SEM = 
7.49) responding more than sated rats (M = 13.67; SEM = 7.90), F(1,17) = 5.67, p = .03, 
ηp
2 = .25. Additionally, a significant day X deprivation state interaction was observed, 
F(1,17) = 5.92, p = .03, ηp
2 = .26. Analysis of this interaction revealed that the FD rats 
had a significantly higher number of responses on the active lever during the test day 
compared to their responding on the baseline day, and compared to the sated rats 
responding on the test day, ps < .05 (see Figure 3). For the responses on the inactive 
lever, there was no significant effect of day, F(1, 17)  = 0.87, p = .36, ηp
2 = .05, 
deprivation state, F(1, 17)  = 0.32, p = .58, ηp
2 = .001 or day X deprivation state 
interaction, F(1, 17)  = 0.02, p = .89, ηp
2 = .001 (see Figure 2B). 
Western Immunoblotting 
In the results reported below there are minor differences in subject numbers 
across regions and subunits of interest. These differences are due to a limited number of 
sample aliquots, finding a low level of protein during the BCA protein assay 
quantification, or problems during gel loading.  
Dorsal Medial Prefrontal Cortex (dmPFC) 
Thirty-nine rats were included in the analysis of GluA1 receptor-subunit 
expression (Her-Sated: n = 8; Her-FD: n = 10; Naïve-Sated: n = 9; FD: n = 12). One rat 
was removed from the analysis because the standard ladder was over-exposed and 
interfered with the GluA1 band. The second rat’s data was not analyzed because of a 
limited number of protein aliquots. Using planned comparisons, no significant effect of 
drug history was revealed when comparing the Her-Sated group to the Naïve-Sated 




                                                                                     


























































   
   




















































Figure 4.  
Mean (+SEM) GluA1 (A), GluA2 (B), and NR1 (C) GluR subunit expression in the 
dmPFC for rats trained to self-administer heroin (0.1 mg/kg for a minimum of 10 days; 3-
3h sessions per day) or drug naïve rats. Heroin-trained rats received extinction training 
and were tested for a reinstatement of drug seeking (2h test) under sated or 21h food 
deprivation (FD) conditions. Drug-naïve rats were sated or food deprived for 23h before 
their brains were collected. GluR subunit expression is presented as percent change from 
the drug-naïve-sated group.  + p = .08 relative to heroin-trained sated rats. Blots to the 
















assessing the effect of FD in the heroin-trained rats, t (16) = 0.41, p = .69, and in drug 
naïve rats, t (19) = 0.40, p = .69 (see Figure 4A).  
Thirty-nine rats (Her-Sated: n = 9; Her-FD: n = 9; Naïve-Sated: n = 9; Naïve-FD: 
n = 12) were included in the analysis of GluA2 receptor subunit expression. Two rats 
were removed from the analysis due to an absence or great reduction in the tubulin band 
for these animals, indicating a problem in the loading of the lanes corresponding to these  
rats. Planned comparisons of GluA2 receptor-subunit expression revealed no significant 
effect of drug history for sated rats, t(16) = 0.75, p = .46. With regard to the effect of FD, 
planned comparisons of GluA2 receptor-subunit expression revealed a tendency toward a 
significant reduction in subunit expression in the Her-FD rats, as compared to the Her- 
Sated rats, t (16) = -1.89, p = .08. However, no such tendency was observed when 
comparing the FD and Naive-Sated rats, t (19) = -0.32, p = .75 (see Figure 4B).  
NR1 receptor subunit expression was analyzed in 40 rats (Her-Sated: n = 9; Her-
FD: n = 10; Naive-Sated: n = 9; FD: n = 12). One rat was eliminated from the analysis 
due to an insufficient number of protein aliquots. No significant differences in the 
expression of the NR1 subunit were observed when comparing the Her-Sated and Naive-
Sated groups, t (16) = 0.83, p = .42. Also, planned comparison investigating the effect of 
FD in rats trained to self-administer heroin, t (17) = -0.86, p = .40, and naïve rats, t (19) = 
0.42, p = .68, showed no significant difference in NR1 receptor-subunit expression (see 






















































                               


























































Mean (+SEM) GluA1 (A), GluA2 (B), and NR1 (C) GluR subunit expression in the NAc 
for rats trained to self-administer heroin (0.1 mg/kg for 10 days) or drug naïve colony 
rats. Heroin-trained rats received extinction training and were tested for a reinstatement 
of drug seeking under sated or 21h food deprivation (FD) conditions. Drug-naïve rats 
were sated or food deprived for 23h before their brains were collected. GluR subunit 
expression is presented as percent change from the drug-naïve-sated group.  + p = .08 
relative to heroin-trained sated rats. Blots to the right show a sample band for Naïve-
















Nucleus Accumbens (NAc) 
GluA1 receptor subunit expression was assessed in 34 rats (Her-Sated: n = 8; Her-
FD: n = 9; Naive-Sated: n = 8; FD: n = 9). Rats were removed from the analyses due to 
an insufficient number of protein aliquots (n = 4), over-exposure of the standard in the 
adjacent lane making analysis impossible (n = 2), or identification as a statistical outlier  
 (n = 1; z-score = 4.05). Planned comparisons assessing GluA1 receptor subunit 
expression in the NAc revealed no significant effect of heroin exposure in sated rats, t 
(14) = 0.36, p = .73. Furthermore, there was no significant effect of FD observed in 
heroin-trained, t (17) = -0.86, p = .40, or drug-naïve rats, t (19) = 0.42, p = .68 (see 
Figure 5A).  
For the GluA2 receptor-subunit, 39 rats (Her-Sated: n = 9; Her-FD: n = 9; Naive-
Sated: n = 10; FD: n = 11) were included in the following analyses. Two rats were not 
run due to an insufficient number of protein aliquots. Planned comparisons assessing 
GluA2 receptor-subunit expression in the NAc revealed no significant effect of heroin 
exposure, in sated rats, t (17) = 1.16, p = .26. Additionally, FD was shown to have no 
effect on GluA2 receptor-subunit expression in heroin-trained, t (16) = 0.44, p = .67, or 
drug-naïve rats, t (19) = 0.99, p = .34 (see Figure 5B).  
 NR1 receptor-subunit expression was analyzed for 37 rats (Her-Sated: n = 9; Her-
FD: n = 9; Naive-Sated: n = 8; FD: n = 11). The samples from 4 rats were not run due to 
an insufficient number of protein aliquots. Planned comparisons showed no significant 
effect of drug history in sated rats, t (16) = 0.83, p = .42, and no significant difference 
between heroin-trained FD and heroin-trained sated rats, t (17) = -0.86, p = .40. However, 
a tendency toward a significant reduction in NR1 receptor-subunit expression was 
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observed in the Her-FD group relative to the Her-AL group, t (16) = -1.91, p = .08 (see 
Figure 5C). In contrast to all the other analyses described in this chapter, a significant 
difference in tubulin expression was observed when comparing the FD (M = 181.06, SEM 
= 16.57) and Naive-Sated (M = 100.00, SEM = 15.27) rats, t (17) = 3.46, p < .01, as well 
as when comparing Her-FD (M =188.44, SEM = 26.43) and Her-Sated (M = 97.26, SEM 
= 14.00) rats, t (16) = 3.05, p < .01. Given these differences in tubulin expression the 
above planned comparisons were repeated using the non-tubulin corrected glutamate  
measure. The results of these comparisons were exactly the same as those described 
above.  
Ventral Tegmental Area (VTA) 
Thirty-seven rats were included in the analysis of GluA1 receptor-subunit 
expression (Her-Sated: n = 7; Her-FD: n = 10; Naive-Sated: n = 9; FD: n = 11). Two rats 
were removed from the analysis because of a limited number of protein aliquots and two 
rats were not included due to a low BCA quantification. Planned comparisons assessing 
differences in GluA1 receptor-subunit expression revealed no significant effect of drug 
history, t (14) = -0.03, p = .98.  Moreover, acute FD had no effect on GluA1 receptor-
subunit expression in drug-naive, t (18) = -1.29, p = .21, or heroin-trained rats, t (15) = 
0.52, p = .52 (see Figure 6A). 
For the GluA2 receptor-subunit, the data from 35 rats were analyzed (Her-Sated: 
n = 6; Her-FD: n = 11; Naive-Sated: n = 8; FD: n = 10). Two rats were not considered in 
the analysis because of low a low BCA protein quantification, one rat was removed due 
to a loading error, one rat was removed due to the presence of an air bubble and two rats 
were not analyzed due to a limited number of samples. Planned comparisons of GluA2 
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Figure 6.  
Mean (+SEM) GluA1 (A), GluA2 (B), and NR1 (C) GluR subunit expression in the VTA 
for rats trained to self-administer heroin (0.1 mg/kg for 10 days) or drug naïve colony 
rats. Heroin-trained rats received extinction training and were tested for a reinstatement 
of drug seeking under sated or 21h food deprivation (FD) conditions. Drug-naïve rats 
were sated or food deprived for 23h before their brains were collected. GluR subunit 
expression is presented as percent change from the drug-naïve-sated group.  * p < .05 
relative to drug-naïve sated rats. Blots to the right show a sample band for Naïve-Sated, 















receptor subunit expression revealed a significant increase in GluA2 receptor-subunit 
expression in the Her-Sated group relative to Naive-Sated group, suggesting an effect for 
drug exposure, t(12) = 2.47, p = .03. Acute FD was shown to have no effect on GluA2 
receptor-subunit expression in heroin trained, t(15) = -1.68, p = .11, and heroin-naïve rats 
(MSated = 100.00, SEM = 12.65; MFD =107.03, SEM = 12.55), t(16) = 0.39, p = .70  (see 
Figure 6B). NR1 receptor-subunit expression was analyzed in 34 rats (Her-Sated: n = 6; 
Her-FD: n = 10; Naive-Sated: n = 8; FD: n = 10). One rat was eliminated due to an 
insufficient number of protein aliquots. Two rats were not considered in the analysis 
because of a low BCA protein quantification, one rat was identified as an outlier and 
removed from the data set (z-score = 5.32), and three rats were not run due to an 
insufficient number of samples. Planned comparisons of NR1 receptor subunit expression 
revealed no statistically significant effect of previous drug history, t(12) = -0.54, p = .60. 
Additionally, acute FD had no effect on NR1 receptor-subunit expression in heroin-
trained rats, t(14) = 0.31, p = .76,  or in drug-naïve rats, t(16) = -0.61, p = .55 (see Figure 
6C).  
Basolateral Amygdala (BLA) 
GluA1 receptor subunit expression in the BLA was not analyzed due to technical 
difficulties resulting in unintelligible data (multiple bands at very similar molecular 
weight positions). 
 GluA2 receptor subunit expression was assessed in 39 rats (Her-Sated: n = 9; Her-
FD: n = 10; Naive-Sated: n = 9; FD: n = 11). One rat was eliminated from this analysis 
due to a lack of protein following BCA quantification and one rat was eliminated due to a 










Figure 7.  
Mean (+SEM) GluA2 (A) and NR1 (B) GluR subunit expression in the VTA for rats 
trained to self-administer heroin (0.1 mg/kg for 10 days) or drug naïve colony rats. 
Heroin-trained rats received extinction training and were tested for a reinstatement of 
drug seeking under sated or 21h food deprivation (FD) conditions. Drug-naïve rats were 
sated or food deprived for 23h before their brains were collected. GluR subunit 
expression is presented as percent change from the drug-naïve-sated group.  * p < .05 
relative to drug-naïve sated rats. Blots to the right show a sample band for Naïve-Sated, 

























































receptor subunit expression in drug naïve, t (18) = 2.23, p = .04, but not in heroin-trained 
rats, t (17) = 0.06, p = .95. In addition, GluA2 receptor subunit expression did not differ 
between rats in the Her-Sated and Naive-Sated groups, t(16) = -0.03, p = .97 (see Figure 
7A). 
The NR1 receptor subunit expression was analyzed in 33 rats (Her-Sated: n = 8; 
Her-FD: n = 7; Naïve -Sated: n = 10; Naïve-FD: n = 8). One rat was removed from the 
analysis due to an air bubble and seven rats were not run due to an insufficient number of 
protein aliquots. Planned comparisons revealed no significant differences for FD-induced 
changes in NR1 receptor-subunit expression in drug naïve, t (16) = 0.30, p = .77, and 
heroin-trained rats (MHer-Sated = 118.24, SEM = 21.79; MHer-FD = 130.32, SEM = 22.19), t 
(13) = 0.34, p = .71. Additionally, there was no significant difference in NR1 receptor 














As previously discussed, drug addiction can be conceptualized as a form of 
aberrant learning resulting from maladaptive synaptic plasticity. As such, it was expected 
that 10 days of heroin self-administration, followed by extinction of drug seeking, and a 
subsequent test of acute 21h FD-induced reinstatement would alter iGluR subunit 
expression, an indicator of changes in the strength of glutamate synapses. Here I report a 
tendency toward a reduction AMPA GluA2 receptor-subunit expression in the dmPFC in 
heroin-trained FD rats relative to heroin-trained sated rats, and a tendency toward a 
reduction in the NMDA NR1 receptor-subunit expression in the NAc in heroin-trained 
FD rats, relative to heroin-trained sated rats. Furthermore, a significant increase in GluA2 
receptor expression was observed in the VTA of heroin-trained sated rats as compared to 
heroin naïve sated rats. Finally, heroin-naïve FD rats were found to have an increased 
GluA2 receptor-subunit expression in the BLA, as compared to drug naïve sated rats.  
In interpreting the significance of these findings there is obvious need for caution  
with regard to the discussion of statistical tendencies. However, with this in mind, the 
observed tendencies will be interpreted within context of the prevailing literature 
addressing iGluR subunit expression and drug exposure.  
Acute FD-Induced Reinstatement and Expression of the NMDA NR1subunit in the NAc 
A tendency toward a reduction in the NMDA NR1 receptor subunit was only 
observed in the NAc of heroin-trained food deprived rats, as compared to heroin-trained 
sated rats. This result is in contrast with previous findings demonstrating that 18 months 
of cocaine self-administration in rhesus monkeys and cocaine overdose in human cocaine 
addicts is associated with an increase in NAc NR1 receptor expression (Hemby et al., 
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2005). Furthermore, NAc NR1 expression is also upregulated in rats made dependent on 
morphine by chronic morphine exposure (Bajo et al., 2006).  
One major difference exists between the current study and the studies cited above. 
This experiment utilized the reinstatement procedure, in which rats were trained to self-
administer heroin for a period of 10 day followed by a prolonged abstinence and 
extinction training period. In contrast, in Bajo et al.’s study (2006) rats were killed 
immediately after morphine treatment. In Hemby et al.’s report (2005) it is stated that 
monkeys were killed after drug self-administration studies ended, but it is not clear what 
this timeframe means. However, since this experiment was intended to compare iGluR 
subunit-expression in human overdose victims and primates it can be assumed that heroin 
was onboard at the time of death. 
Similar to the current study, a reduction in NR1 subunit mRNA is observed in the 
NAc of rats given experimenter administered injections of cocaine for 14 days and 
exposed to 24h of withdrawal (Yamaguchi et al., 2002). However, here reduction in the 
expression of NR1 receptor subunit is only observed in heroin-trained food deprived rats. 
Thus it may be the case that extinction training reversed the effects of heroin self-
administration on the NR1 receptor subunit in the NAc (see Self, 2004 for a discussion of 
extinction-induced reversal of drug-induced neuroplasticity). However, following acute-
FD and subsequent reinstatement of heroin seeking, these changes were once again 
apparent. In support of this conclusion NAc NR1 receptor subunit expression is reduced 
in the NAc shell following 1 week of forced abstinence from cocaine self-administration 
an effect which is associated with a withdrawal induced LTD in the NAc shell. However, 
extinction training has been shown to normalize both NR1 receptor subunit expression 
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and reverse LTD in the NAc shell (no effect of extinction on NR1 regulation was 
observed in the core), a process which is involved in restoring inhibitory control over 
behavior (Self, 2004). 
 Acute FD-Induced Reinstatement and Expression of the AMPA GluA2 Receptor Subunit 
 A tendency toward an increase in GluA2 receptor subunit expression was 
observed in the dmPFC of heroin-trained FD rats relative to heroin-trained sated rats. 
Furthermore, a statistically significant increase in the GluA2 receptor subunit was 
observed in the VTA of heroin-trained stated rats, relative to heroin naïve sated rats, and 
in the BLA of drug naïve FD rats relative to drug naïve sated rats.  
The Dorsal Medial Prefrontal Cortex (dmPFC) 
 While caution must also be exercised in interpreting the tendency toward a 
reduction in GluA2 receptor expression in the dmPFC, the current findings are in 
agreement with those of Van den Oever et al. (2008) which demonstrate a 
downregulation of the GluA2 receptor subunit in mPFC synaptic membranes following 
cue-induced reinstatement of heroin seeking. Also, these authors assessed synaptic 
plasticity within the mPFC, 30 min after exposure to drug cues, and found a significantly 
lower AMPA/NMDA current ratio suggesting a decrease in the strength of glutamate 
synapses onto neurons in the vmPFC.   
In contrast, in the current study tissue punches were taken from the dmPFC, 
corresponding to the infralimbic and cingulate cortex. Thus, the current experimental 
design does not allow any conclusions regarding the contribution of glutamatergic 
transmission in the vmPFC to acute FD-induced reinstatement of heroin seeking. 
However, using the same rational as Van den Oever et al. (2008), my findings suggest 
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that a reduction in GluA2 receptor-subunit expression in the dmPFC, leading to inhibited 
synaptic transmission in the dmPFC, underlies acute FD-induced reinstatement of 
extinguished heroin seeking.  
However, this interpretation does contradict with the suggested role of the 
dmPFC, as described by Kalivas and colleagues (Peters et al., 2008; 2009), whereby 
activation of this region drives, and inhibition attenuates, the reinstatement of drug 
seeking. Interestingly, as mentioned above, the over-expression of GluA2-lacking AMPA 
receptors (as would be expected by the reduced expression of GluA2, but not GluA1, 
subunits) could be interpreted as an increase in the excitability of the relevant synapses 
(Conrad et al. 2008; Liu et al. 2007). Consequently, the current findings suggest that the 
exposure to FD in heroin-trained rats resulted in an excitation of the dmPFC-NAc 
pathway, resulting in the reinstatement of drug seeking (Peters et al., 2008; 2009), 
The Ventral Tegmental Area (VTA) 
 Within the VTA, a significant increase in GluA2 receptor-subunit 
expression was observed in in heroin-trained sated rats as compared to heroin naïve sated 
rats suggesting a drug-induced change in synaptic plasticity. Similarly, in rats trained to 
self-administer cocaine and exposed to forced abstinence, an increase in GluA2 receptor-
subunit was observed in the VTA following 24h of withdrawal. However, GluA2 
receptor-subunit expression was not elevated after 30 days of withdrawal, suggesting a 
transient elevation of VTA GluA2 receptor subunits in cocaine-trained rats. In the current 
study, rats were killed after approximately 12 days of extinction, thus it appears that the 
increase in GluA2 receptor subunit, in the VTA of heroin-trained rats, is relatively long-
lasting. However, in contrast to the current findings, 10 days of intermittent morphine 
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injections resulted in an elevation of GluA1, but not GluA2, in the VTA. As discussed 
above, these discrepant results may be the result of differences in self- versus 
experimenter-administered drug. Alternatively, it may be the case that the increase in 
GluA2 receptor expression observed in the current study is the results of learning that 
drug predictive cues no longer signal drug availability. Thus, increased GluA2 receptor 
expression may signal that a long-term change in synaptic plasticity has already occurred 
at glutamate synapses in the VTA. For instance, following the induction of LTP, a 
transient increase in synaptic GluA2-lacking AMPA receptor subunits is observed. 
However, these subunits are replaced by GluA2 receptor subunits following a short 
period of time (Plant et al., 2006). Thus, increased GluA2 subunits may indicate a 
strengthening of synapses in the VTA. However, the nature of this potential synaptic 
change is unclear (i.e., drug- or extinction-induced). The data also suggest that the 
observed change in the expression of GluA2 subunit in the VTA is not related to FD-
induced reinstatement, since the levels of GluA2 were not changed in FD rats.  
 The Basolateral Amygdala (BLA)  
Within the BLA, acute FD, was shown to increase GluA2 receptor 
subunit expression in the food deprived drug-naïve rats relative to sated drug-naïve 
animals. This finding is somewhat unexpected. Given that morphine-induced behavioral 
sensitization is associated with a reduction in BLA GluA2 expression (Sepehrizadeh et 
al., 2008), a drug-dependent change in GluA2 receptor-subunit expression was expected. 
However, in rats trained to self-administer cocaine and subsequently exposed to 
withdrawal, an increase in GluA1, but not GluA2, expression in the BLA was observed 
(Lu, Dempsey, Shaham, & Hope, 2005). Thus, neuroadaptions in glutamate synapses 
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may differ in animals trained to self-administer drug and animals passively exposed to 
drug. 
 Despite the extensive literature regarding the involvement of the BLA in stress 
responsivity, there appear to be no studies addressing the effect of acute stress on GluA2 
receptor subunit expression in the BLA. However, in knockout mice with a targeted 
deletion of the gene encoding the GluA2 receptor, an impairment in the performance of a 
conditional emotional response and a reduced anxiety in an elevated plus maze is 
observed (Mead et al., 2006). Thus, while GluA2 receptors are typically associated with 
an inhibition of synaptic plasticity, these receptors appear to be necessary for learning. In 
particular, as discussed above, learning depends upon the maintenance of LTP which 
relies upon GluA2-dependent trafficking of AMPA receptors to the synapse (Yao et al., 
2008). Moreover, corticosterone, which is released as a result of the HPA axis response 
to stress, has been shown to increase the trafficking of GluA2 receptors to the synapse in 
the hippocampus, a process which may also occur in the BLA (Groc, Choquet, & 
Chaouloff, 2008).  
Methodological Considerations   
 Finally, some methodological considerations should be presented.  First, beta-
tubulin was used to control for differences in the loading of samples, as is the standard 
practice (see Edwards, Graham, Whisler, & Self, 2009; Fourgeaud, 2004; Levine et al., 
2005). However, beta-tubulin is a scaffolding protein involved in the development of new 
synapses. Recently, it has been shown that tubulin is downregulated following cocaine 
self-administration and extinction (Reissner et al., 2011). In contrast, binge cocaine 
administration and chronic morphine exposure have been shown to have no effect on 
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tubulin expression in the rat (Beitner-Johnson, Guitart, & Nestler, 1992; Perrine, Miller, 
& Unterwald, 2008), and long-term heroin use has been shown to have no effect on 
tubulin in humans (Sastre, Ventayol, & García-Sevilla, 1996 but see Reynolds, Mahajan, 
Sykes, & Nair, 2006). Thus, it seems unlikely that differences in the expression of tubulin 
are masking differences in GluR subunit expression in the current study. However, it 
must be noted that a difference in tubulin express was observed in the Western 
immunoblots assessing the NR1 receptor-subunit in the NAc. This finding was surprising 
since it was not replicated in blots assessing the expression of GluA1 and GluA2 subunits 
in the same samples. I therefore believe that the observed difference in tubulin in these 
particular analyses were not due to a real effect of heroin exposure, but rather a result of a 
coincidental sample-loading-related variance.  
Second, the current analysis did not distinguish between the GluR subunit protein 
expressed on the cellular membrane and intracellular GluR expression. The actions of 
glutamate are determined by GluRs expressed at the synapse; thus, it is surface rather 
than intracellular iGluR subunits, which regulate the actions of glutamate and it is the 
trafficking of these receptors into and out of the synapse that is critical for synaptic 
plasticity (Boudreau & Wolf, 2005). Over the past few years, several methods have been 
developed that allow dissociation between membrane bound and cytoplasmic receptor 
pools. Future follow-up studies in our laboratory will utilize the BS3 protein cross-linking 
assay (Boudreau & Wolf, 2005) to address this issue, as well as assess AMPA receptor 
phosphorylation-state, as an indication of receptor functionality.   
Conclusion 
The findings of the current studies suggest a role for adaptations in glutamate 
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synapses in drug addiction. Here, I observe changes in the AMPA and NMDA receptors 
subunits, iGluRs which have been extensively investigated for their role in synaptic 
plasticity. While a significant increase in the expression of the GluA2 subunit in the BLA 
was observed in FD rats, my most interesting results relate to changes in GluA2 and NR1 
receptor expression in dmPFC, VTA, and NAc. These changes are particularly interesting 
within the context of long-term changes in synaptic plasticity, such as LTP, that may 
underlie the long-lasting risk for relapse in drug addicts.  
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The current series of experiments expand upon previous work demonstrating a 
reinstatement of heroin and cocaine seeking following acute 21-48h FD (Shalev et al., 
2000; 2001; Shalev, Marinelli, Baumann, Piazza, & Shaham, 2003; Tobin et al., 2009). 
The precise nature of this form of reinstatement has not been fully elucidated. However, 
acute FD-induced reinstatement has been conceptualized as a type of stress-induced 
reinstatement. Yet, acute FD differs substantially from footshock-induced reinstatement, 
a more common model of stress-induced relapse. In particular, acute FD-, but not 
footshock-induced reinstatement, is attenuated by systemic administration of the DA D1 
receptor antagonist SCH 23390 (Tobin et al., 2009), and central administration of the 
anorexigenic hormone, leptin (Shalev et al., 2001). Thus, in the experiments described in 
chapter 1, I administered SCH 23390 locally to elucidate the neuronal circuitry mediating 
the effect of DA, acting on the D1 receptor, in acute FD-induced reinstatement. The 
results of these experiments show that acute FD-induced reinstatement relies upon the 
activation of DA D1 receptors in the NAc shell, dmPFC, and BLA. 
Moreover, as previously discussed, drug addiction can be conceptualized as a 
perversion of normal learning resulting from maladaptive neuroplasticity (Kalivas, 2004). 
Consequently, recent research has highlighted a role for glutamate as well as an 
interaction between the DAeric and glutamatergic systems in the reinstatement of drug 
seeking behavior. Thus, in chapters 2 and 3 I investigated the role of adaptations in 
glutamatergic pathways and synapses in acute FD-induced reinstatement. These studies 
employed two distinct approaches. In chapter 2, synaptic plasticity was investigated in 
the glutamatergic projection from the vSub of the hippocampus to the NAc shell. This 
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pathway provides a direct link between the neuronal circuitry involved in memory and 
learning, and the neuronal circuitry involved in drug reward (Dong et al., 2007; Sesack & 
Grace, 2010; Setlow, 1997). In this chapter, an impairment in the induction of LTP, a 
cellular correlate of learning and memory (Bliss & Collingridge, 1993), within the vSub-
NAc shell pathway, was observed in rats exposed to 48h of FD regardless of previous 
drug history. However, amongst drug-trained rats, a significant inverse correlation was 
observed between drug seeking on the reinstatement test and the magnitude of LTP. 
Thus, acute FD-induced reinstatement of heroin seeking may depend upon changes in 
synaptic plasticity within the vSub-NAc shell pathway. As a complement to these 
findings, in chapter 3 changes in the expression of iGluR subunits, known to be 
associated with synaptic plasticity, were investigated (Malinow & Malenka, 2002). Here I 
showed a significant effect of drug history in sated, but not in FD rats, with heroin-
trained sated rats demonstrating greater GluA2 receptor subunit expression in the VTA 
compared to drug-naive sated rats. Additionally, acute FD, in the absence of drug self-
administration, increased BLA GluA2 receptor subunit expression. Furthermore, amongst 
heroin-trained food deprived rats a tendency toward a reduction in the expression of 
GluA2 and NR1 receptor subunits was observed in the dmPFC and the NAc, 
respectively.   
Collectively these studies suggest that an understanding of the role played by the 
DAergic and glutamatergic systems, as well as an understanding of the interactions 
between these systems is necessary to fully elucidate the neuronal mechanisms through 
which acute FD induces a reinstatement of heroin seeking. In particular, glutamate and 
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DA have numerous regulatory interactions and DA, predominantly acting at the D1 
receptor, has been implicated in the regulation of synaptic plasticity. 
Acute Food Deprivation-Induced Reinstatement is a Unique Form of Stress-Induced 
Reinstatement 
 Understanding the neuronal mechanisms mediating stress-induced relapse is of 
the utmost importance as stress is a frequently cited reason for relapse amongst human 
drug abusers (see Bradley, Phillips, Green, & Gossop, 1989; Litman et al., 1977; McKay 
et al., 1996; Wallace, 1989). In the rodent literature there are two main models of stress-
induced relapse: footshock-induced reinstatement (Shaham & Stewart, 1995) and acute 
FD-induced reinstatement (Shalev et al., 2000; Tobin et al., 2009). A third reinstatement 
trigger, yohimbine, a norepinephrine α2 receptor antagonist, has also been conceptualized 
as a model of stress-induced relapse. Yohimbine has been shown to reinstate cocaine 
(Kupferschmidt, Tribe, & Erb, 2009; Lee, Tiefenbacher, Platt, & Spealman, 2004), 
methamphetamine (Shepard et al., 2004), and alcohol (Dzung Lê, Funk, Harding, 
Juzytsch, & Fletcher, 2009) seeking in rodents and induce drug craving in opiate 
dependent individuals (Stine et al., 2002). However, yohimbine has been shown to 
produce anxiety and panic attacks in human drug abusers (McDougle et al., 1994; Stine et 
al., 2002). Thus, yohimbine-induced reinstatement may differ in a physiological and 
qualitative sense from ‘true’ models of stress-induced relapse.   
Furthermore, as alluded to previously, acute FD-induced reinstatement, as a 
model of stress-induced relapse, differs from other forms of reinstatement. Firstly, acute 
FD-induced reinstatement involves a single 21-48h deprivation. This timeframe contrasts 
drastically with footshock stress, which typically involves a 10-15 min intermittent stress 
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exposure (for examples see Buffalari & See, 2009; McFarland et al., 2004; Shaham & 
Stewart, 1995). Secondly, footshock stress occurs within the previously drug-paired 
context but terminates prior to the start of the reinstatement test. In contrast, rats in the 
current study remained food deprived throughout the reinstatement test. Finally, acute 
FD, unlike other forms of stress-induced reinstatement, represents a homeostatic 
metabolic challenge. As such, a period of acute 48h FD has been shown to dramatically 
reduce body weight and alter the release of neuropeptides involved in the regulation of 
feeding. For instance, rats euthanized after 48h of FD have lower levels of circulating 
leptin, glucose and insulin. Furthermore, acute 48h FD causes a significant increase in 
arcuate nucleus neuropeptide Y and agouti-related peptide mRNA, two peptides which 
stimulate appetite, and a decrease in Pro-opiomelanocortin mRNA, a peptide which 
inhibits appetite (Bi, Robinson, & Moran, 2003).  
Also relevant to the current studies is the finding that plasma leptin level and 
cerebral spinal fluid DA concentration are both reduced, in a significantly correlated 
manner, in human participants asked to fast for 12-20h, suggesting that acute FD may 
cause a reduction in the synthesis of DA (Hagan et al., 1999). These findings might 
indicate that an acute FD-induced increase in DA transmission is not involved in acute 
FD-induce reinstatement.  However, DA transmission is dependent upon other factors in 
addition to DA synthesis.  For example, acute 24-36h FD has been shown to decrease DA 
transporter (DAT) mRNA in the VTA/SN of rats. However, no change was found in the 
concentration of DAT protein (Bmax) in the major target areas of the mid-brain DA 
neurons, the NAc and dorsal striatum (Patterson et al., 1998). Surprisingly, DAT activity 
was reduced in the dorsal striatum of FD rats, suggesting that the effect of FD on the 
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function of DAT is mediated by posttranslational mechanisms, possibly through changes 
in the phosphorylation state of the DAT protein (Patterson et al., 1998). Reduced DAT 
activity in DA terminal areas could result in an overall increase in DA function due to an 
increase in the length of time DA remains in the extracellular space. It is intriguing, 
however, that no change in DAT activity was found in the NAc of the FD rats (Patterson 
et al., 1998).  This lack of effect might be explained by limitations in the method used, 
which did not allow for a differentiation between the shell and core compartments of the 
NAc, areas known to be differentially innervated by mid-brain DA neurons (Ikemoto, 
2007). 
While it is unclear to what degree acute FD and chronic food restriction are 
similar, it is worth noting that chronic food restriction augments morphine- and cocaine-
induced DA release in the NAc (Piazza & Le Moal, 1998; 1996), increases amphetamine-
induced NAc c-fos expression (Carr & Kutchukhidze, 2000), and increases self-
administration of electrical BSR (Fulton et al., 2000). Furthermore, central administration 
of leptin causes a reversal of chronic food restriction-induced sensitization of lateral 
hypothalamic BSR, possibly by interaction with DA neurons (Hommel et al., 2006). 
Similarly, leptin has been shown to block acute FD-induced reinstatement while having 
no effect on footshock- or heroin priming-induced reinstatement of heroin seeking 
(Shalev et al., 2001).  
The Relationship Between the DA D1 Receptor and Feeding 
 Given that the current studies employed acute FD and the above findings, 
demonstrating that manipulations of the DAergic system can modulate the effects of 
acute FD stress, it is interesting to consider the possibility that SCH 23390 attenuated 
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drug seeking by acting directly on the neuronal circuitry mediating feeding. For example, 
systemic administration of SCH 23390 has been shown to produce a dose-dependent 
reduction in feeding (Terry & Katz, 1992). Furthermore, treatment with SCH 23390 has 
been shown to in inhibit Tetrhydrocannabinol-induced feeding and decrease FR 
responding for food, at a drug dose that did not attenuate feeding when given alone 
(Verty, McGregor, & Mallet, 2004). Similarly, DA depletion via icv 6-OHDA infusion, 
produces a marked decrease in 24h food consumption (Breese, Smith, Cooper, & Grant, 
1973) and the DA D1 receptor agonist, SKF 38393, has been shown to increase highly 
palatable chocolate food consumption, in chronically food-restricted rats (Cooper, Al-
Naser & Clifton, 2006b). Collectively, these findings suggest that activation of the DA 
D1 receptor facilitates feeding while blocking the D1 receptor inhibits feeding. Given 
that FD is thought to increase the immediate valence of food, and presumably drug cues 
due to a shared neuronal substrate (Kenny, 2011), my findings seem to support this 
conclusion.  
However, the role of DA in feeding is not simple and presents somewhat of a 
paradox. For instance, systemic administration of the DA D1 receptor agonists SKF 
82958, SKF 77434 or SKF 38393 suppressed feeding in food restricted rats, in a manner 
which was related to their efficacy and selectivity to the DA D1 receptor. Thus, SKF 
82958 was shown to have the lowest effective dose 50 (ED50) for inducing anorexia and 
the greatest efficacy. Furthermore, SKF 82958-induced anorexia, but not anorexia 
induced by other DA D1 receptor agonists, was surmounted by the DA D1 receptor 
antagonist SCH 23390 (Terry & Katz, 1992). Thus, SKF 77434- and SKF 38393-induced 
anorexia is not mediated by the DA D1 receptor exclusively (for a discussion of the DA 
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D2 and 5-HT receptors see Terry & Katz, 1992; Zarrindast, Owji, & Hosseini-Nia, 1991). 
Similarly, the DA D1 receptor agonist, A-77636, administered just prior to the start of a 
nightly feeding period produces a reduction in meal size and duration of meal 
consumption (Cooper et al., 2006b). The apparent dissociation between the role of DA 
observed in the above studies may relate to procedural differences, such as DA agonist or 
antagonist dose, and metabolic state (i.e., food restricted or sated).  
Furthermore, the effect of systemically administered DA D1 receptor antagonists, 
on feeding behavior, may differ from the effect of these antagonists on feeding when 
administered locally, as is the case in chapter 1. The vast majority of research 
investigating DAergic modulation of feeding has focused on the role of DA in the NAc. 
For instance, microdialysis studies have shown an increase in extracellular NAc DA prior 
to lever pressing for food reinforcement (Kiyatkin & Gratton, 1994) and during food 
delivery (McCullough & Salamone, 1992). Moreover, when focusing on the differential 
role of NAc subregions, glutamate receptor antagonists or GABA agonists have been 
shown to produce an intense hyperphagia following infusion into the NAc shell, but not 
NAc core (Maldonado-Irizarry, Swanson, & Kelley, 1995; Stratford & Kelly, 1997). 
Similarly, first exposure to a highly palatable food elevates extracellular DA release to a 
much greater extent in the NAc shell than in the NAc core (Bassareo & Di Chiara, 1999). 
In contrast, conditioned stimuli associated with palatable food increase DA in the NAc 
core, but not shell (Bassareo & Di Chiara, 1999). Furthermore, antagonism of DA D1 or 
D2 receptors in the NAc shell or NAc core, with SCH 23390 or raclopride, respectively, 
has been shown to have no effect on total food intake or latency to eat in rats exposed to 
chronic food restriction. However, raclopride infusion into the NAc core and raclopride 
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or SCH 23390 infusion into the NAc shell results in a reduction in the number of feeding 
bouts with a significant increase in feeding bout duration observed following raclopride 
infusion in the NAc core and SCH 23390 infusion in the NAc shell (Baldo, Sadeghian, 
Basso, & Kelley, 2002). It is worth noting that in Baldo et al.’s (2002) study, SCH 23390 
was infused bilaterally at a dose of 1.0 or 2.0 ug/side; whereas, in the experiments 
described in chapter 1 SCH 23390 was infused at a dose of 0.3 or 0.6 ug/side. It is 
therefore unclear how SCH 23390, at the current dose range, may have affected hunger 
during the FD test.  
To the best of my knowledge, there are no reported findings on the effect of SCH 
23390 infusion into the dmPFC or BLA, on feeding. However, both the dmPFC and the 
BLA have been implicated, to some degree, in feeding. For instance, in a modified 
reinstatement model, SCH 23390 infused into the dmPFC blocked yohimbine- and pellet 
priming-induced reinstatement of food seeking (Nair et al., 2011). Furthermore, the BLA 
is implicated in neuropeptide regulation of feeding behavior and may act as a satiety 
center (Vigh, Lenard, & Fekete, 1999). Thus, intra-BLA bombesin infusion, a homologue 
of gastrin-releasing peptide, a proposed satiety signal released peripherally during 
feeding, reduces food consumption in rats that have been food deprived for 24h (Vigh et 
al., 1999). 
Acute FD-Induced Reinstatement: Potential Neuronal Circuitry 
As demonstrated in chapter 1, DA transmission within the NAc shell, dmPFC and 
BLA, is critical for the induction of acute FD-induced reinstatement. Thus, my results are 
in agreement with those of Park et al. (2002) who demonstrate the importance of DA 
transmission in the mPFC in the reinstatement of cocaine seeking. In particular, these 
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authors show that priming-induced reinstatement of cocaine seeking is blocked by intra-
mPFC administration of the mixed DA receptor antagonist, flupenthixol. Furthermore, 
this study also demonstrates that intra-mPFC or NAc injection of the DA agonist, 
cocaine, reinstates drug seeking, supporting the critical role of DA transmission in these 
regions. Moreover, intra-mPFC cocaine-induced reinstatement was blocked by infusion 
of the AMPA receptor antagonist CNQX into the NAc demonstrating the importance of a 
glutamatergic projection from the mPFC to the NAc in the reinstatement of drug seeking. 
Kalivas and his colleagues (Peters et al., 2008) have proposed a model of drug 
seeking which involves two parallel circuits: a ‘Go circuit’ involved in driving drug 
seeking, and a ‘Stop circuit’ involved in inhibiting drug seeking (Peters et al., 2008, 
2009). The ‘Go circuit’ consists of the prelimbic cortex (located in the dmPFC) and the, 
NAc core; whereas, the ‘Stop circuit’ consists of the infralimbic cortex (located in the 
vmPFC) and NAc shell. In line with this proposed circuitry, TTX infusions into the 
prelimbic cortex has been shown to block both footshock and priming-induced 
reinstatement of cocaine seeking (Capriles et al., 2003). Furthermore, in the current thesis 
and in Capriles et al.’s study (2003), infusion of SCH 23390 into the dmPFC, but not 
vmPFC, was shown to block acute FD- and footshock-induced reinstatement, 
respectively. Additionally, a direct interaction between the BLA and the NAc core, has 
been demonstrated by Di Ciano and Everitt (2004). In an elegant neuropharamacological 
disconnection study, these authors showed that unilateral infusion of α-flupenthixol, a 
non-selective DA receptor antagonist, into the BLA, and contralateral infusion of 
LY293558, an AMPA receptor antagonist, into the NAc core produced a reduction in 
cocaine seeking under a second order schedule of reinforcement. Thus, this finding in 
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conjunction with the proposed model of Kalivas and his colleagues (Peters et al., 2008, 
2009) highlight the importance of a limbic-cortical-ventral striatal circuit in drug seeking.  
 The notion of two parallel and functionally distinct circuits in drug seeking and 
the inhibition of drug seeking is intuitively appealing and relatively well supported by 
studies of reinstatement in cocaine-trained rats (see examples cited throughout this 
thesis). Furthermore, a limbic-cortical-ventral striatal drug seeking circuit supports the 
current findings with regard to the importance of the dmPFC and BLA, in acute FD-
induced reinstatement. Moreover, a role for DA in the NAc shell, rather than NAc core, 
in acute FD-induced reinstatement of heroin seeking was shown. Similarly, McFarland et 
al. (2004) have demonstrated that it is glutamate transmission in the NAc core, and not 
DA, that is critically involved in footshock-induced reinstatement of cocaine seeking. 
Finally, these authors also report that transient inactivation of the NAc shell attenuates 
footshock-induced reinstatement, suggesting a critical role for the NAc shell in stress-
induced reinstatement of drug seeking. The current results, therefore, are in good 
agreement with the model suggested by Kalivas and colleagues.  
The Gating of Glutamatergic Inputs to the NAc 
 As discussed in chapter 2, the NAc receives glutamatergic input from the mPFC, 
BLA and vSub (French & Totterdell, 2002; French et al., 2003). As a result of this 
converging information, the NAc must integrate limbic input from the BLA and vSub and 
cortical input from the mPFC (Goto & Grace, 2008). The balance between the relative 
importance of these inputs into the NAc has been shown to depend on the two activity 
states of VTA DA neurons: phasic bursting and slow tonic firing (Grace, 1991), and the 
subsequent pattern of NAc DA release. For instance, phasic DA release facilitates the 
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vSub input to the NAc, by activating DA D1 receptors. In contrast, an increase or 
decrease in tonic DA release attenuates or facilitates, respectively, mPFC input to the 
NAc (Goto & Grace, 2005a). Thus, DA transmission in the NAc serves to regulate the 
influence of input from the vSub and mPFC regions involved in context-dependent 
processing and executive functions such as action monitoring, respectively (Goto & 
Grace, 2008). It is not yet clear how tonic and phasic DA release in the NAc modulate 
sensory and emotional input from the BLA (Davis, 1992; Ledoux, 1993) to the NAc. 
However, this input has been shown to be sensitive to DA D1 receptor activation and 
antagonism (for further details see Charara & Grace, 2003).  
The regulation of glutamatergic input from the mPFC and vSub to the NAc, by 
DA receptor subtypes, suggests a DA dependent balance between mPFC control of 
behavioral flexibility and vSub control of context related behavior (Belujon & Grace, 
2008; Grace, Floresco, Goto, & Lodge, 2007). Related to these findings, cocaine 
sensitization has been shown to block vSub/CA1 stimulation-induced LTP at vSub/CA1-
NAc shell synapses and prevent vSub/CA1 stimulation-induced LTD in mPFC-NAc 
synapses. Thus, repeated cocaine exposure may disrupt cellular mechanisms involved in 
the induction of LTP. Alternatively, repeated drug use may induce an ‘LTP-like’ state in 
the vSub-NAc pathway which would prevent the induction of LTP due to the 
mechanisms of LTP already being engaged (Goto & Grace, 2005b see chapter 3 for a 
discussion of the importance of this dissociation). Similarly, an impairment in the 
induction of LTP, at vSub-NAc shell synapses, has been observed in chronically 
morphine-treated rats 12h after withdrawal. However, LTP was restored and LTD was 
impaired in this pathway following a 4-day withdrawal period (Dong et al., 2007). In 
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chapter 2, I expand upon these findings by demonstrating an impairment in the induction 
of LTP, in the vSub-NAc shell pathway, following acute FD. However, this effect was 
observed in both heroin-trained and heroin-naïve rats, suggesting that the observed 
modulation in synaptic plasticity occurred as a result of FD and was not related to 
previous drug history. 
Nevertheless, I also found an inverse correlation between LTP in the vSub-NAc 
shell pathway and active lever pressing on the reinstatement test, suggesting that acute 
FD-induced plasticity in this pathway may play an important role in the reinstatement of 
heroin seeking. Using the current experimental procedure it is not possible to say with 
certainty that the impairment in LTP-induction, observed in food deprived rats, was due 
to the previous induction of an ‘LTP-like’ state. However, it is not unreasonable to 
speculate that this indeed was the case. For instance, if acute FD does produce an ‘LTP-
like’ effect in the vSub-NAc shell pathway, it can be expected that this pathway will be 
strengthened, and as a result of this strengthening cortical regulation would be dampened. 
Related to this hypothesis, tetanic stimulation of the vSub induces an LTP of vSub-
evoked EPSPs in the NAc shell and core, as well as a persistent decrease in mPFC 
evoked NAc EPSPs (Goto & Grace, 2005a). Furthermore, inactivation of the mPFC, with 
TTX, blocks the ability of stimulation to the fimbria, which carries glutamatergic fibers 
from the vSub to the NAc, to increase spike firing in individual NAc neurons (localized 
mainly within the shell). However, following the induction of LTP in the vSub-NAc 
pathway, mPFC TTX infusion was shown to have no effect on fimbria-induced NAc 
spike firing (Belujon & Grace, 2008). Thus, it appears that mPFC initially plays a 
permissive role in allowing the vSub to stimulate the NAc; however, following repeated 
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activation of this pathway the mPFC no longer exerts control over the functioning of the 
vSub-NAc pathway allowing for a reduction in cortical control of contextually driven 
behavior (Belujon & Grace, 2008). Related to this finding, the transition from voluntary 
drug use, motivated by the acutely rewarding effects of the drug, to more compulsive and 
habitual drug use, as is the case in drug addiction, involves a shift away from cortical 
control of behavior (Everitt & Robbins, 2005).  
The Involvement of DA in the Trafficking of iGluR Subunits  
 The interaction between DA and glutamate systems is likely mediated, at least in 
part, by the downstream effects of DA D1 receptor activation.  For example, within the 
NAc, stimulation of DA D1 receptors activates cAMP, a second messenger involved in 
intracellular signal transduction, and PKA, a family of enzymes activated by cAMP and 
critical to protein phosphorylation (Anderson et al., 2008). Activation or inactivation of 
NAc PKA has been shown to increase and decrease, respectively, responding for cocaine 
on a progressive ratio schedule of reinforcement (Lynch & Taylor, 2005). Moreover, 
inactivation of NAc PKA has been shown to reduce cocaine self-administration, shift the 
dose response curve for cocaine to the left, and reinstate drug seeking in abstinent rats 
(Stewart & Vezina, 1988). The intracellular effects of NAc PKA are numerous; however, 
a particularly interesting target of PKA is voltage-gated L-type calcium channels. 
Calcium influx through these channels activates the CaMKII, which play a central role in 
transporting AMPA glutamate receptors, particularly the GluA1 receptor subunit, to the 
surface of the cellular membrane (Anderson et al., 2008; Boehm & Malinow, 2005). The 
relevance of these effects to drug seeking has been demonstrated by Anderson et al. 
(2008) who have reported that the reinstatement of cocaine seeking is associated with a 
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DA D1 receptor dependent increase in NAc shell CaMKII and an increase in membrane 
surface GluA1 receptor expression. Furthermore, these authors have shown that 
impairing the transport of the GluA1 receptor subunit causes an attenuation of cocaine 
seeking.  
Acute FD-Induced Reinstatement and iGluR trafficking 
Interestingly, no change in GluA1 receptor subunit expression in the NAc, or in 
any of the other regions investigated was observed in the current manipulation. This lack 
of effect may be the result of a pharmacological difference between repeated cocaine and 
heroin self-administration. An indication that this may be the case comes from studies 
addressing drug-induced changes in dendritic spine morphology, a reflection of synaptic 
strength (Alvarez & Sabatini, 2007; Holtmaat & Svoboda, 2009). For instance, stimulant 
drugs increase dendritic spine density in the NAc and mPFC; whereas, the opiate drug 
morphine decreases spine density in these regions (Robinson & Kolb, 2004). 
Furthermore, as discussed in chapter 3, I assessed total iGluR subunit expression, rather 
than membrane surface and intracellular iGluR subunit expression. Thus, a change in the 
configuration of membrane-embedded AMPA receptors might not be reflected in the 
amount of receptor subunit expressed in the whole cell. However, a near significant 
reduction in NR1 receptor subunit expression in the NAc of heroin-trained food deprived 
rats relative to heroin-trained sated rats was observed. As the NR1 subunit is an 
obligatory subunit of the NMDA receptor (Gass & Olive, 2008) this indicates a probable 
reduction in NMDA receptors within the NAc of heroin-trained rats exposed to acute FD. 
Interestingly, NAc infusion of the NMDA receptor antagonist, AP-5, dose dependently 
increases cocaine self-administration, suggesting a reduction in the rewarding value of 
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cocaine, but has no effect on ongoing heroin self-administration (Pulvirenti, Maldonado-
Lopez, & Koob, 1992). Moreover, AP-5 causes a dose dependent potentiation of restraint 
stress-induced DA release in the NAc (Doherty & Gratton, 1997). In contrast to my 
findings, NAc NR1 receptor subunit expression is not altered following priming-induced 
reinstatement of an amphetamine induced CPP; however, GluA1 receptor subunit 
expression is decreased (Cruz, Marin, & Planeta, 2008). Thus, it may be the case the NR1 
receptor subunit is selectively involved in stress-induced reinstatement. It is tempting to 
suggest the existence of a relationship between the reduction in NAc NR1 receptors, 
observed following acute FD-induced reinstatement, and activation of DA D1 receptors. 
However, existing evidence, although supporting NMDA-DA D1 receptor interactions, 
suggests a synergistic, rather than opposing effect. Thus, it has been demonstrated that in 
the striatum, DA D1 receptors are co-localized with NMDA receptors (Fiorentini, 
Gardoni, Spano, Di Luca & Missale, 2003).  
However, in neostriatal slice preparations, DA and DA D1 receptor agonists have 
been shown to potentiate responses made by activation of NMDA receptors, an effect 
which is markedly decreased in mutant mice lacking the DA D1 receptor (Levine et al., 
1996). Furthermore, activation of neostriatal NMDA receptors has been shown to recruit 
functional DA D1, but not DA D2, receptors to the plasma membrane (Scott et al., 2002). 
It is possible, though, that opiate drugs, which do not act directly on DA neurons, have a 
different impact on NMDA receptors.   
In addition to a potential change in the expression of the NR1 receptor subunit I 
also found a significant increase in GluA2 receptor subunit expression in the BLA of 
drug-naïve food deprived rats, relative to drug-naïve sated rats, and a significant increase 
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in GluA2 receptor subunit expression in the VTA of heroin-trained sated rats relative to 
drug naïve sated rats. Finally, a tendency toward a reduction in GluA2 receptor subunit 
expression was observed in the dmPFC of heroin-trained food deprived rats relative to 
heroin-trained sated rats. Changes in the GluA2 AMPA receptor subunit are of particular 
interest because as mentioned in the introduction, this subunit regulates AMPA receptor 
calcium permeability (Derkach et al. 2007; Gass & Olive, 2008; Hollmann et al., 1991, 
Vandenberghe, et al., 2000). Although there are a few exceptions (see Dickinson et al., 
2009; Fitzjohn et al., 2001), it is widely accepted that synaptic plasticity, both LTP and 
LTD, rely upon calcium-dependent mechanisms (Kerrigan, Daniel, Regan, & Cho, 2012; 
Malenka, 1994). Thus, the presence or absence of the AMPA GluA2 receptor subunit 
prevents or allows for calcium influx through the AMPA receptor (Mead & Stephens, 
2003). AMPA receptor mediated calcium influx can influence synaptic plastic by 
regulating AMPA receptor trafficking, thereby producing long-term changes in synaptic 
strength, and/or can induce a change in the subunits of the AMPA receptor, thereby 
modifying the electrophysiological properties of the AMPA receptor (Liu & Zukin, 
2007).  
During the induction of LTP, GluA2-lacking receptors are transiently 
incorporated into the synapse; however, following the induction of LTP there is an 
increase in GluA2-containing AMPA receptors (Plant et al., 2006).  Thus, an increase in 
the expression of the GluA2 receptor subunit, within a particular region, may indicate a 
strengthening of synapses within this area. In the current study, the increased expression 
of the GluA2 subunit, within the BLA, was observed only in the food-deprived drug-
naive, but not the heroin-trained rats, suggesting that drug self-administration might 
 179 
interfere with this FD-induced adaptation.  
In contrast, the finding of an increase in GluA2 receptor subunit expression in the 
VTA of heroin-trained sated rats relative to drug-naive sated rats suggests that FD stress 
reverses the heroin-induced increased expression of GluA2 subunits in this area, or 
blocks the changes in GluA2 subunit expression that occur following exposure to the 
drug self-administration environment. The former idea is in agreement with the reported 
increase in VTA GluA2 receptor subunit expression in cocaine-trained rats, that is found 
following 30 days of forced abstinence (Lu, Grimm, Shaham, & Hope, 2003).  
Finally, within the dmPFC, a tendency toward a reduction in GluA2 receptor 
subunit expression was observed in heroin-trained food deprived rats compared to heroin-
trained sated rats. Similarly, cue-induced reinstatement of heroin seeking is associated 
with a reduction in GluR2 receptor subunit expression and a decrease in synaptic strength 
in mPFC pyramidal neurons, which was indicated by a reduction in AMPA/NMDA 
current ratio (Van den Oever et al., 2008). Unfortunately, these authors do not distinguish 
between dmPFC and vmPFC with regard to the GluA2 receptor subunit. However, they 
do show that blocking GluA2 receptor endocytosis in the ventral, but not dorsal, mPFC 
attenuates cue-induced reinstatement. Thus, these authors suggest a critical role for 
endocytosis of the GluA2 subunit in the vmPFC, i.e., increased proportion of GluA2-
lacking AMPA receptors, in cue-induced reinstatement. The current findings suggest an 
important role for dmPFC GluA2-lacking AMPA receptors in acute FD-induced 
reinstatement of heroin seeking; however, I cannot comment on the involvement of the 




The results of the current thesis do no fully elucidate the neuronal circuitry 
involved in acute FD-induced reinstatement of heroin seeking; however, it does highlight 
several key components of this circuitry. In particular, the current study highlights the 
importance of DA acting at the D1 receptor in the NAc shell, dmPFC, and BLA, but not 
the NAc core or vmPFC. As discussed previously, acute FD has been shown to have a 
direct effect on the neuronal circuitry mediating reward. Thus, acute FD may enhance the 
effect of DA in the NAc in response to drug associated cues. Furthermore, the actions of 
DA, at the D1 receptor, in acute FD-induced reinstatement are likely mediated by an 
interaction between DA and glutamate. As evidence of the importance of glutamatergic 
inputs to the NAc, a change in synaptic plasticity in the gltuamatergic projection from the 
vSub to the NAc shell following acute FD was observed. Furthermore, it appears that 
acute FD and heroin self-administration serve to modify the expression of iGluR subunits 
in the BLA, VTA and dmPFC. In particular, acute FD is associated with changes, or the 
blocking of changes, in the AMPA GluA2 receptor subunit, the subunit that regulates the 
calcium permeability of AMPA receptors. Thus, acute FD stress may lead to changes in 
iGluR subunit expression, which contributes to the facilitation and inhibition of synaptic 
plasticity.  
In order to further elucidate the interaction between DA and glutamate in acute 
FD-induced reinstatement of heroin seeking, future studies should investigate synaptic 
plasticity and iGluR subunit expression, in rats treated with the DA D1 receptor 
antagonist SCH 23390, prior to being tested for acute FD-induced reinstatement. Studies 
of this nature could demonstrate a functional link between DA acting at the D1 receptor 
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and drug- or FD-induced changes in glutamate synapses. Furthermore, to ensure that the 
methodology employed in the current studies did not obscure changes in iGluR subunit 
membrane expression or phosphorylation, future studies should include a measure of 
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